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CHAPTER ONE
INTRODUCTION

1

A.
1.

Termino1..2.g:£

Types Qf Biological Rhythms
Halberg (1959) differentiates the terms "rhythm"

and "biorhythm" by defining a rhythm as a "statistically
validated physiologic change recurring with a reproducible waveform" and by defining "biorhythm" as a rhythm
"which persists under a variety of test conditions, such
as blinding, constancy (as far as possible) with respect

•

to light (or darkness), and environmental temperature, as
well as ad libitum feeding or other conditions and schedules".

The frequency or period of a rhythm may be in-

dicated by the adjective preceding it

(~infra).

The word "circadian" is derived from the Latin
circa~.

which means "about one day".

This term refers

to rhythms having a period of 20-28 hours and a frequency
of about one cycle per day (Halberg, 1959).

Subsequently,

this term was used by some workers only in reference to
those rhythms which are endogenous and have a characteristic free-running pattern (Aschoff, 1960; Pittendrigh,
1960).

The term "diurnal" was then used to indicate

rhythms which had only been
measured on a 24-hour basis,
t
but it is ambiguous due to its secondary meaning of
"daily" as opposed to nocturnal, or nightly.

Halberg

(1963a) and Mills (1966) consider the use of the term

2

"diurnal" inappropriate because of this lack of clarity.
wurtman (1967) criticized the ambiguous use of the term
"circadian" and suggested that it be restricted only to
those studies which qualify as free-running as determined
by continuous monitoring.

He suggested that the use of

the term "daily rhythm" or "24-hour rhythm" be utilized
to refer to those systems which are sampled on a single
24-hour cycle.
Halberg has also coined other terms to refer to

•

those rhythms which are non-circadian.

The roots of

these terms are based on the common prefixes used in
physics with reference to light spectra.

Ultradian

rhythms are those which have a frequency greater than one
cycle per day, or a period of between one and 19.9 hours
(Halberg, Engeli, Hamburger, and Hillman, 1965).

The

term "infradian" refers to a rhythm with a frequency of
less than one cycle per day, or a period of greater than
28.5 hours (Halberg and Reinberg, 1967).
In addition to these common types of rhythms,
Halberg and Reinberg (1967) have subdivided physiological
rhythms as follows:

"1) a high frequency domain of

rhythms with periods

sho~ter

than 0.5 hours; 2) a medial

frequency domain of rhythms with periods ranging in length
from 0.5 hours to 2.5 days, including the regions of ultradian (periods of 0.5 - 19.9 hours), circadian (periods

from

20~28

hours), and infradian (28.5 hours - 2.5 days)

rhythms; 3) a low frequency domain of rhythms with periods
longer than 2.5 days:

inter alia, circasepten (with a

period of approximately 7 days), circavigintan (with a
period of approximately 20 days), circatrigintan (a period of approximately 30 days), and circannual (a period of
approximately one year) rhythms".
2.

Other Terminology ~ 1.!! Reference
to Biological .,:Ehythms
The term "cycle" refers to the smallest part of a

rhythm which repeats itself.

A period is the time in-

terval occupied by a single cycle.

The frequency of a

rhythm refers to the number of cycles produced in a given
time period.

Exogenous rhythms are those rhythms which

may be altered by alteration of environmental parameters,
whereas endogenous rhythms are those which persist under
conditions of constant environmental factors, such as
constant light or darkness.

These latter rhythms are

also referred to as "free-running" (Mills, 1966).

Phase-

shifting is a term used to describe manipulations of the
synchronization routine, which may lead to a shifting of
the rhythms along the time axis.

A sudden shift of twelve

hours in a controlled environmental parameter is generally
described as inversion.

Zeitgeber (sometimes used in the

German form as a tribute to Aschoff), or entraining agents

4

(Pittendrigh, 1960) are terms referring to those environmental factors which are important in setting the phase
of a biological rhythm, such as light, temperature, noise
cues, feeding schedules, etc.

3.

Circadian Versus Local

~

The time axis of any study of rhythms can be expressed by either circadian time or local clock time.
Circadian

~

is based on a time scale utilizing dawn,

or first light ex,osure as time zero.

This method of

temporal expression is often used by authors in the study
of biological rhythms in lower animal forms.
~

Local clock

(eg. Central Standard Time, CST, in this area) will

be used throughout this thesis for two reasons:

1) the

animals used for these studies were purchased from commercial breeders, and their first exposure to light is
therefore unknown, and 2) this type of data is more readily
appreciated when expressed on a clock time basis.
B.

Historical Aspects

The first known publication in the area of the
physiological effects of light was a book written by J.
~

Ebermaier, the court-bookseller of Osnabruck, Germany,
entitled "Versuch einer Geschichte des Lichtes in Rucksicht seines Einflusses auf die gesamte Natur, und auf

c.
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den menschlichen Korper, auber dem Gesicht, besonders."*
(Ebermaier, 1799).

This book dealt with the effects of

light on human subjects as well as with the concepts of
circadian and seasonal rhythms in humans.

M. Deyeux (1815)

published a doctoral thesis dealing with body temperature
variations on a 24-hour basis in human subjects.

Many

studies on body temperature fluctuation followed this
initial work of Deyeux's, and by 1925 investigators had
examined variability in such phenomena as urinary ex-

•

cretion, excretory rhythms, gonadal weights, and the influence of day-length on migrational habits of birds
(Lahr, 1889; Campbell and Webster, 1921, 1922; Simpson,
1924; Rowan, 1925).

Cannon's concept of homeostasis was

eventually modified to envisage a constantly changing
milieu rather than a static condition, and this milieu
was believed

~o

have a predominently circadian rhythm,

which included some components of shorter or longer duration.

In August 1937, the Society for Biological Rhythms

held its first meeting at Ronneby, Sweden (Mills, 1966).
The more recent studies in this field will be considered in the Review of Literature.

*"An essay on the history of light, concerned with its
influence on man, with or without the sense of sight."

6

C.

Practical Considerations

Environmental alterations will often reflect themselves in the life patterns of the organism.

In the case

of man, there are variable environmental exposures such as
the equivalent periods of light or darkness found at the
equator as opposed to the long midsummer and midwinter
periods of light or darkness at the poles.

Thus, dif-

ferent populations are out of phase with one another
(Mills, 1966).

TAese differences presented very little

problem to man until he improved travel to speeds which
were faster than his capability to adapt to a new environment.

When man flies at supersonic speeds, he may cross

several time zones, and he subsequently must adapt his internal milieu to a new pattern.

In long distance flights,

70% of the travelers experience some physiological discomfort.

Stru.ghold (1962) has termed this condition

"asynchronosis", and it is exhibited by most higher mammals traversing four or more time zones in succession.

He

suggests three possible prophylactic measures for this prob1 em:

"1) arrive at one's destination several days in ad-

vance and allow the biological system to adjust rhythmically to the environment: 2) pre-adaptation or pre-flight
synchronization by initiating a sleep/wake schedule identical to that at the point of destination several days

7

before travel, or 3) the use of mild drugs to accelerate
the physiological adjustment".

However, "asynchronosis"

may also be used by some companies to accelerate the retirement of executives.

This is accomplished by extended

global travel for the executive, without allowing proper
time for adjustment to the local rhythms (Parkinson, 1957).
These environmental problems also affect pilot
efficiency.

Crane (1963)

has described a higher inci-

dence of flight accidents at night than during the day.
0

The increased accident rate coincides with the trough of
mental and psychomotor efficiency in man (Browne, 1961).
Klein et.!!:!• (1970) have noted that pilots exhibit a circadian pattern when tested on a supersonic simulator.

The

peak and trough of this pattern occur at 2-3 pm and 4-5 am
respectively.

Eastward, but not westward, flight patterns

also caused decreased efficiency due to the increased
sleep loss manifested by pilots traveling eastward.
During space travel, man encounters a day of 1.5
hours duration.

This has led to work/sleep cycle prob-

lems in the Apollo space program.

On Apollo 7, cycles

were quite irregular and the crew was poorly adapted.
commander fell asleep

d~ing

The

his watch, while another crew

member was taking d-amphetamine to stay alert during his
work period.

On Apollo 8, sleep period scheduling was

8

left at the option of the crew.

Secobarbital was included

in the medical kit to aid in sedation for the sleep periods.

Sleep cycles still varied markedly from the orig-

inal patterns of the crew, and crew fatigue led to procedural errors and forced "time-changes" in the flight
plan.

Apollo missions 9 and 10 allowed the crew to sleep

simultaneously.

This improvement was a factor in the

ability of these crews to maintain their original sleep
patterns.

On the Apollo 11 mission, the crew slept well

•

except for the period of time spent by two of the crewmembers in the lunar module (LM).

The environment was

too noisy and the space suits were too cold to allow adequate sleep.

The LM commander had little, if any, sleep;

the LM pilot estimated his sleeping time at two hours
(Berry, 1970).
Such studies indicate the need to develop techniques that minimize the undesirable physiological distress associated with man's biological clock, when it is
forced to run out of phase with its "normal" environment.

CHAPTER TWO
REVIEW OF LITERATURE

10

A.

Parameters AffectiQg Biological Rhythms

The synchronization of circadian rhythms has been
explained by various mechanisms.

One theory (Bunning,

1964) proposed that rhythms are acquired by evolutionary
selection, while another (Went, 1960) deals with the possibility of rate-limiting feedback steps, which are selflimiting within a given oscillatory range.

A third (Brown,

1960) has been proposed which suggests that circadian
rhythms are contrelled from the surrounding environment
by both strong synchronizers (Zeitgeber), eg. light, and
weak synchronizers, eg. barometric pressure (cf. Sollberger, 1969).

Some of these parameters and their influ-

ence on biological rhythms will be considered.
1.

Temperature
The effects of ambient temperature on circadian

oscillations appear to be minimal within a 5-10° F.
range from the normal environmental temperature.

Harker

(1958) showed that changes of 5-10° F. in ambient temperature cause no alteration in circadian patterns; however,
Brown and Webb (1948) have shown that a large temperature change (to an envirpnmental temperature of

o°

C.) can

result in delay of the diurnal color changes in Uca pugnax,
a species of crab.

It appears that temperature changes

might become a strong synchronizing factor if they are

L

sufficiently altered, but small fluctuations in temperature appear to have no effect on biological rhythms
(Sollberger, 1969).
A body temperature rhythm is exhibited by many
mammalian species, and one might question whether this
rhythm is a cause or an effect of the various circadian
oscillations.
Body temperature results from the balance between
heat production and
heat loss.
0

Heat production varies in

a circadian fashion and is directly proportional to the
body temperature rhythm (Bornstein and Volker, 1926).
Kleitman and Ramsaroop (1948) noted similarities in the
rhythm of body temperature and heart rate.

They admin-

istered thyroid hormone over a two week period, and
noted a definite association between the pulse rate and
the body temperature, Kleitman (1949) demonstrated that
the body temperature rhythm of the rabbit is associated
with the feeding pattern.

The rhythm in mouse rectal

temperature has been associated with the motor activity
rhythm (Halberg, 1959).

This investigation has shown

that artificial alterations of body temperature have no
effect on the activity nhythm.

Brahmachary (1967) sug-

gested that the motor activity rhythm is a primary rhythm,
and that the body temperature follows the metabolic activity associated with this primary rhythm.

12

It is interesting to digress and consider the
Feldberg hypothesis concerning temperature regulation.
Feldberg and Myers (1964) noted that application of 5-HT
close to the hypothalamus increases body temperature,
whereas that of norepinephrine (NE) decreases body temperature.

They suggested that the biogenic amines might

be directly concerned with the control of body temperature.
To summarize, the body temperature rhythm is an
effect rather than a cause of the various circadian os-

•

cillations; it is also possible that alterations of biogenie amine levels in the vicinity of the "temperature
control center" of the hypothalamus are responsible for
this rhythm.
2.

Illumination
The influence of illumination on biological rhythms

should be considered with regard to photoperiod, intensity,
and spectrum of the light. source.
The importance of photoperiod as a primary
geber is discussed extensively by Aschoff (1960).

~

The

connection between the illumination period and the many
light-related circadian variables has been developed in
recent years.

The effects of light are believed to be

mediated via the pineal gland in mammals (Wurtman et al.,
1968a).

Continual light or increased timing of
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photoperiods results in decreased pineal weight, decreased
size of the pineal parenchymal cells, decreased pineal
lipids, and a loss of the gonadal inhibitory effects of
the pineal (cf. Reiter and Fraschini, 1969).

The in-

fluence of the pineal gland on body growth, pituitary,
adrenal, thyroidal, and gonadal function has been pointed
out by these investigators.

The pathway for the light-

mediated effects on the pineal appears to be mediated via
the retina, inferior accessory optic tract, and posto

ganglionic sympathetic fibers from the superior cervical
ganglion to the pineal gland (Kappers, 1960; Moore et al.,
1968).

Taylor and Wilson (1970) recently demonstrated

the inhibitory actions of light on the electrophysiologically-recorded impulses from the pineal gland.

They have

also confirmed the pathway proposed by Moore et al. (1968)
by the use of photic alteration and ganglion-blocking
drugs.

Light entering the eyes is the important factor

in this pathway, although light, which directly penetrates
the skull, cannot be discounted (Lisk and Kannwischer,
1964).
The effects of light intensity on circadian periodicity has not been examined as extensively as those of
'
the photoperiod. The intensity of light in most artificially-lit animal rooms ranges from 10-150 foot-candles.
Reiter (1969) demonstrated that these levels of

l~ght

are
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inhibitory to the pineal gland.
Marshall and Bowden (1936) described the effects
of various wavelengths of liBht on the timing of the
ferret sexual cycle.

They found that estrus began ear-

lier in the season in animals exposed to ultraviolet
0

light (3650 A.), while heat rays and infrared illumination
have no effect on this cycle.

A similar study by Luce-

Clausen and Brown (1939) indicated delayed onset of estrus
in rats bred in darkness; normal onset of estrus oc-

•

curred in rats exposed to visible or infrared illumination.

Ott (1964) described some effects of spectral al-

terations on cells in tissue culture, and on reproductive characteristics and sexual ratio of offspring in
both fish and mice.

Spalding et al. (1969) described

the spectral effects of light on motor activity in albino
mice.

They noted that the lowest activity occurred in

mice exposed to blue or green light, or daylight; intermediate activity occurred under yellow, and the highest
activity was noted in either red light or darkness.

The

retinal receptors of this nocturnal species are mainly
composed of rods, which contain a red substance, rhodopsin.

This substance

regio~s

except red.

ab~orbs

in all of the spectral

Thus, the red light spectrun is

practically equivalent to darkness in this species, (cf.
Spalding~~.,

1969).

Wurtman and Weisel (1969) noted
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that rats reared under Vita-Lite (93% of daylight spectrum) have larger gonads and smaller spleens than those
reared under a conventional cool-white fluorescent source.

3.

Barometric Pressure
Harker (1958) described barometric pressure as a

weak synchronizer, suggesting that although it is incapable of controlling a circadian rhythm, it might have an
influence on an existing rhythm.
that an increase

~n

Brown (1954) proposed

the respiratory rates of various

species of crabs and salamanders is caused by an increase
in the rate of barometric pressure change.

Brown et al.

(1956a) also noted a direct relationship between the
activity of oysters and rate of environmental pressure
changes.

Hayden and Lindberg (1969) demonstrated that a

body temperature circadian rhythm can be entrained in
pocket mice (Perognathus longimembria) by fluctuations
in ambient barometric pressure in the face of constant
ambient temperature and darkness.

However, positive en-

trainment was obtained in only 50% of the mice tested,
and the investigators have concluded that the "normal
daily cycle of barometric pressure is probably seldom,
(

if ever, an adequate synchronizing agent for circadian
rhythms".
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4.

Sound
Halberg~

al. (1954) hold that the sound due to the

activity of normal mice has an effect on the activity of
blind mice.

However, the influence of sound on biological

rhythms has rarely been studied.

In 1966, "the first clear

demonstration that a biological clock can be influenced by
sound" was presented by Menaker and Eskin.

They used re-

corded bird songs to entrain activity rhythms in sparrows.
It is apparent that sound might be a weak synchronizer •

•

5.

Feeding Habits
Alterations in feeding patterns have been suggested

to cause circadian fluctuations.

Calhoun (1945) demon-

strated that altered motor activity in rodents can occur
by changes in feeding schedules..

Stein ( 1951) noted that

feeding rhythms in birds will persist in constant light or
darkness, even though the sleep pattern has been altered.
Harker (1958) proposed that feeding schedules might change
biological rhythms associated with motor activity and metabolism in mammals.

Honova and co-workers (1968) suggested

that the rhythm in the activity of tyrosine transaminase
might be controlled by the feeding pattern in both rats
and humans.

~

Rohles and Osbaldiston (1969) noted that the

feeding patterns in monkeys are independent of light and
temperature, but appear to be related to social entrainment.

Thus, feeding habits appear to be a weak
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synchronizer in biological oscillations.

However, more

extensive studies involving mammals maintained in the absence of temperature and light fluctuations are not available.
6.

Popula.1:!:..2n
The size of the group of animals used in a circadi-

an study might have a weak effect on synchronization of the
biological rhythm.
Studies in°insects such as the beetle (Park and
Sejba, 1935) and the fruitfly (Harker, 1958) indicated
that insect activity might be related to the size of the
population.

Isolation produces aggressive behavior in

mice, which is accompanied by changes in serotonin metabolism (Valzelli and Garattini, 1967).

These changes in

5-HT metabolism could alter the sleep/wakefulness cycle.
The possible role of 5-HT in sleep will be considered
elsewhere

(~infra).

Harker (1958) noted a reversal

of motor activity in those rats, which are low in the
social order of their colony.

Rohles and Osbaldiston

(1969) noted that the individual feeding rhythms of two
isolated monkeys coincided when the animals were placed
(

together.

They attribute this alteration to the social

entrainment of the feeding rhythm, and they intimate that
social entrainment might be as important as light or temperature for rhythm entrainment.

Quay and co-workers

18
(1969) examined the effects that population factors of the
environment had on the CNS.

They found that isolated rats

have greater body pineal gland weights, and a higher
ratio of pineal to brain weight than do grouped animals.
Grouped animals exhibited a greater mean cerebral cortical
weight than the isolated animals.

No difference was noted

in the concentration of pineal 5-HT or in the pineal activity of acetylserotonin methyltransferase (HIOMT) between grouped and isolated rats, but differences in brain

•

acetycholinesterase were noted.

The ratio of cortical

AChE/ChE decreased in grouped rats; the critical mass for
this change appears to be 3-4 rats/cage regardless of
cage dimension.
7.

Species
The species of an organism appears to have some

bearing on the nature of its biological rhythm, eg. man
exhibits a diurnal pattern, whereas rodent species exhibit a nocturnal one (Harker, 1958).

The ability of

various animal species to adapt to altered photoperiods
is also reflected by the species involved.

Phase-

shifting leads to a resynchronization of the biological
~

rhythms in two days in spiders (Aschoff, 1963), while
about three weeks are required for this process in mice
and rats (Massarelli

et~.,

1970).

However,
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resynchronization time is not constant for all rat species
(Kleitman, 1949).
8.

~

Sex hormones can affect circadian oscillations.
Slonaker (1912) demonstrated that motor activity in the
rat increased during the estrus cycle and was maximal at
the peak of estrus.

Colvin and co-workers (1968) noted

circadian alterations in sleep/wakefulness cycles superimposed on the

e~rus

cycle.

By means of chronically im-

planted electrodes, they monitored females and found that
the pre-estrus rat exhibits paradoxical sleep in the afternoon followed by an alert pattern in the evening.

The

day of vaginal cornification is marked by a high percentage of paradoxical sleep after a night in which ther.e
is no paradoxical sleep and the animal is alert.

The in-

vestigators state that "hormonal changes during the day
of proestrus appear to increase alertness that night, compensated by an increase in sleep, especially paradoxical
sleep, the following day'1 •

It is apparent that monthly

rhythms influence circadian ones.

9.

Other Influences .QQtBiological Rhythms
Kleitman (1949) described many periodic phenomena

related to lunar variations, eg. 1) the severity of scarlet fever is related to the blood pH, which exhibits a
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rhythm that correlates with the lunar phase, 2) epileptic
attacks are more frequent during the full moon, 3) more
male and fewer female deaths occur during the period of
the full moon.

Brown and co-workers (1956b) reported

that male rats in a continuous dim light environment exhibited greater motor activity when the moon was below the
horizon.·
Brown's group have proposed the presence of an "internal clock", bY.0 which biological rhythms are controlled
independently from environmental time-signals.

Various

atmospheric rhythms have been proposed to control this
"internal clock".
~.

The color change rhythm of the crab,

exhibits a tidal rhythm as does its daily oxygen

consumption rate.

Oysters from New Haven, Conn. were ship-

ped to Evanston, Ill. for such an experiment.

The open-

ing of their valves was timed to the lunar cycle of New
Haven for two weeks until they phase-shifted to the Evanston lunar cycle (cf. Harker, 1958)0

Some correlation

has also been noted between cosmic ray cycles and metabolic cycles (Brown et al., 1958).

Terrestrial magnetism

has also been shown to fluctuate rhythmically with solar
and lunar periods.

Thetdirectional movement of the mud

snail Nassarius has been shown to be related to this magnetic-lunar cycle (Brown et al., 1960).
Olfaction has been included because of a report in
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the literature concerning the relationship between pineal
gland activity and olfactory stimulation.

Miline et al.

(1963) exposed rats to the pungent odor of isonitrile for
six hours, and noted atrophic alterations of the pineal
parenchymal cells.
The aforementioned factors might function as underlying rhythms which are responsible for some of the biological variations associated with circadian oscillations.
B. •Cyclic Patterns in Mammals
1.

Rhythms in Physiological Activity
Circadian rhythms in motor activity have been

studied extensively in the mouse (Davis, 1933; Johnson,
1939; Park and Woods, 1940; Saelens et al., 1968) and the
rat (Slonaker, 1912; Shirley, 1928; Browman, 1937; Quay,
1970).

These investigators established that rodents are

nocturnal animals with motor activity peaks during the dark
phase of an illumination cycle.

Holmquest and co-workers

(1966) defined the relationship in rats between motor activity and body weight as well as adrenal function.

After

forty days of random illumination, activity rhythms were
lost with no effect on

~he

steady rise of body weight and

no effect on the weights of the endocrine organs.

Quay

(1970) described the effects of pinealectomy on the motor
activity rhythms in the rat.

He noted that both normal and
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pinealectomized rats will reverse their activity rhythms in
response to photoperiod reversal, but there was a difference
between the two groups with regard to the characteristics
of the phase-shifting response.
Curtis (1937) reported motor activity rhythms for
both the sheep and the pig; these marnraals exhibit peak
activity during the day.

Lindsley et al. (1964) initiated

a diurnal motor activity rhythm in infant monkeys that had
lived in darkness for three years.

This rhythm took from

0

3-5 weeks for stabilization following the initiation of a
standard light period.

Winget et al. ( 1 969) described the

correlation between the diurnal motor activity rhythm of
the monkey and its deep body temperature rhythm.

These

workers view the two rhythms as coupled oscillators ("oscillators which are normally synchronized, but may oscillate independently of each.other"), which is the same situation that exists in man between human body temperature and
activity

(Aschoff~

al., 1967).

In summary, man, sheep,

pig, and monkey are all diurnal species, while the rat and
the mouse are among the nocturnal species.
Hoshizaki

~

!!1.· (1969) demonstrated circadian as-

pects of electroencephalographic patterns, cardiovascular
~

responses, respiration, and food and water intake in the
monkey.

They noted that the EEG generally shows a waking

pattern during the light phase and a sleeping pattern in
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the dark phase.

They noted peaks of the ECG and blood

pressure curves during the light hours.
peared to peak during the dark phase.

Respiration apFood and water con-

sumption were greater during the light phase.
Rats exhibit a circadian rhythm with regard to selfinduced hypothalamic and septal reinforcing brain stimulation (Terman and Terman, 1970).

This study was conducted

in constant light, sound, temperature, and humidity.

The

rhythms were similar to those normally seen for mo.tor ac-

•

tivity in rodents.

Sofia and Salama (1970) demonstrated a

circadian rhythm for shock-induced aggressive behavior in
mice.

This rhythm coincides with the locomotor activity

rhythm in mice, and it appeared to be exogenous in nature
because it is lost under continuous illumination.
One can generalize that in a given species, most of
the physiological parameters appear to peak concomitantly
with the peak of motor activity.
2.

Rhythms Involving Hormone Levels of Blood

~

Urine

Circadian variations .in the levels of plasma 17hydroxycorticosteroids (17-0HCS) have been well documented
in the human and many species (cf. Krieger, 1970).

This

(

biological fluctuation in 17-0HCS levels mimics the rhythm
noted for plasma adrenocorticotrophic hormone (ACTH) levels.
Since the rhythm of ACTH levels is noted in the absence of
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adrenal tissue, it is assumed that the circadian periodicity of plasma 17-0HCS is secondary to that of the ACTH
levels (cf. Krieger, 1970).
In man, the rhythm in 17-0HCS levels peaks in the
early morning hours, while in nocturnal animals, eg. rat,
the rhythm peaks in the early evening hours.

The rhythm

can be reversed within eight days in either species by a
reversal of the photoperiod (cf. Krieger, 1970).

The

human infant, who exhibits an inconsistent sleep pattern,

•

does not exhibit a circadian cycle in the levels of 170HCS.

This cycle is developed between 3 and 13 years of

age, and its development lags behind the development of a
circadian sleep/wakefulness cycle, which occurs at 5-8
months of age (Franks, 1967).

However, the infant monkey

exhibits a circadian pattern for 17-0HCS levels in the
first week of life

(Bowman~

al., 1970).

The rhythm in plasma 17-0HCS levels is absent in
Cushing's disease (Doe et al., 1960), in which pituitary
ACTH production increases.

The response of humans to ACTH

administration is lowered at night, suggesting _that a
rhythm might also occur in adrenal sensitivity (Perkoff

ltl al., 1959).

However, the main factor in the control of

17-0HCS rhythm might actually be a circadian rhythm in the
levels of the peptide which releases ACTH, viz., corticotrophin releasing factor (CRF).
~-

~

The sensitivity of the
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neurosecretory cells of the anterior pituitary to the eff ects of CRF might also account for the circadian rhythm

(Clayton et al., 1963).

The neurohumoral agents which

affect the neurosecretion process have been examined.
Krieger et al. (1968) noted that atropine and sodium
thiamylal both lead to a loss of the peak in 17-0HCS levels.
They proposed that cholinergic mechanisms are involved in
the release of ACTH and that these might be responsible
for the rise of P.lasma corticosteroids.

•

Krieger and Rizzo

(1969) demonstrated that any alteration of 5-HT levels
will block the circadian rise in 17-0HCS levels; however,
alteration of central NE content had no effect on this
rhythm.

It appears that both cholinergic and serotonergic

mechanisms might be involved in ACTH release.
Zimmerman and Critchlow (1967) studied the effects
of stress on the rise of plasma corticosterone levels at
different times of the light/dark cycle.

They found that,

although a circadian rhythm in plasma 17-0HCS levels was
present, the stress-induced increases in steriod levels
did not differ significantly between peak and trough times
of the rhythm.
Bartter and co-wQrkers (1962) showed that the daily
rhythms in the urinary excretion of aldosterone, 17-ketosteroids, and 17-0HCS lag two to three hours behind the
plasma rhythm of 17-0HCS levels.

They noted correlations
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between the ACTH rhythm and the rhythms in sodium, potassium and hydrogen ion excretion, the circulatory levels of
white blood cells, and the secretion of glucocorticoids
and mineralocorticoids.

Boyd and McLeod (1964) noted

correlations between the circadian rhythm of plasma 17-0HCS
and intraocular pressure, with the latter rhythm lagging
about four hours behind the former.
The release of human growth hormone (HGH) has also
been shown to var/ on a circadian basis.

Sassin et al.

(1969) related the release of HGH to the period of slowwave sleep.

If the sleep pattern is reversed, the rhythm

of HGH release is also reversed.
Groot (1967) demonstrated that the ovaries of prolactin-treated (pseudopregnant) rats contain less ascorbic
acid and more progesterone at 1600 hours, than at 1000,
1200, or 1400 hours.

Endogenous release of lutenizing

hormone (LH) is believed to be the cause of this rhythm.
The rate of release of anti-diuretic hormone (ADH)
has also been considered as a circadian variable.

Zsoter

and Sebok (1955) demonstrated a circadian pattern for serum
ADH levels in man, with a peak at night.
in ADH levels helps to

~xplain

This alteration

the decreased urinary out-

put associated with the sleeping phase.
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3.

Rhythms in the

~els

of

~trolytes

Mills (1966) described the circadian fluctuations
in the levels of urinary phosphate excretion, which exhibit
low values during sleep and rise upon waking.

This rhythm

appears to be related to.the behavioral and activity patterns of the subject.

Norn (1929) demonstrated that the

circadian patterns of urinary sodium, potassium, and chloride exhibited a trough during the sleeping phase with a
peak in the

waki~g

phase in man.

These rhythms are altered

by alteration of environmental parameters, and they appear
to be exogenous (Mills, 1966).

The effects of glomerular

filtration rate on these urinary rhythms are uncertain,
according to Mills (1966).
Ammonia and acid excretion in man is high at night
and decreases in the morning; these rhythms are unaffected
by alteration in food intake.

The urinary excretions of

urea, uric acid, and creatinine are decreased at night.
Calcium and magnesium excretion rises during the early
daylight hours, and exhibits a nadir at night.

The levels

of these ions vary markedly with food intake (cf. Mills,
1 966).
Min and co-worke4s (1966) described renal rhythms
in the excretion of various ions; these rhythms were monitored in human subjects who were inactive and fed at

28.

constant intervals.

Magnesium and calcium excretions were

highest in the early morning hours, while peak excretion
of either sodium or potassium occurred in the late morning
hours.

The rhythm of phosphorous excretion exhibited a

·peak late in the day with a trough in the early morning
hours.

Fasting resulted in a loss of the excretory rhythms

of potassium and phosphorous.

Bahorsky and Bernardis

(1967) observed that fed rats exhibited rhythms in the
serum levels of sodium and potassium with peaks in the

•

early dark phase; however, they found no rhythm in the serum levels of phosphorous or urea nitrogen.

Fasted rats

exhibited a significant peak in serum sodium in the early
dark phase, but the rhythm in serum potassium was lost.
It appears that most of the human circadian rhythms of
urinary metabolites are also present in nocturnal animals,
although they are 180° out of phase with each other as one
might anticipate.
4.

Rhythms in Constituents of Carbohydrate, Lipid and
Protein Metabolism
Blood glucose levels vary in a circadian fashion in

the rat (Pauly and Scheving, 1967; Friedman and Walker,
1969a), mouse (Dziekanowska and Andrzej, 1961), chicken
(Twiest and Smith, 1970), and cow (Allcroft, 1933).

The

nocturnal rodent species exhibit maximal levels of serum
glucose during the dark, while the latter two diurnal
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species exhibit maximal levels during the light.

Bahorsky

and Bernardis (1967) noted that the circadian pattern of
serum glucose levels is abolished in fasted rats, although
a definite pattern was found in fed rats similar to that
found by other investigators.

Jarrett and Keen (1969)

noted that normal individuals exhibited diurnal variations
in the glucose tolerance test, but hyperglycemic patients
did not.
A

circadia~

pattern has been demonstrated for the

liver glycogen levels of the rat and the rabbit (Agren
et al., 1931).
ectomy.

These rhythms were abolished by adrenal-

Sollberger (1964) demonstrated circadian varia-

tions in hepatic glycogen levels in several species; the
rhythm generally peaks during the light phase in the diurnal, and during the dark in the nocturnal species.

He

contends that the two primary synchronizers for the glycogen rhythm are food intake and light.

Fuller and Diller

(1970) found that the hepatic glycogen rhythm, in rats
fed ad libitum, peaks at 0500-0800 hours, late in the dark
phase.

In rats fed a single meal from 0800-1200 hours,

hepatic glycogen levels exhibited a prolonged peak from
1200-2000 hours, suggesting the importance of food intake
in this rhythm.
Fuller and Diller (1970) also noted that plasma
free fatty acid (PFFA) levels exhibit a circadian pattern,
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inversely related to glycogen levels.

They propose that

the control of both the hepatic glycogen and PFFA rhythms
might be due to food intake, hormonal factors, or neural
control via the autonomic nervous system.
Feigin and co-workers (1968) demonstrated that
total whole blood amino acid levels in man exhibit a peak
at 1200-2000 hours and a trough at 0400-0800 hours.

Tewks-

bury and Lohrenz (1970) demonstrated that urinary amino
acid levels exhibit a similar rhythm to those of whole
blood, and they propose that a basic rhythm in amino acid
levels is normally present, and that the levels are augmented by food intake.
Forsgren (1935) established the presence of circadian variations in albumin content in rodents and man.
Nir and co-workers (1969) have shown that pineal RNA levels
as well as protein synthesis are depressed by continuous
light exposure, but not by an altered illumination schedule; no change in pineal DNA levels was noted.

The RNA

and DNA content and the level of protein synthesis of
animals in continuous darkness and those on an alternating
illumination schedule were similar.
results that continuous

~ight

It appears from these

exposure leads to a decreased

cellular metabolism in the pineal gland.
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5.

Periodicity in Enzyme Sistems
The activities of various enzymes have been examined

on a circadian basis.
Most of the studies of circadian enzyme rhythms in
the CNS have been done on the pineal gland.

Hydroxyindole-

O-methyl transferase (HIOMT), the enzyme which forms melatonin in the pineal, exhibits a circadian pattern in rats.
This pattern of HIOMT activity appears to be inhibited by
light, since it is abolished in blinded animals or in the

•

presence of continuous light (Axelrod et al., 1963).
This exogenous rhythm is also lost by lesion of the accessory optic tract, but not by lesions in the primary optic tract (Chase et al., 1969).

The increased activity of

HIOMT in the darkness appears to be related to a cholinergic mechanism since atropine methylbromide inhibited the
rise in HIOMT activity normally seen during darkness.

Ac-

tivity was restored by the administration of oxotremorine
oxalate, a cholinomimetic (Wartman et al., 1969).

A dif-

ferent type of biorhythm was noted in the activity of
pineal 5-hydroxytryptophan decarboxylase (5-HTPD).

Ac-

tivity of this enzyme is highest at midday and lowest at
midnight in nocturnal mammals (Quay, 1963a), in sharp contrast to the rhythm of HIOMT activity.

Snyder et al.

(1965a) demonstrated that blinding or sympathetic denerva-

l

~

tion pr€vent the increased enzymatic activity of 5-HTPD
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normally produced by light.

The adenyl cyclase activity

of the pineal also appears to be sensitive to alterations
in illumination since Weiss (1969) demonstrated that rats
exposed to continuous light exhibit a potentiation in the
norepinephrine-induced activation of this enzyme.

Quay

(1963b) showed that continuous light decreased activity of
succinate dehydrogenase in the rat pineal, which indicates
that illumination can affect the metabolism of the Krebs
cycle.

McGeer ana_McGeer (1966) noted that the activity

of tyrosine hydroxylase, which limits the synthesis of
catecholamines, also exhibits a circadian rhythm in the
rat pineal.

Tyrosine hydroxylase activity is also maximal

during the dark phase in this nocturnal species.
Several hepatic enzymes exhibit circadian patterns.
Hepatic tyrosine transaminase (TAT) fluctuates on a circadian basis, which appears to be determined by the pattern
of food intake (Fuller, 1970).

This rhythm persists in the

absence of the pituitary gland, adrenal glands, thyroid
glands, or the pancreas.

The activity of TAT in the brain

does not fluctuate, which suggests that the control mechanisms of hepatic TAT activity are not effective centrally
(cf. Fuller, 1970).

The(presence of 24-hour rhythms in the

activities of hepatic steriod hydroxylase (Colas

et~.,

1969) and tryptophan pyrrolase (Rapoport et al., 1966) have
also been demonstrated.

Radzialowski and Bousquet (1968)
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noted that a circadian pattern exists in the activities of
the drug-metabolizing enzymes in the rat liver.
tivity was noted at 1400 hours.

Maximal ac-

Phillips and Berry (1970)

demonstrated a similar circadian pattern in the activity of
mouse lever phosphoenolpyruvate carboxykinase, which catalyzes the synthesis of phosphoenolpyruvate from pyruvate.
Van Pilsum and Halberg (1964) noted a circadian pattern in the activity of transamidase in the mouse kidney;
highest activity was noted in the light period •

•

A circadian rhythm in the activity of cholesterol7-alphahydroxylase, which is controlled by the adrenocortical system and involved in the biosynthesis of bile acids,
has been demonstrated (Gielen et al., 1970).
Circadian variation of enzyme activity might be influenced by fluctuations in the levels of available cofactors.

The concentration of brain S-adenosylmethionine

(SAM), which plays an important role as a methyl donor in
several reactions, has been shown to vary on a 24-hour
basis.

Peak levels were noted in rat brain during the dark

phase, and trough levels during the light phase (Wurtman
~

6.

.§:1., 1970).

Periodicity in~ Levels of Putative Transmitter
Substances and Their Metabolites
The levels of putative CNS transmitters in various

areas of the CNS as well as in the whole brain have been

34
shown to exhibit 24-hour fluctuations by many investigators.
Wurtman and co-workers (1968b) noted a circadian
pattern in the plasma levels ·of the precursor amino acids
of monoamine biosynthesis.

In man levels of phenylalanine,

tyrosine and tryptophan are generally lowest at 0200 hours
and maximal at 1050 hours.

Methionine, cysteine, and iso-

leucine levels also exhibit 24-hour fluctuations, while
alanine, glycine, and glutamate levels vary slightly.
burn~~·

Co-

(1968J demonstrated that the rhythm in plasma

tyrosine levels appears to be regulated by dietary protein
intake and by the activity of TAT.
Scheving and co-workers (1968a) demonstrated an ultradian pattern for DM levels of whole rat brain.
Norepinephrine levels in the CNS have been shown to
vary on a 24-hour basis in most brain regions.

However,

Scheving and co-workers (1968a) have found an ultradian
pattern for NE levels in the whole brain of the rat.

The

norepinephrine rhythm of the caudate nucleus of the rat is
circadian with maximal levels occurring during the dark
phase (Friedman and Walker, 1968; 1969a).

Manshardt and

Wurtman (1968) examined the circadian rhythms of the NE
levels in the hypothalamus, midbrain, thalamus, and striatum of the rat.

Peaks occurred during the dark phase

except in the striatum and midbrain, in which no rhythm
was noted.

Reis and Wurtman (1968) demonstrated a

.~
.
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circadian alteration in the NE content of the cat hypothalamus and cervical cord.

They did not find 24-hour fluctu-

ations in any other area of the cat brain, but they utilized only two sacrifice points on the 24-hour time base,
one at the onset of the light phase, the other at the onset of the dark phase; thus, they might have missed peak
values during the middle of either phase.

This appears

to have been the case, since in a study in the cat brain
extended to four J>Oints, Reis et al. (1968) noted circadian fluctuations in the NE content of the cat cervical
_cord, pons, substantia nigra-lateral tegmentum, anterior
hypothalamus, tuber cinereum, and pineal gland.

Ultradian

patterns were described for the superior colliculi and the
lateral thalamus.

Reis and Gutnick (1970) noted that the

NE levels of the cervical and sacral-coccygeal areas of the
cat spinal cord varied in a circadian pattern peaking at
1900 hours while those of the thoracic cord exhibited a
biphasic pattern.

Wurtman et al. (1967) examined the fac-

tors controlling the circadian fluctuations of the NE content of the rat pineal gland.

Norepinephrine levels of

this tissue at the end of the dark period were three times
greater than those of

t~e

light period.

They found that

the rhythm is abolished by continuous light, continuous
darkness or blinding.

Rat adrenal epinephrine varies on a

24-hour basis with maximal levels during the light phase
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(Scheving et al., 1968b).

Pohorecky et al. (1969) noted

that continuous illumination or darkness, as compared to
cyclic illumination, leads to a decreased activity of
phenylethanolamine-N-methyl transferase (PN1'-1T) in the rat
adrenal, and to a decreased epinephrine content.

The ac-

tivity of PNMT in the olfactory bulb and tubercle of the
rat brain is increased during darkness, suggesting that
epinephrine production increases in these areas during
darkness.
Circadian rhythms in brain 5-HT levels have been
found in the mouse

(Albrecht~

al., 1956) and rat (Dixit

and Buckley, 1967; Scheving et al., 1968a; Friedman and
Walker, 1 968, 1969a).

Maximal levels occur in the light,

minimal levels in the dark, in these nocturnal species:
Pineal 5-HT levels also vary in a circadian fashion with
the peak in the daytime (Quay, 1963a).

Snyder~

al.

(1965b) discovered that this 5-HT rhythm bears an inverse
relationship to the pineal melatonin rhythm and that it is
abolished by superior cervical ganglionectomy.

However,

the pineal 5-HT rhythm in immature rats is unaffected by
sympathectomy (Machado
vestigated the 5-HT

et~.,

rhy~hms

1969).

Quay (1968) in-

in various regions of the rat

brain and noted that levels are maximal during the light
phase in the frontal cortex, hypothalamus, and lateral
lower brainstem.

l

He further noted very little rhythmic
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alteration in the 5-HT levels of the cerebral cortex.
et al.
--

Reis

(1969a) observed that the 5-HT content of the cat

upper brainstem and telencephalon varied on a circadian
basis.

Ultradian rhythms were demonstrated in the sub-

stantia nigra-lateral tegmentum and in the anterior hypothalamus.

In general, 5-HT levels are inversely related to

those of the catecholamines in the CNS, suggesting the possibility of different control mechanisms or that the enzymatic systems involved alternately used one or the other

•

amines (Valzelli and Garattini, 1967).
Acetylcholine levels of the rat brain describe
similar circadian patterns whether measured by bioassay
(Friedman and Walker, 1969b) or by gas chromatography
(Massarelli et al., 1970).

This rhythm is marked by a

peak during the dark, with a nadir in the light.
Wilson (1965) demonstrated a circadian pattern in
the primary excretion of histamine in the rat.

Maximal

levels were noted in the urine during the dark phase.
Friedman and Walker (1968) showed that the histamine content of the rat caudate nucleus varied on a circadian pattern with maximal levels during the dark phase.

They

(1969a) further noted that serum histamine levels exhibited a circadian pattern with maximal levels prior to the
onset of the dark phase.
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Rhythms Inv.Qlying the Formed Elements of the Blood
In the first hour of wakefulness, the eosinophil

.

and lymphocyte counts decrease, while that of neutrophils
increases (Sharp, 1960; Bartter et al., 1962).

These

changes might be related to the rhythm of 17-0HCS; however, light and social habits appeared to be primary synchronizers for the rhythm in eosinophil count (cf. Mills,
1966).
C.

Ci:r'badian Rhythms in Drug Response

Several studies have been conducted which indicate
the importance of information regarding circadian effects
in drug dosage regimens.

Holmgren (1933) noted that the

effect of insulin and E on rabbit blood sugar depended on
the time of their administration.

Mollerstrom (1937) rec-

ognized the presence of this insulin rhythm in his treatment of diabetic patients.

Some drug firms have begun

manufacture of "day" and "night" pills to compensate for the
diurnal fluctuations in drug metabolism (Sollberger, 1969).
1.

Drugs Affecting the Cholinergic System
Pauly and Scheving (1964) demonstrated in rats that
t

the peak toxicity of tremorine occurred between 2200-0400
hours.

A trough was obtained in the mid-afternoon.

Sub-

lethal doses of tremorine produced tremors after a shorter
latency during the dark phase.

Walker (1969) noted in mice
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that peak toxicity of acetylcholine, pilocarpine, and oxotremorine was greatest during the dark.

He also noted that

the circadian toxicity curve for atropine sulphate exhibited a pattern inverse to that of ACh with peak toxicity
occurring during the light.

Spoor and Jackson (1966) dem-

onstrated that the response to the isolated right atrium
of the rat to ACh varied with the time of day.

A greater

bradycardia was noted at 1100 hours than at 2300 hours.
Merritt and

Sulk~wski

(1969) reported that the injection

of JB-336, an anticholinergic psychotogenic compound, disrupted the circadian pattern of 5-HT levels in the rat
pineal gland.
2.

Drugs Affecting the

~nergic

System

Wurtman et al. (1970) demonstrated the presence of
a circadian rhythm in s-adenosylmethionine, in rat brain,
which was markedly affected by the administration of
1-DOPA; they suggested that this phenomenon may be important with regard to the therapeutic effects of this compound in Parkinsonism.
Wahlstrom (1964) noted in the canary that MAO inhibition by pheniprazine, pargyline, or nialamide decreased
the duration of the motor activity rhythm for a few days and
then increased it.
was demonstrated.

A circadian variation in drug response
Greater effects were obtained when drugs

,
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were administered in the late evening than in the early
morning.
Saelens !U .§:!• (1968) have noted the effects of pargyline and alpha-methyl-m-tyrosine on motor activity in
mice.

Pargyline was found to cause an increase in the mo-

tor activity of the dark phase, while alpha-methyl-mtyrosine had an opposite effect during the dark phase.
The investigators concluded that "adrenergic systems in
the brain have a _,ariable influence on locomotor activity".
Black and co-workers (1969) demonstrated a daily
rhythm in the effects of reserpine in the rat.

The per-

cent of NE depletion by reserpine was greater at night than
during the day.

They also noted a non-significant decrease

in brain NE half-life at night.

The effects of reserpine

on the sleep patterns of rabbits have been demonstrated by
Tabushi and Himwich (1969).

They found that reserpine

dosage caused a marked suppression of paradoxical sleep.
The pattern following reserpine administration is characterized by an alert pattern for 1.5-2 hours followed by
slow-wave sleep.

3.

Qli§. Stimulants and

Convuls~

Wahlstrom (1968) demonstrated that the activity of
amphetamine sulphate in the canary was greater at night
than early in the morning.

~

Webb and Russell (1966) studied the influence of
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24-hour rhythms on the convulsant effects of hexafluorodiethyl ether in the rat.

Seizure component times were

shorter at 2200 hours (dark phase) than at 1000 hours
(light phase).

The time interval for the occurrence of

tonic convulsions and the onset of post-ictal depression
was greater in the dark than in the light phase.

A cir-

cadian fluctuation was also noted in the percentage of
animals exhibiting two clonic seizures following a single
exposure to the d;ug.

Fifty percent responded at 1000

hours, while only ten percent responded at 2200 hours.
Lutsch and Morris (1967) demonstrated that peak convulsant
activity of lidocaine hydrochloride in mice occurred at
2100 hours; minimal activity was noted at 1500 hours.
4.

QN§. Depressants

Davis (1962) observed that both isolated and grouped
mice exhibited a similar trough response in pentobarbital
sodium sleeping times, but the grouped mice exhibited a
longer sleeping time during the day than did the isolated
mice.

Pauly and Scheving (1964) noted in the rat that the

peak circadian toxicity of pentobarbital sodium occurred
at 2200-0400 hours, and the nadir in the mid-afternoon.
Friedman and Walker (1969a) showed that the longest sleep
onset time and the shortest sleep duration following pentobarbi tal sodium administration in the rat occurred during
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the dark phase of an alternating light/dark cycle.

An in-

verse relationship occurred during the light phase.

It was

further noted that pentobarbital sodium reversed the circadian pattern in body temperature.
Marte and Halberg (1961) described a peak susceptibility to chlordiazepoxide-induced lethal depression in the
mouse at 2400 hours.

Haus and Halberg (1959) noted that

the crest and trough responses in the mouse to lethal depression from ethanol are at 2000 and 0800 hours, respec-

•

tively.
Morris and Lutsch (1967) demonstrated a 24-hour pattern in the analgesic potency of a standard dose of morphine in the mouse.

They found that peak analgesia oc-

curred at 2100 hours with a trough at .1500 hours.
~al.

Reis

(1969b) correlated the daily rhythm in NE levels in

a given brain region of the cat and the susceptibility of
that region to the norepinephrine-induced action of mor- ·
phine.

5.

Antihistamines
A circadian pattern in the effects of antihista-

minic drugs in humans has been demonstrated by Reinberg
t

and Sidi (1965).

They adapted six male subjects to a rou-

tine circadian cycle for one week and tested the antihis-

'l~
'
'
...•.

taminic drug, cyproheptadine.

The skin reaction to his-

tamine gave a peak response at 2300 hours, but differences
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in its time course of action were noted between 0700 hours
and 1900 hours.
6.

Antipyretics
Reinberg et al. (1967) showed that the duration of

urinary salicylate excretion exhibits circadian fluctuations.

They tested the rhythm in six human subjects, pre-

viously adapted to a programmed illumination cycle.

The

time course of salicylate excretion was longest when the
drug was given at°1900 hours.

Radzialowski and Bousquet

(1968) noted in the rat that metabolism of aminopyrine is
maximal at 0200 hours and minimal at 1400 hours.

Adrenal-

ectomy abolished the rhythm, suggesting the possibility
that the rhythm of 17-0HCS might have a function in this
rhythmic effect.
7.

Antibiotics
Wilson (1965) showed that chloramphenicol influenced

the pattern of rat histamine excretion in the urine.

Chlor-

amphenicol shifted the peak response in this rhythm from
the early dark phase to the center of that phase.

Krauer

and Dettli (1969) noted a 24-hour rhythm in children under one year old for
idine.

th~.rate

of excretion of sulfisom-

The rate is twenty percent lower during the night.

Halberg et.§:!. (1955) described a 24-hour periodicity in
the resistance of mice to an E. coli endotoxin; this type
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of altered systemic resistance to bacterial strains might
be a partial cause of the circadian effects of antibacterials.
8.

Miscellaneous Rhythms in Drug Response
Ertel et al. (1964) demonstrated a circadian effect

in lethality following the administration of methopyrapone,
an adrenal corticosteroid inhibitor (SU-4885), in mice.
Szeberenyi and co-workers (1969) noted that the plasma
half-life of SU-4~85 in rats was much longer at 2200 hours
than at 1000 hours.
In summary, only a small number of drugs from the
myriad of therapeutic compounds now in use have actually
been examined for their efficacy over a 24-hour period.
Many of those examined exhibited a periodicity in response,
suggesting the possibility that dosage should be evaluated
with reference to the time of administration as well as to
the other factors, which are now generally considered in
the administration of therapy.
D.

1.

Putative Transmitter Substances and Their
Relationsh.!.E to ~bral Excitabilit~

Dopamine
Blaschko (1957) first proposed that 3,4-dihydroxy-

phenylethylamine, or dopamine (DM), a biochemical precursor of NE, might have a physiological role of its own.

45
Dopamine has subsequently been shown to be present in the
brain of all mammalian species (cf. Hornykiewicz, 1966)
and differentially distributed in the CNS.

High levels

are found in the corpus striatum, substantia nigra, and
globus pallidus, whereas low levels are found in NE-rich
areas as the hypothalamus (Hornykiewicz, 1966).

The turn-

over of DM is also very high in the striatum, with a halflife of 2-4 hours depending on the technique used (Iversen and

Glowinsk~,

1966).

The DM-rich corpus striatum might have a role in
the control of cortical excitability as Umbach (1959) has
demonstrated that stimulation of the cat caudate nucleus
decreases seizure activity in various brain areas.

This

restraining effect was confirmed by Jung and Hassler
( 1 960)

0

The inhibitory activity of DM has been documented
in a number of physiological preparationso

McGeer and co-

workers (1961) found the inhibitory effect of DM to be
sixty times that of GABA on the crayfish stretch receptor
neuron.

It was also found to be ten times as potent as

1-NE or 1-E in this regard.

Iontophoretic application

of DM has been used to Terify this inhibitory action in
various areas of the cat brain, viz. the lateral geniculate nucleus (Curtis and Davis, 1962), cerebral cortex
(Krnj evic and Phillis, 1963a), hippocampus (Bloem et &·,

r
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~,,
["''

1965), caudate nucleus (York, 1967), and nucleus cuneatus
and gracilis of the dorsal spinal column (Steiner and
Meyer, 1966).

York (1967) also demonstrated that the in-

hibitory action of DM was blocked by phenoxybenzamine, an
alpha-adrenergic blocking agent.
Relationships between central DM levels and motor
activity have also been proposed.

Everett and Wiegand

(1962) found a correlation between the level of brain DM
and the degree of motor hyperactivity in mice.

•

Dominic

and Moore (1969) have shown that motor activity and brain
DM levels fall progressively as the dose of alpha-methyltyrosine is increased.

Dopamine has also been implicated

as an important compound in dextroamphetamine-induced hyperactivity (Laverty and Sharman, 1965).

The extensive

literature on the role of DM in the formation of Parkinsonian tremor has been reviewed by Hornykiewicz (1966).
The level of striatal DM appears to be critical for proper function in the extrapyramidal system, and decreased
DM levels can be found consistently in the corpus striatum
of Parkinsonian patients (Bernheimer .£1 .§!.., 1963).

Homo-

vanillic acid, the major metabolite of DM in the stria,tum, also exhibits

decr~ased

levels in Parkinsonism, in-

dicating a disruption of DM synthesis in these patients
(Bernheimer and Hornykiewicz, 1965).
The role of DM in the alteration of seizure
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phenomena has not been extensively studied, although some
reports are available.

Engel and co-workers (1968) evalu-

ated the effects of electroshock convulsions on the cerebral metabolism of DM.

They found that DM levels of the

cerebrum are not significantly altered by electroshock,
when they are measured ten minutes after the seizure episode.

However, homovanillic acid levels are increased 54%

over those of control animals, suggesting that the synthesis and metabolism of DM is increased following the

•

seizure.

Hanigan (1971) has noted that DM levels are di-

rectly proportional to the seizure latency time; thus, it
is possible that this post-seizure increase in DM levels
may play a role in the refractoriness following the seizure.
Spencer and Turner (1969), on the other hand, have
shown that the effects of pentylenetetrazol-induced convulsions are potentiated by the prior administration of dexamphetamine.

An intact DM synthesis is necessary for this

potentiation, but altered synthesis of either NE or 5-HT
had no effect on the seizures.

Thus, DM appears to have a

facilitatory action in seizures induced by pentylenetetrazol, although its action in electroconvulsive shock appears to be inhibitory to the seizure due to its action in
increasing latency time (Hanigan, 1971).
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2.

NorepineEhrine and Epinephrine
The physiological significance of NE was elucidated

by Barger and Dale in 1910 when they noted that it mimicked
some of the actions of sympathetic stimulation.

Von Euler

(1946) first described the presence of "sympathin" in mammalian brain and spinal cord.

He also described a high

concentration of NE in the CNS compared with that of E.
The highest levels of NE are found in the hypothalamus,
1-3 mcg. per gral\ in man (Bertler, 1961), rat (Glowinski
and Iversen, 1966), and cat (Bertler and Rosengren, 1959).
The midbrain and pons also contain relatively high levels
of NE, while low levels are found in the striatum, cerebral hemispheres, hippocampus, and cerebellum (Carlsson,
1959).

Fifty percent of the total CNS content of NE is

found in the "aminergic" nerve endings (DeRobertis, 1966).
The importance of E in the mammalian nervous system
is questionable.

Extremely low levels of E are found in

the rat CNS, although conversion of NE to E has been demonstrated via the enzyme, phenylethanolamine-N-methyltransferase, or PNMT (Pohorecky et al., 1968).

Barchas and co-

workers (1969) have noted the presence of a heat-labile
substance that inhibits tthe activity of adrenal PNMT, which
they have isolated from the rat brainstem.

They suggest

that "the low ratio of epinephrine formation in rat brain
may be associated with this substance".
"
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Electrophysiological studies on the central actions

of NE have often been contradictory.

Some investigators

indicate that the predominant action of catecholamines on
the cerebral cortex is inhibitory (Krnjevic, 1967; Malcolm
et al.,
--

1967).

On the other hand, recent studies have

shown that NE may be excitatory to cortical cells (Roberts
and Straughan, 1968; Johnson et al., 1968).

These inves-

tigators demonstrated that the pharmacological state of the
preparation may bG crucial in demonstration of the actions
of NE.

,,

On encephale isole preparations, twice as many

cells were excited by NE as were inhibited.

In prepara-

tions anesthetized with nitrous oxide-halothane mixtures,

4t

times as many cells were excited by NE as were depressed.

However, under barbiturate anesthesia, which is commonly
used, eight times as many cells were depressed by NE as
were excited.
Bradley and Wolstencroft (1965) found that 48% of
pontine and medullar neurons responded to NE with differing
responses:

29% were excited and 19% were inhibited.

These

investigators (cf. Bradley, 1969) reported that 80% of
brainstem neurons responded to NE:
60% were inhibited in this study.

20% were excited and
Boakes et al. (1968)

have shown that the excitatory responses of the brainstem
are stereospecific for NE as they only occur with 1-NE,
whereas the inhibitory responses were found to occur with
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either the 1- or d- form.
Norepinephrine has also been shown to be depressant
in various brain areas, viz. the medial geniculate nucleus
of cats (Tebecis, 1967), the hypothalamus (Bloom et al.,

1963), hippocampus, caudate nucleus, and mitral cells of
the olfactory bulb (cf. Bradley, 1969).
Studies of intact animals have also led to some
conflicting reports.

Many investigators view NE as an ex-

citatory factor :iJ1 behavioral studies, while others refer
to it as a behavioral depressant.

Systemic administration

of NE sometimes leads to an arousal response.

Administra-

tion of 1-DOPA and amphetamine result in behavioral stimulation.

In spite of these seemingly excitatory phenomena,

the direct actions of NE appear to be inhibitory.

A re-

view by Himwich and Alpers (1970) provides a thorough discussion of the role of catecholamines in various behavioral
disorders.

Dewhurst (1968) has proposed a theory which at-

tempts to explain some of the conflicts that have evolved
in catecholamine research.

He classifies amines as "type

A" (fat-soluble), excitant; "type B", with biphasic action;
and "type C" (water soluble), depressant..

(1966) has proposed

two~types

Salmoiraghi

of adrenergic receptors that

are responsible for the dual actions of catecholamines in
the CNS.
The effects of these catecholamines on various
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types of convulsive behavior have been investigated by several researchers.

Swinyard and co-workers noted that the

intravenous administration of either NE or E in mice raises
the threshold for pentylenetetrazol-induced seizures,
while only E increased the threshold for MES-induced seizures (Swinyard et al., 1964).
The role of these amines during the course of the
seizure is difficult to assess, but in several studies
the levels of am\nes following a seizure have been examined.

Breitner and co-workers (1964) reported that NE lev-

els in the rat brain are decreased after multiple shocks
delivered over a short period of time.

This fact is not

surprising since Kopin and Baldessarini (cf. Glowinski and
Baldessarini, 1966) have shown release of labelled NE from
brain slices into a perfusing medium after low voltage
electrical stimulation.

Hinesley and co-workers (1968) ex-

amined the effects of both electroshock and pseudoshock (a
sham shock procedure) in order to assess the actual role of
neurotransmitter substances in convulsive seizures.

They

found that NE levels are significantly decreased in the
cerebral hemispheres of shocked animals, but no alteration
was noted in the other brain areas examined.

These re-

duced NE levels may reflect an increased turnover rate
during the seizure state as has been noted in rats exposed to electroconvulsive shock twice daily for one week
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(Kety et

.§1., 1967), or to seizures induced by hyperbaric

oxygen (OHP; Neff and Costa, 1967).

Partial confirmation

of this supposition can be found in the work of Ladisich
and co-workers, who have shown that chronic ECS treatment
decreased levels of NE, and simultaneously increased the
levels of the acid metabolites of NE in all brain parts
examined (Ladisich et al., 1969).

They also demonstrated

that brain homogenates from shocked animals have a lower
capacity for NE uptake •

•

Most of the pharmacological manipulations involving
the catecholamines also involve 5-HT, so several studies
will be considered under the heading of "biogenic amines",
(cf. Section II-D-4).

A few studies have been done util-

izing specific inhibition of the rate-limiting step in
catecholamine biosynthesis.

Blenkarn .and co-workers (1969)

demonstrated that neither alpha-methyl tyrosine or dl-DOPA
has any effect on OHP-induced seizures.

Musacchio and co-

workers (1969) have shown that the activity of tyrosine
hydroxylase, the rate-limiting step in catecholamine biosynthesis, was increased by 15% in the whole brain of rats
exposed to ECS treatment twice daily for one week; activity
was increased by 10% int the cortex and by 24% in the brainstem.

The aforementioned studies suggest that convulsions

lead to an increased NE synthesis and may alter its uptake
as well.

This process is accompanied by increased
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degradation since turnover is augmented in the post-seizure
period(~

3.

supra).

Serotonin
Serotonin, or 5-hydroxytryptamine, was initially

isolated from blood platelets and the intestinal mucosa
by Page and Erspamer in 1948.

They also noted its vaso-

constrictor properties, and Rapport (1949) identified the
compound chemically in 1949.
reported the

pre~ence

Amin and co-workers (1954)

of 5-HT in the CNS of the dog.

Since

that time, 5-HT has been found in several plant species,
and in all invertebrate and vertebrate species that have
been examined (cf. Erspamer, 1966).
The differential distribution of 5-HT in the CNS has
been recognized for several years (Gaddum and Giarman,
1965).

The pineal gland contains an exceptionally high con-

centration of 5-HT, 56.9-72.6 micrograms/grams of tissue in
the rat (Owman, 1963).

Other brain areas rich in 5-HT in-

elude the midbrain, hypothalamus, and the septal area.
Low concentrations are found in the cerebral cortex, cerebellum, and the.CNS white matter

(Bogdanski~

al., 1957).

The neurophysiological actions of 5-HT on the CNS
have been extensively examined.

Marrazzi and Hart (1956)

suggested that 5-HT might be an inhibitory substance as
they found that it depressed evoked transcallosal responses.

r
'
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Krnjevic and Phillis (1963a) found that 5-HT depressed
cortical activity induced by both glutamate and peripheral
stimulation.

Roberts and Straughan (1967) demonstrated

that 5-HT has both excitatory and inhibitory actions on the
/

cat encephale isole.

Hoffer et al. (1968) found that the

application of 5-HT leads to activation of cerebellar
Purkinje cells.

The actions of 5-HT on the brainstem are

also seemingly paradoxical.

Bradley and Wolstencroft

(1965) found tha• 5-HT application to single neurons of
the pons and medulla led to variable effects: 40% of the
neurons tested were excited by 5-HT, while 49% were inhibited.

The effects of 5-HT on the lateral geniculate

nucleus are depressant when stimulation is induced by the
optic tract, but no effect is noted with antidromic stimulation or application of excitant amino acids (Curtis
and Davis, 1962; 1963).
the hypothalamus

Serotonin is also depressant to

(Bloom~

al., 1963), olfactory bulb

(Bloom et al., 1964), hippocampus (Biscoe and Straughan,
1965), and spinal cord (Phillis et al., 1968).
Although most of the studies of 5-HT previously
mentioned describe the substance as an inhibitory factor,
several studies on 5-HTtlevels in convulsive states have
minimized its impbrtance in the production of the seizure
pattern.

i.~

Bonnycastle and co-workers (1957) reported no

change in 5-HT levels following ECS seizure activity, but
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an increase after diphenylhydantoin administration.

Ly-

sergic acid diethylamide, a potent blocker of the action of
5-HT in the CNS, does not affect seizure susceptibility
(Lessin and Parkes, 1959).

Garattini and co-workers (1960)

reported an increase of 5-HT in the CNS following ECS activity, but they are cautious in interpreting these results due to contradictory data presented by other workers
(cf. Garattini and Valzelli, 1965, p. 213).
co-workers

(1968~

Hinesley and

have clarified this paradox somewhat in

demonstrating that CNS levels of 5-HT are elevated significantly by both ECS and pseudoshock procedures.

This

increase was not seen in animals that were handled only.
Thus, stress and handling contribute to these increases in
5-HT levels which were assumed to be due to the convu.lsion
process.
A diet with excess tryptophan, a precursor of 5-HT
in the CNS, lowered the hexafluorodiethyl ether seizure
threshold in immature rats (Gallagher, 1969).

Brain levels

of 5-HT are unchanged one hour after exposure to OHP.
Neither p-chlorophenylalanine, which decreases central
5-HT levels, nor 5-HTP, which increases them, has any effect on ORF-induced seieures (Blenkarn et al., 1969).
Neff and Costa (1967) reported that the turnover rate of
5-HT in the brain is increased in QI-IP-treated animals.
The exact role of 5-HT in these seizure induction methods
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deserves further study.
Para-chloroamphetamine, which appears to increase
the level of free 5-HT, has anti-convulsant actions, but
these require cautious interpretation due to the amphetamine-like actions of this drug on catecholamine receptorso
Schlesinger and co-workers have reported that p-chlorophenylalanine increases the susceptibility to audiogenic
seizures in mice (Schlesinger et al., 1969).

The adminis-

tration of 5-HTP.has been reported to decrease seizure
susceptibility (cf. Maynert, 1969; Prockop et al., 1959).
The data above indicates that 5-HT might play an inhibitory
role in central convulsive mechanisms, but more study is
necessary to confirm this hypothesis.
4.

The~

of Biogenic Amines iQ Seizure Susceptibility

The purpose of this section is to review some of the
studies which have dealt with simultaneous alterations in
the levels of two or more biogenic amines.
Extensive research has been undertaken to examine
the relationship of decreased biogenic amine levels to seizure susceptibility.

Toman and Everett (1958) found that

drug-induced depletion of biogenic amines shortens the
electroshock latency time, and that increased amine levels

F-

produced an opposite effect.

Reserpine, which lowers

levels of both catecholamines and serotonin, also lowers

r
'·
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the threshold to both electroshock and chemoshock seizures
(Chen et al., 1954).

DeSchaepdryver and co-workers (1962)

demonstrated a threefold increase in electroshock threshold in reserpinized rabbits, in which catecholamine levels
had been restored by administration of DOPA and an MAO
inhibitor.

When the catecholamine levels are reduced by

the administration of alpha-methyl tyrosine, an increase in
seizure susceptibility occurs (Rudzik and Mennear, 1966).
It appears that &ecreases in the levels of biogenic amines
are directly proportional to decreases in the resistance to
electroshock or chemoshock seizure induction.
Similar studies have been performed which demonstrate that increased levels of biogenic amines increase
resistance to seizure.

Kobinger and co-workers (1958)

noted that administration of DOPA with an MAO inhibitor
elevated the threshold for pentylenetetrazol-induced seizures.

However,_ DOPA alone had no effect on the seizure

threshold in mice pretreated with either iproniazid or reserpine (Prockop et al., 1959).

Oliver and co-workers

(1970) found that tranylcypromine counteracted reserpineinduced increases in the incidence of OHP seizures and the
decrease in average onset times.

Increased levels of free

catecholamines could be a critical factor in seizure reduction.

The anticonvulsant action of amphetamine might

be due to an action of this type.

Administration of other
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blockers of catecholamine reuptake, such as imipramine,
amitriptyline, and cocaine, have also been shown to decrease the seizure susceptibility (cf. Maynert, 1969).
MAO inhibition by either pargyline or iproniazid increases
latency time and survival, and decreases the frequency of
OHP-induced convulsions.

This effect appears to be dis-

sociated from the metabolism of either 5-HT or NE (Blenkarn
et al., 1969).

This suggests that DM might be the substance

responsible for

~his

action.

Pfeifer and Galambos (1967)

have implicated DM as the substance involved in the actions
of reserpine and of MAO inhibitors on seizure susceptibility.
The inverse relationship between catecholamine levels and seizure susceptibility is well illustrated by the
actions of metaraminol on seizure susceptibility.

This

drug, which displaces NE from its intracellular storage
sites, first reduces and then increases seizure susceptibility.

Thus, NE levels are increased (in the free state)

initially, and then depleted as the free NE is broken
down and not replaced (Mennear and Rudzik, 1966).
Although many of the studies on the relationship between catecholamine levels and decreased seizure susceptibility have involved MAO inhibition, Lehmann (1967) has
also shown that pyrogallol, an inhibitor of COMT, increases
the threshold for audiogenic seizures.

Furthermore, this
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effect is markedly enhanced by the use of imipramine or an
MAO inhibitor.
Six genera of mice were evaluated on the basis of
their electroshock threshold and their brain biogenic amine
levels (Scudder et al., 1966).

Those strains of mice that

exhibited the longest latency to minimal electroshock seizures also had the highest central levels of biogenic amines,
and vice versa.
Thus, it appears that most of the available litera-

•

ture is in agreement on the relationship between the biogenie amines and seizure susceptibility; the levels of these
amines appear to be directly proportional to seizure resistance.

5.

Glutamate and 4-aminobutyric Acid (GABA)
The actions of both glutamate and GABA will be con-

sidered under the same heading since their physiological
actions are interrelated.

1-Glutamic acid is the main pre-

cursor of GABA; this conversion is catalyzed by the enzyme,
glutamic acid decarboxylase (GAD), and it is essentially
irreversible (cf. Roberts, 1960).

The relationship between

these two compounds has been amplified further by Roberts
t

(1968), who has proposed that "the variation of chloride
ion content at nerve endings may regulate the GAD activity
and thus determine the proportions of glutamic acid and

l
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GABA which might be released on stimulation".
GABA was first identified in 1910 by Ackerman and
Kutscher.

In 1950, two independent research groups local-

ized large quantities of GABA in the mammalian CNS (Awapara
et al.,
--

1950).

Kuffler and Eyzaguirre (1955) proposed that

GABA might play a role in inhibitory transraission in the
CNS;

this supposition was partially confirmed when GABA

was found to be a major component of an inhibitory brain extract called Factor I (Bazemore, Elliot, and Florey, 1957) •

•

Until recently, GABA was believed to be present
only in the mammalian CNS, but Scriver and Whelen ( 1969)
found it in rat kidney.
pertains to the CNS.

Most of the data on GABA levels

Fahn and Cote (1968), in a study of

GABA distribution in the monkey brain, found the highest
levels in the substantia nigra, globus pallidus, and hypothalamus.

Certain areas of the thalamus and cerebral cor-

tex contained lower amounts, while white matter contained
the lowest concentrations of GABA.

In keeping with the

proposed inhibitory action of GABA, cerebellar levels are
highest in the axons of cells with proposed inhibitory
function, viz., Purkinje, basket, stellate, and Golgi
Type II cells (Kuriyamatet al., 1966a).

On the other hand,

glutamic acid, a fairly ubiquitous substance, is the most
abundant amino acid in brain tissue (Tallan, 1962).
est levels are found in the cerebral hemispheres, and

High-
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lowest levels are noted in the spinal cord (Shaw and Heine,
1 965) •
Physiological actions of these amino acids have been
investigated and these studies tend to strengthen theories
concerning their functional roles (vide supra).

Glutamic

acid leads to a reversible depolarization of spinal motoneurons (Curtis et al., 1960) and cortical neurons (Krnjevic,
1964) when applied extracellularly.

Intracellular appli-

cation has little.effect (Coombs, Eccles, and Fatt, 1955).
Eccles (1964) proposed that glutamate acts extracellularly
by increasing membrane permeability to sodium and potassium
ions.

The role of glutamic acid as a putative excitatory

transmitter has been discussed (Curtis, 1969).

On the

other hand, the extracellular administration of GABA leads
to hyperpolarization and an increased membrane conductance
in cortical neurons (Krnjevic and Schwartz, 1967), Deiter's
cells (Obata et al., 1967), and spinal motoneurons (Curtis
et al., 1968a&b).

Krnjevic and Schwartz (1967) demon-

strated that the equilibrium potential for GABA is close to
that evoked by direct cortical stimulation.

GABA inhibits

cortical activity at low dose levels with rapid onset and
a transient time course uf action; it is capable of blocking most types of cortical activity (Bradley, 1969).
Rogozea and co-workers (1969) proposed that GABA depresses
-

hippocampal neurons, and is responsible for supression of
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the orienting reflex.

Electrophoretic application of GABA

to the retinal ganglion inhibits both spontaneous and light
driven activity (Straschill and Perwein, 1969).
Some recent studies have attempted to relate the
central levels of these amino acids with the functional
state of the animal.

Jasper and co-workers (1965) measured

levels of these substances following their extraction from
the pia-arachnoid space.
sociated with

bot~

They found that arousal is as-

a high rate of glutamate release and

a low rate of GABA release; the opposite was noted in animals with an EEG pattern of sleep.

Stimulation of either

the lateral geniculate body or of the cortex, which lead to
a powerful inhibition of cortical discharge, caused an increased efflux of GABA (Mitchell and Srinivasan, 1969).
Jasper and Koyama (1969) demonstrated that reticular stimulation increases glutamate levels in the superfusate from
cat cerebral cortex.· They also noted GABA release during
sleep periods, confirming the previous studies of Jasper
and co-workers (1965).

Obata and Takeda (1969) demon-

strated the release of GABA into the perfusate of the
fourth ventricle following stimulation of the cat cerebellar cortex.
Intracerebral, intracarotid, or intraventricular
injection of glutamate produces convulsions, which can be
antagonized by GABA administration (Hayashi, 1952, 1958;
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Ta.ni, 1954).

The intracarotid and intraventricular admin-

istration of GABA as well as its topical application to
the cortex, increased the threshold for both electroshock
and chemoshock seizures (Guleti and Stanton, 1960; !Iayashi,
1958; Rech and Domino, 1960).

The balance between gluta-

mate and GABA might actually be the key factor with regard
to the effects of this amino acid system (vide supra) on
cerebral excitability (Roberts and Kuriyama, 1968; :Maynert, 1969).

•

The effects of many convulsion-producing substances
and procedures are associated with a decrease in the central levels of GABA.

Relationships have been established

between lowered GABA levels and OHP (Wood and Watson, 1963;
Wood et al., 1969), pyridoxine deficiency (Tower, 1960;
cf. Ann. N.Y. Acad. Sci., 166, 1-364, 1969), hydrazide
convulsants such as thiosemicarbazide (Killam and Bain,
1957), picrotoxin (Sytinsky and Thinh, 1964; Saito and
Tokunaga, 1967; Galindo, 1969), methionine sulfoximine
(DeRobertis et al., 1967), pentylenetetrazol (Whistler
et al., 1968), bemegride (Whistler et al., 1968), and
allylglycine (Alberici et al., 1969).

Reserpine, which

decreased seizure resistance (vide supra), lead to decreases in GABA levels (Tada, 1963).

Conversely, cer-

tain substances that increase the central GABA levels have
been shown to possess anti-convulsant actions.

Substances
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of this type include hydroxylamine (Eidelberg et al., 1960),
and aminoxyacetic acid (Kuriyama et al., 1966b).

Maynert

and Kaji (1962) disputed the action of GABA by noting that
animals with increased GABA levels were indistinguishable
from controls in response to either electroshock or chemoshock.

Diphenylhydantoin, a commonly used anti-convulsant

drug, increases GABA levels; however, this drug exerts actions on a number of other metabolic processes (Woodbury,
1969).

The

incre~se

in GABA levels might be the result,

rather than the cause of the action of diphenylhydantoin in
the control of seizures.
The current status of GABA can be summed up in the
following comment by Eugene Roberts (1968):

"much more re-

fined systems must be sought in which to measure accurately
the total quantity of GABA released in response to an exactly known amount of stimulation.

Until such experiments

are performed, GABA must remain only a promising candidate
for the role of inhibitory transmitter in vertebrates"
4.

o

Glycine
Glycine, the first amino acid to be isolated, was
•

identified in 1820 by Braconnot.

He termed the substance

sugar of gelatin, and Berzelius (1848) later termed it
"glycine".

The substance has recently been proposed as an

inhibitory transmitter in the mammalian spinal cord.

In

1960, Curtis and Watkins described a non-specific inhibitory
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action of glycine on spinal nerves.

However, subsequent in-

vestigation has indicated that glycine may have a role as
an inhibitory transmitter in the lumbosacral spinal cord
of the cat (Aprison and Werman, 1965; Davidoff et al., 1967;
Graham et al., 1967; Werman et al., 1967; 1968).

Evidence

for this role is presented in recent reviews by Aprison and
co-workers (1969a) and Werman and Aprison (1968).
Glycine, the simplest of amino acids, is found ubiquitously in mammals.

•

Its distribution in the CNS of mam-

mals exhibits a rostral-caudal gradient with the.highest
levels being noted in the medulla oblongata and the spinal
cord (Aprison et al., 1968; Aprison et al., 1969b).

In

general it was found that "glycine concentration was a)
two to five times higher in the medulla oblongata, cervical
enlargement, and lumbar enlargement than in four brain areas
rostral to the medulla oblongata, b) lower in the midthoracic cord than in the cervical and lumbar enlargements,
and c) generally invariant in the brain areas other than in
the medulla oblongata" (Aprison et al., 1969b).

The in-

vestigators correlated these high levels of glycine with
the amount of musculature supplied by the various spinal
areas investigated.

Thew found that a positive correlation

existed between the number of interneurons and the glycine
concentration (Davidoff et al., 1967; Graham et al., 1967).
Glycine has been shown to hyperpolarize both
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cortical (Curtis et al., 1968b) and spinal motoneurons
(Curtis et

~1.·,

1 968a; Werman et al., 1 968) • The reversal

potential of glycine hyperpolarization is similar to that
of the actual inhibitory processes of spinal motoneurons
(Curtis et al., 1968a; Werman et al., 1968).

Glycine is

a more potent depressant of spinal motoneurons and interneurons than is GABA, and the reverse is true for cortical
neurons.

Glycine and GABA are equipotent on the Renshaw

cell and cuneate neurons of the spinal cord (Curtis et al.,
1968b).

•

Glycine also possess potent inhibitory actions on

the cuneate nucleus of the medulla (Galindo et al., 1967).
The inhibitory actions of glycine in the spinal cord
are prevented by the iontophoretic application of two potent convulsant agents, strychnine (Curtis, 1963; 1969) and
picrotoxin (Davidoff and Aprison, 1969).

Wood and co-

workers demonstrated that glycine can protect rats from
the effects of OI1P-induced seizures (Wood

et~.,

1966).

Immature rats fed a diet with excess glycine exhibited no
change from controls in response to hexafluorodiethyl ether
(Gallagher, 1969).

Glycine has been shown to protect rats

from convulsions induced by homocysteine; however, homoserine, serine, betaine,tand glucose all share this action
(Sprince et al., 1969).

Although some studies indicate

that glycine may play a part in convulsive phenomena, much
study is needed for the confirmation of this role.

r
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Acet~lcholine

The intracarotid, intraventricular, or intracisternal
administration of acetylcholine (ACh), as well as local application to exposed brain areas, results in precipitation
of grand mal seizures, or EEG symptoms similar to those of
grand mal epilepsy (cf. Maynert, 1969).

Similar results

occur when cholinesterase is inhibited in the CNS, allowing an increased central level of ACh (Feldberg and Sherwood, 1954).

•

Richter and Crossland (1949) have reported that ACh
content in the CNS is decreased during the initial shock
stimulus, returns to normal levels, and is then decreased
again during the convulsive episode.

Acetylcholine levels

of the brain are also decreased during chemoshock seizures
elicited by pentylenetetrazol or picrotoxin (Stone, 1957).
Longo (1966) has shown that atropine has no effect on the
convulsant response to pentylenetetrazol.

Stone has also

demonstrated the convulsive effects of tetraethyl pyrophosphate (TEPP), a potent anticholinesterase; he found that
these seizures c.ould be antagonized by the administration
of atropine.

It appears that the ACh content of the brain

is decreased following various types of seizure patterns
induced by different convulsant procedures.

This decreased

ACh content is believed to be associated with an increased
release and degradation of this neurotransmitter agent;
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such a decrease is not unexpected in light of the increased
transmission associated with the convulsive episode (Stone,
1 969) •

Maynert (1969) has evaluated some of the older
studies on the role of ACh in seizure susceptibility, and
he has noted that many of these studies were performed in
anesthetized animals, which show an altered metabolism of
ACh.

Sobotka (1969) demonstrated that brain levels of ACh

in the mouse are

~ncreased

following administration of

MSO, a convulsant substance with a 60-90 minute latent period prior to convulsion.

Thus, it appears that ACh levels

might be normal or increased prior to the actual convulsive
episode, and they are decreased due to the release of the
stored ACh during the convulsion.

The role of ACh in con-

vulsive episodes has been thoroughly reviewed by Curtis
(1969) and Maynert (1969).
8.

Generalizations
In general an increased level of any of these puta-

tive inhibitory transmitters leads to a decrease in seizure
susceptibility; conversely, seizure susceptibility appears
to be increased by the administration of putative excitatory substances.
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E.

Objectives

It is difficult to ascertain accurately the nature
of drug efficacy without adequate information regarding the
background upon which a drug acts.

Inhibitory systems are

involved in convulsive disorders and their amelioration,
and a number of chemical substances have been considered as
inhibitory transmitter candidates in the CNS.

It is the

purpose of this study:
1)

• background information by determinto acquire
ing the levels of putative inhibitory transmitters of the CNS as a function of the time
of day using a "normalu light cycle, and to
examine the effect of a "reversed" light
cycle on some of these amine levels.

2)

to determine the role of these circadian variations in transmitter levels on the. response
to maximal electric shock ~eizures.

3)

to determine the diurnal and nocturnal fluctuations in the response of rodents to selected
convulsant drugs and to common anti-convulsants in antagonizing maximal electroshock
seizures.

•
CHAPTER III
MATERIALS AfID METHODS
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A. Basic
1.

~xperimental

Conditions and Procedures

Animals
Male albino rats of Sprague-Dawley

strair~

(Holtzman

Breeders, Madison, Wisconsin), weighing 275-315 grams,
were used for all rat experiments.

':::hey were housed in

pairs in stainless steel wire mesh cages, 11x9x9 inches.
Pel-E-Cel bedding (Paxton Products, Paxton, N. J.) was used
as an absorbent material beneath the mesh bottoms of the
cages, so that an!'mals had no direct contact with the bedding.
Male albino mice of Ha/ICR strain (A. R. Schmidt
Breeders, Madison, Wisconsin), weighing 32-37 grams, were
used.

These animals were caged in groups of twenty ani-

mals each in stainless steel wire mesh cages, 16x6x9
incheso

Softwood sawdust was used for bedding material,

but animals had no contact with this material, which can
influence drug responsiveness (Vesell, 1968).
2.

Environmental Conditions
Both mice and rats were given food (Purina Rat Chow)

and tap water ad 1.i!2J:tum.

The composition of Rat Chow con-

sisted of 24% crude protein, not less than 4% fat, 5% crude
fiber and

9~~

ash, with vitamins and minerals added.

Feed-

ing, watering, and cage cleaning were performed at various
times of the day to prevent these procedures from becoming

l

l
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entrainment stimuli.

Cage racks were kept in a quiet, well

ventilated, windowless room, which measured 9x12x13.5 feet.
Temperature was stable at 23 + 1°

c.

Ambient humidity was

fairly constant at 25 ± 5%, as was the barometric pressure
at 732-762 mm. of mercury.

These three parameters were re-

corded on a 24-hour basis by a Lambrecht KG recorder
(Gottingen Type 235).

3.

Lighting Conditions and Photoperiods
Animals us~d for the initial studies of dopamine

and GABA levels (in corpus striatum, thalamus-hypothalamus,
and corpora quadrigemina) were exposed to 85 foot-candles
of incandescant light as measured by a Gossen Luna-Pro CdS
light meter.

Light was provided by General Electric

150

watt light bulbs at a distance of four feet from the cage
front.

These bulbs had no appreciable effect on the tem-

perature of the room as monitored by the Lambrecht recorder.
Animals for all subsequent studies were adapted under conditions of Vita-Lite (Duro-Test Corp., North Bergen,
N. J.) lighting, a fluorescent light source with a spectrum
approximating that of daylight.

This similarity can be

noted in spectra A and C of Figure 1.

The lights were

placed at a distance of 5-6 feet from the front of the
cages, and their output was measured at 100 foot-candles
by the Gossen light meter.
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All animals were adapted for a minimum of three weeks
prior to experimentation.
used:

1) a

~al

Two types of light cycles were

cycle in which the photoperiod lasted

from 0800-2000 hours CST., and 2) a reverse cycle in which
the photoperiod lasted from 2000-0800 hours CST.

These

photoperiods were automatically timed by a Sears Kenmore
timer (All purpose 24-hour timer, 15 amps output).
4.

Dissection of Tissues
a.

Brain Areas

Groups of six rats were killed by decapitation
(Harvard Decapitator, Model No. 130 RM) at 3-6 hour intervals around the clock.

The skull was opened by an incision

with surgical scissors following the midline suture.

The

dura was incised, and the brain was removed following separation from the cranial nerves.

The brain was immediately

placed on a cold aluminum block or on a cold glass plate,
and rinsed with cold 0.9% saline solution to remove visible blood.

It was blotted on filter paper and dissected

into the following regions (depending upon the experiment):
cerebellum, frontal cortex, corpus striatum, thalamushypothalamus, corpora quadrigemina, pons, medulla; upper
brainstem consisting of thalamus, hypothalamus, and midbrain; and lower brainstem consisting of pons and medulla
(cf. Figure 9 in Zeman and Innes, 1963).

Excised tissues
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were weighed on a Holler-Smith tissue balance (Model G,
500 mg. counter-weight), and frozen in liquid nitrogen
within three minutes after decapitation.
stored at

-~5°

c.

Tissues were

for periods up to three weeks prior to

amine quantification.
b.

Spinal Cord Dissection

Groups of six animals were killed by decapitation,
and the spinal cord was exposed by laminectomy with a finepointed surgical scissors.

•

Any excess tissue was trimmed

away from the rostral area of the cord.

The cord was

lifted from the canal by a probe, which had been used to
break the dorsal and ventral roots in order that the cord
could be removed

~

The cord was rinsed with O. ~~

bloc.

saline solution, and was placed on a cold glass

plate~

The

cord was then divided into the cervical enlargement, lumbar enlargement, and the thoracic spinal cord (cf. Figure
20, Zeman and Innes, 196)).

These areas were weighed and

frozen in liquid nitrogen within 4-5 minutes following decapitation.

They were stored at

-~5°

c.

for 1-2 weeks

prior to glycine assay.

5.

Methods of Amine Analysis
a.

Dopamine

Tissues were analyzed for dopamine (DM) by the
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method of Sourkes and Murphey (1961).

The tissues were

homogenized in 5 ml. of 10% trichloracetic acid (TCA) in a
glass Potter-Elevjehm homogenizer.

The pestle was rinsed

with 1.0 ml. of 10% TCA, which was allowed to run off into
the homogenizing tube.

The tubes were centrifuged at 1000g

for 10 minutes in a IEC Model V centrifuge (radius head,
7.5 inch).

The supernatant fluid, which contained the cat-

echolamines, was placed in a 50 ml. glass-stoppered centrifuge tube cont•ining 1 ml. of a freshly prepared 0.2%
ascorbic acid solution, which prevented the oxidation of
DM.

The tissue pellet was washed twice with 2 ml. portions

of 10% TCA, and the washes added to the centrifuge tube.
Standard tubes containing O, 0.25, 0.50, or 1.00 micrograms
of DM were. carried siII).ul taneously through the entire method
in order to establish the standard curve for DM in this procedure.

2.5 ml. of 10% EDTA solution, one drop of 1% phen-

olphthalein solution, and 0.5 grams of Woelm alumina (Alupharm Chemicals, New Orleans, La.) were added to each tubeo
EDTA, disodium form, aided in the chelation of divalent
cations, and its presence facilitated consistent recoveries
of DM.

Woelm non-alkaline alumina was specified because of

its low percentage of "fines", which prevent rapid settling,
as well as for its neutrality, which allows more rapid pH
adjustment.

Phenolphthalein was used as an indicator for

the following titration.

The solutions were titrated to
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a pale pink (pH 8.2-8.4) with 5N, and then 1N, sodium hydroxide.

This pH range has been shm·m to be optimal for

catecholamine adsorption onto the alumina (Anton and Sayre,
1962).

The tubes were then stoppered and shaken at high

speed for 15 minutes on an Eberbach shaker.

After the

alumina had settled, the supernatant fluid was removed by
suction with a small-bore glass tube connected to a faucet
aspirator.
tions of

The alumina was washed twice with 5 ml. por-

distille~

water, pH 7.0.

After removal of the

second wash, 5 ml. of 0.5 N acetic acid were added to each
tube.

The tubes were shaken on high speed for 15 minutes,

and were centrifuged 15 minutes at 1000g.

This step re-

moved the catecholamines from the alumina and separated the
alumina, so that 2.0 ml. of the acid solution containing
dopamine could be removed from each vessel sans alumina.
Recovery of catecholamines was in the range of 60 ± 4%.
Two sets of test tubes (18 x 150 mm.) were designated
set A and set B.

Each tube received 2.0 ml. of 1M sodium

acetate buffer, pH 6.0.

1.0 ml. of acid eluate from each

centrifuge vessel was added to each tube of sets A and B.
Set B tubes were developed for the fluorimetric analysis of
DM by the addition of

O.~

ml. of Oo01 N iodine (in absolute

ethanol), 0.5 ml. of alkaline sulfite solution exactly
three minutes later, and 1.0 ml. of 5N hydrochloric acid,

78
containing 2 mg./ml. of ascorbic acid, exactly three minutes
after the alkali addition.

Set A tubes were used as blanks

and treated similarly except that the added alkaline sulfite contained 2 mg./ml. of ascorbic acid, and the 5N hydrochloric acid was added just prior to reading the fluorimeter.

The tubes were allowed to stand in diffuse daylight,

or under an ultra-violet source, for at least forty-five
minutes before reading.
for up to one week.

•

The fluorophore formed was stable

The solution was transferred to a

quartz cuvette with a 10 mm. light path.

DM fluorescence

was read at an excitation wavelength of 330 millimicrons
(uncorrected) and an emission wavelength of 375 millimicrons
(uncorrected).

An Aminco-Bowman Spectrophotofluorimeter

(SPF model) was used for all fluorimetric analyseso

A num-

ber 2 slit scheme was used for DM analysis and the emitted
fluorescence was amplified on a RCA 1P21 photomultplier
tube.
Treatment of catechols with iodine at weak acid pH
leads to formation of products which isomerize in alkaline
media to dihydroxyindoles in the case of dopamine-like substances (trihydroxyindoles in the case of epinephrine or
norepinephrine).

Figure 2 depicts this conversiono

In

alkali, however, the DM fluorophore will emit light in the
same region of the spectrum as will the fluorophores of
epinephrine or norepinephrine; therefore, the solution is
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Figure 2.

The conversion of dopamine to a fluorophore

(A) via dihydroxyindole condensation .

l
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acidified with 5 N hydrochloric acid.

The DM fluorophore

then fluoresces at a lower wavelength allowing a quantification free from extraneous catechol fluorescence.
Calculation of DM. content in the tissues was performed by construction of a standard curve based on the
standard solutions treated concomitantly with the samples
(minus their respective blanks).

Then, the dopamine con-

tent of any tissue was calculated as follows:
Bx -Ax = the• relative fluorescence of tube "B"
Bx
= the reading for tube "x" in set B
Ax

= the reading for tube

11

x" in set A

The amount (mcg.) of DM in the tissue sample "x"
could then be ascertained from the standard curve.

This

amount was then multiplied by the tissue factor (the reciprocal of the tissue weight in grams)" to give the concentration of DM in the tissue in micrograms/gram of wet
tissue weighto
b.

Dopamine, Serotonin, and Norepinephrine
Determination in a Single Tissue Sample

The technique of Ansell and Beeson (1968) was used
for simultaneous determinations of NE, 5-HT, and DM in the
same brain sample (Figure 3).

A tissue sample, weighing

from 100-500 mg. was homogenized in 5 ml. of acid butanol
using a glass Potter-Elvejhem homogenizing tube with a
Teflon pestle (Kontes).

One liter of acid butanol consists

...
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of 0. 999 1 • of washed bu tanol mixed with 0. 85 ml. of concentrated hydrochloric acid, 1.0 gram of potassium metabisulfite as an anti-oxidant, and 0.1 cram of EDTA, disodium
salt, used as a chelating agent for divalent cations.
Homogenization was carried out with the base of the tube
cooled in a beaker of ice to prevent monoamine degradation.
All tissues were homogenized in 5 ml. of acid butanol with
the exception of the cortex blank, which contained 400-500
mg. of cortical
tanol.

t~sue

homogenized in 10 ml. of acid bu-

This homogenate was split, and one portion was

shaken with a 50 lambda portion of mixed standard solution
containing 250 nanograms each of DM, NE, and 5-HT.

All

homogenates were centrifuged at 1000g for five minutes.
4.0 ml. of the supernatant butanol layer was then
shaken in a 50 ml. glass-stoppered centrifuge tube with
10 ml. of 2,2,4-trimethylpentane (iso-octane) and 5.0 ml.
of double distilled water.

This melange was shaken at

high speed on an Eberbach shaker for two minutes.

This step

transfers the monoamines from the butanol layer into the
aqueous layer by solvent saturation.

These vessels were

centrifuged for two minutes at 1000g to separate the liquid
layers.

The upper (organic) phase was aspirated off with

a Pasteur paper tip attached to a Tygon tube-faucet aspirator combination.

4.5 ml. of the aqueous phase was added

to 1.0 ml. of 2M sodium acetate solution and 200 mg. of

8)

pre-washed Woelm alumina in a 12. ml. glass-stoppered centrifuge tube (Kontes).

Woelm alumina was pre washed with

1N hydrochloric acid followed by 35-40 rinses of distilled
water to raise the pH to above 4.0, and then heated to
200° C. for two hours prior to storage in a dessicator.
The pH of each sample tube was checked with a Beckman pH
meter, and was adjusted to a range of 7.2.-7.4 with 0.5N
sodium hydroxide, when necessary.
This

mixtu~e

was shaken for ten minutes, and then

centrifuged for five minutes at 1500g.

This step involves

the adsorption of catecholamines onto the alumina, while
the 5-HT remains in solution.

Since catecholamines are un-

stable in alkaline media, the adsorption of catecholamines
at pH 7.2 represents an improvement in methodology, which
is possible because of the use of pre-washed alumina nd
the absence of phosphate ions.

The aqueous solution, con-

taining 5-HT, was transferred to a 50 ml. glass-stoppered
centrifuge tube containing 11.0 ml. of purified butanol.
1.0 ml. of 0.35 M borate buffer, pH 10, and 3.0 grams of
sodium chloride.

This melange was shaken for ten minutes

on high speed and centrifuged for two minutes at 1000g.
This step transfers the t5-HT from the salt-saturated, alkaline aqueous media into the organic phase.

Then ten ml.

of the organic phase were added to a 50 ml tube containing
15 ml. of iso-octane and 1.0 ml. of freshly prepared 0.05 M
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phosphate buffer, pH 7.0o
minutes at 1000g.

This mixture was shaken for two

This solvent saturation drove the 5-HT

back into the aqueous media, and the upper organic layer
was removed by aspiration.
A portion (1.2 ml.) of the aqueous phase from each
tube was added to 0.1 ml. of fresh 0.1 M ninhydrin solution,
and heated at 75° C. for thirty minutes.

An unextracted

standard ( 50 ng.), a blank, and a tissue blank were also
treated similarly.

•

After heating, the tubes were allowed

to cool for a minimum of one hour.

The fluorophore that

is developed remains stable for several days.

These

samples were read in the Aminco-Bowman SPF at an excitation
wavelength of 385 millimicrons (uncorrected) and at an
emission wavelength of 495 millimicrons (uncorrected).
Slit scheme number 5 is used for the quantification of the
serotonin-ninhydrin cendensation product, which is linear
in absorbance from 5-HT concentrations of 0.5-5000ng.
Meanwhile, the alumina was washed with 2 ml. of
double distilled water, pH 7.0, by shaking for two minutes
at high speed.

The tubes were then eluted with 1.0 ml. of

0.25 M acetic acid.

The tubes were shaken for fifteen min-

utes at high speed, and(spun at 1500g for five minutes.
supernatant

ac~d

The

was transferred to an 18 x 150 mm. test

tube with a Pasteur pipet.

These samples were adjusted to
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pH 6.50 by the addition of 10 N sodium hydroxide from a
micrometer syringe.

The pH was continuously monitored with

a probe electrode and Beckman pH meter, while the tube was
shaken on a table-top vortex mixer.
A 0.5 ml. portion of the adjusted supernatant was
mixed with 50 microliters of Oo1 M EDTA in 1.0 M sodium
acetate buffer, pH 6.50.

EDTA is added to stabilize the

catecholamine fluorophores, and it increases fluorescence
in this procedure 0 by 50-75%.

Fifty microliters of 0.1 M

iodine (in absolute ethanol) was added to begin the oxidation step of the hydroxyindole formation (Figure 2).

This

was followed exactly two minutes later by the addition of
freshly prepared alkaline sulfite (0.1 ml.).

Then, after

two additional minutes, 0.1 ml. of 6 M acetic acid was added to each tube.

The tubes were heated at 100°

minutes and cooled rapidly to room temperature.

c.

for two

One ml. of

double distilled water was then added to each tube, and
these samples were read immediately for NE fluorescence.
This fluorescence was read at an excitation wavelength of
385 millimicrons (uncorrected) and at an emission wavelength
of 485 millimicrons (uncorrected).

These samples, as well

as those of DM, were read at slit scheme number 2 in the
Aminco-Bowman SPF.

The samples were then transferred from

the cuvette back into their respective tubes, and they were
re-heated for four minutes at 100°

c.,

to destroy the NE

r
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fl uorophore.

To assure the absence of NE interference, the

samples were assayed for DM on the following day.

DM

fluorescence is excited at a wavelength of 330 millimicrons
and read at emission wavelength of 385 millimicrons (both
uncorrected).
Amine content is calculated by comparison with the
internal standard as described below:
4

x 4-"";5

x

250

x

2.
4

x

1
y

=

ng./gram
of amine

R
x
Bx

= fluormetric reading of tissue blank

Rstd

= fluormetric

Bstd

=

=

fluormetric reading of tube "x"

reading of cortex standard

fluormetric reading of cortex blank

4/4.5 (250)= actual amount of amine extracted
5/4

= correction factor for the volume of

butanol homogenate used
1/y

= the tissue factor, where y is the wet

tissue weight
This method has sensitivity for each of the amines as follows:

20 ng. for NE, 30 ng. for 5-HT, and 100 ng. for DM;

where sensitivity is defined as that quantity of each amine
which must be present

i~

order to give a reading which is

equal to twice that of its blank value.

The recoveries

with this method are in the range of 51 ± 8%.
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c.

4-aminobutyric Acid (GABA)

GABA was extracted from tissues in ethanol (Baxter,
1961) and was assayed by the method of Jakoby ,1962).

The

tissues were homogenized in a Potter-Elvejhem homogenizer
with a Teflon pestle.

The frozen sample was placed direct-

ly into the homogenizing vessel containing six ml. of icecold ethanol (80%).

After homogenization, the pestle was

rinsed into the tube with 2 ml. of 75% ethanol.

The samples

were then

The super-

centrif~ged

at 1500g for ten minutes.

natant fluid was decanted into a twenty ml. beaker following centrifugation.

The contents were evaporated to dry-

ness under an infra-red lamp (Infra-dry cabinet, Precision
Scientific Co.).

Beakers were removed just at the point

of complete evaporation to avoid the formation of a brown
denaturation product, which increased blank values.
w~.

One

of distilled water per 100 mg. of wet tissue was added

to each beaker, and the resuspended extract was transferred
to a 3 ml. polycarbonate centrifuge tube (11 x 77 mm.).
These tubes were centrifuged at 20,000 x g@ 4°

c.

for

thirty minutes on an IEC B-20 high speed refrigerated centrifuge.

A 0.2 ml. aliquot of each supernatant was pipet-

ted into a 1 ml. Pyrex beaker, and the fluid was evaporated
at 50°

c.

in vacuo (20-25 psi.).

The tubes were stored in

a vacuum desicator until the enzymatic determinations were
performed.

l
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Determinations were made by adding 0.5 ml. of double
distilled water to the dried contents in the 1 ml. beaker.
The resuspended solution was quantitatively transferred to
a microcuvette of 10 mm. light path, 1.25 ml. total volume
(Sargent Chemical Co.).

0.4 ml. of a reagent mixture was

then added to the microcuvette.

This reagent mixture con-

tained 0.05 mls. of 1.0 M Tris buffer,

pH

7.9, 0.15 ml.

of 1.0 M sodium sulfate solution, 0.05 ml. of 0.7% mercaptoethanol in Tris buffer, pH 7.9, 0.05 ml. of nicotine

•

adenine dinucleotide phosphate (NADP), solution, 20 mgo/ml.,
and 0.1 ml. of a solution of GABASE-CF, 50 mg./ml. (concentration was increased

onl~

when aging of the enzyme

necessitated a greater amount of enzyme so that the reaction
could be completed in ten minutes).

At this point, a con-

trol absorbancy reading was recorded at 340 millimicrons on
a Beckman DU spectrophotometer.

0.1 ml. of a 0.02 M alpha-

ketoglutarate solution, pH 7.9, is added to initiate the
reaction indicated in Figure 4.

Absorbance readings were

then taken every thirty seconds until maximum absorption
was attained.
The Tris buff er stabilizes the system against any
pH change due to the release of hydrogen ions.

Sodium

sulfate is used to prevent protein precipitation during
the reaction.
reaction per

N.ADP and alpha-ketoglutarate initiate the
~·

GABASE-CF is a cell-free preparation of
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NH2

succinic acid

Figure 4.

glutamic acid

Reaction of GABA wi t h GABASE-CFo

r
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an enzyme, purified following extraction from Pseudomonas
fluorescens (Worthington Biochemical Co.).

This prepara-

tion is free from TPNH oxidase activity, and glutamate does
not interfere in the reactions of this enzyme.
A standard curve of 4, 6, 8, and 10 microgr&ms standards was run with each group of samples, and these readings were used to plot a curve, which was linear in this
range.

The method was sensitive to 30 ng. of GABA in the

tissue extract.

1*)1.e control reading for each sample was

subtracted from the maximum absorbance change, and the actual value of GABA in the tissue was calculated as follows:
micrograms GABA
50

=

103.1

=

x

10 ~~ 1 = micromoles

of GABA/gram WTW

a constant based on resuspension of the tissue
with 10 ml. water/gm. of tissue, and the subsequent use of 0.2 ml. of extract for the final
reading
the molecular weight of one micromole of GABA
50/103.1 is reduced to a constant, 0.48496,
which is used when the calculations are made
d.

Determination of Glycine

Glycine was quantified by modification of the
co::..orimetric method of Aprison and Werman (1965).
tissues were homogenized in

5~~

The

TCA (in a volume equal to

a 10% w/v homogenate) in a Potter-Elvejhem homogenizing
tube (Kontes).

~he

(

homogenate was transferred to a poly-

carbonate centrifuge tube (11 x 77 mm.), and samples were
centrifuged at 23,000g at a temperature of 4° C. for twenty
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minutes (IEC :S-20 High Speed Refrigerated Centrifuge, no.
870 Head).

100 microliters of the supernatant from each

sample were placed in 6 x 50 mm. Pyrex tubes.

A similar

quantity of 8 mcg./ml., 16 mcg./ml., and 32 mcg./ml. s-candard solutions was treated in the same manner.
microli ters of a freshly prepared

7~~

Forty

sodium nitrite solu-

tion were added to each tube with the exception of a "glycine" blank (32 mcg./ml. glycine) and the tissue blanks.
The blanks

receiv~d

nitrite solution.
micromixer.

distilled water in place of the sodium

. The tubes were "buzzed" on a Beckman

Forty microliters of 1N sulfuric acid were ad-

ded to each tube, and the tubes were "buzzed" again.
tube was capped with a parafilm cover.

Each

A small pinhole

was placed in each cover to allow for the escape of gaseous
products, and the tubes were placed in a covered water bath
at 100° C. for forty-five minutes.

This step results in the

diazotization of glycine to glycollic acid in the presence
of nitrous acid and heat (the glycine content of the blank
tubes is not converted, but remains as glycine throughout
the procedure).
The tubes were cooled and centrifuged at 1500 rpm
for five minutes to remove the condensation from the walls
of the tube and concentrate it in the bottom of the tube.
Forty lambdas from each tube were removed and placed in a
Pyrex 10 x 75 mm. test tube.

Five lambdas of a freshly
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prepared 200% stannous chloride solution were added to each
tube, and the tubes were "buzzed".

This addition of stan-

nous chloride results in the elimination of excess nitrite,
which will otherwise interfere with the next reaction.
:nl.

1o0

of concentrated sulfuric acid, reagent grade, was added

to each tube in order to convert the glycollic acid to

formaldehyde.

Then 20 microliters of a fresh 5% chromo-

tropic acid solution were added to each tube in subdued
light, and the

t~es

were "buzzed".

Each tube was "buzzed"

and placed in darkness immediately following this addition
because chromotropic acid is extremely sensitive to light,
and any extended exposure will disrupt the colorimetric reaction.

All tubes were allowed to cool for forty-five

minutes in the dark.

Samples were then measured for their

absorbance in a Coleman 6/10 spectrophotometer by using
10 x 75 mm. glass cuvettes.

The chromophore is measured

at 580 millimicrons (Figure 5).
Glycine concentration, in mcg./ml., for the original
solution was calculated from the standard curve.
were subtracted from their respective samples.

Blanks
Then, the

concentration of glycine in mcg./ml. was multiplied by
10/75.1, and the result (of this manipulation was equal to
the concentration of glycine in the tissue in micromoles
per gram of wet tissue weight.

The number "10" is used as
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THANSFOIMATION OF GLYCINE TO A CHROMOPHOHE

NaN0
Glycine in
5 % TCA

2

/

lN H so 4
2

HEAT

)

HO-CH -COOH
2
glycollic acid

I
SnC1

Purple color
@ 580 mu.

Figure

5.

<

2

/ cone. H so
2 4

~

HCHO
formaldehyde
Chromotropic
Acid

Transformation of glycine to a chromophore.
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a multi plication factor because of the 1o~~ dilution during
homogenization.
of glycine.

The figure "75 .1" is the molecular weight

This method is highly specific, and does not

suffer from the recovery losses associated with chromategraphic techniques. It has been found to be sensitive to
-8
2 x 10
moles of glycine.
B.

Determination of Rectal Temnerature Rhythm
Rectal temperature was monitored in a group of sixty

• hour intervals over a 24 hour period.
male rats at three

A

Yellow Springs Telethermometer (Model no. 44 TA) equipped
with a flexible thermister probe (YSI Model no. 42 SC) was
used for these measurements.

The probe was cleaned with

water at 320 C. and dried after each temperature determination.

This procedure allowed rapid equilibration to the

actual animal temperature because the temperature of the
probe approached that of the animal.

The probe was lub-

ricated with Mazola Corn Oil (Corn Products Co., New York)
and inserted approximately five centimeters into the colon.
The thermister probe was maintained in

~

until the tem-

perature reading remained constant for a period of 40-50
seconds.

The probe was then removed, and the temperature
~

recorded.

Animals were handled in a gentle manner in order

to avoid any excitement which could interfere with the ternperature measurement.

r
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C.

Motor Ac ti vi ty Rhyt:f'F::s in Mice

Animals were adapted for four weeks to either a
normal or reverse cycle.

Six mice were then placed into

individual photoactometer chambers with food and water
available ad libitum.

They were allowed to acclimate to

this condition for at least twelve hours prior to activity
monitoring.

The photometer unit is shown in the photograph

in Figure 6A and 6B.
equidistantly

aro~nd

This cage has six photocells placed
the perimeter of the cage.

An infra-

red light, located in the center of the unit, emits a continuous beam to the photocell; whenever that beam is broken,
and activity count is recorded on a separate counting unit.
The counters were placed outside of the animal quarters to
prevent the clicking sound of the counters from affecting
the activity of the mice.

Animal activity was monitored for

a sixty minute period, which was checked with a stop-watch
to assure accurate timing of the counters.

At the end of

the 24-hour observation period, the availability of food
and water was confirmed in each unit.
D.

1.

l\1easurement of Response to Maximal Electroshock (MES)
and the Evaluation of the Effects of Various
Convulsant ~ Anti-convulsant Drugs
MES Methodology
MES seizures were evoked in mice using a shock
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Figure 6A. Front view of photoactome ter cag e. The scale
n ot ed on the c h e c kered ~uler in t he for egr ound of the picture is equal to one inch per division. A complete description of the apparatus is g iv en in the text .
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Figure 6B. Top vie1v of photoactome t e r c a g eo The scale
noted on the c he c kered ruler in the foreground of the picture is equal to one ineh per division . A complete description of the apparatus is given in the text.
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apparatus as described by Woodbury and Davenport (1952, cf.
Figure 7).

The shock was administered via corneal elec-

trodes, which had been moistened with 0.9% saline solution.
The stimulus parameters were current intensity of 50 ma.
with a duration of 0.2 second as described by Swinyard et

alo, 1952.

Three Cramer timers were arranged to start

simultaneoulsy with each stimulus, and these timers were
stopped following the various phases of the seizure (Figure

8).

•
A similar study was performed in rats that were

adapted and shocked at the University of Nebraska College
of Pharmacy.

The adaptation lighting at the latter in-

stitution consisted of sunlight (through window glass) rather than Vita-lite.

The MES technique was also similar

to that previously described for mice except that the stimulus parameters were 150 ma. at 0.2 seconds.
Animals to be shocked were picked up and held by the
scruff of the neck; their eyes placed in contact with the
premoistened corneal electrodes, and the shock was delivered
by the depression of a foot-switch.

The components of MES

seizure, as described by Toman et al. (1946), were measured on a temporal basis by stoping a timer precisely
when each phase ended.
was 0.15-0.20 second.

It was noted that my reaction time
This time was equal to the time of

duration of the initial shock, so that all times given in
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Figure 7. Woodbury-Dav enport shock ap paratus.
(Copied
with permission of the publisher, Ar c h . Intl. Pharmacodyn.
192 , 100, 1952).
See next page for diagram legends.
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Figure 7 diagram legends:
Interlock switch on caoinet door
Master switch
Push button to initiate timer; normally connected
to timer
Timer switch 5 pole, single circuit wafer type
Current range switch, porcelain base, high voltage

S1

S2

S3
S4
S5

Small replacement type transformer 350-0-350 volts
Variable autotransformer, 3 ampere capacity

T1
T2

T3

c
Ry~
I

Ry2
R1
R2-R6

Plate supply transformer, primary 110 volts,
secondary 2000 volts, 400 ma.
Timer condenser, 5 mfd, 1000 volts
0
Sensitive relay, 10,000 ohm winding
Heavy duty, double pole relay or contactor, 110
volt coil
Adjust to give 25-30 ma. through regulator tubes;
approximately 2,000 ohms, 10 watts
Select to give desired time of closure

Adjust to give slight changes in timing of all
timing positions
Wire
wound, 100 watt variable resistors with slidR8-R12
ing taps. Adjust to give desired full scale
current. The following values are approximate:

R7

R8
R9
R10
R11
R12

120,000
40,000
20,000
16,000
4,000

ohms
ohms
ohms
ohms
ohms

Meter:
(Indicated by circle-enclosed arrow in lower left
part of diagram) Any meter capable of reading rms-a-c
volts; scale may be hand-calibrated to give desired current rangeso

10 1

RTM ;J

110 \" • .\ ,.

0

0

0

0

0

J J.'i , . ' .\ ("

s2

Figure 8. Ele c tri c al dia g ram of timing apparatus u sed f o r
measu rement of se i zur e component time s .
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the text are actually timed from the end of shock administration.

The times recorded were: 1) the time to the be-

ginning of the tonic extensor phase, or extensor latency
~;

2) the time to the end of the tonic extensor phase;

and. 3) the time to the end of the clonic phase prior to
post-ictal depression.
Animals were used only once, and discarded following
MES treatment.

MES treatment and the testing of anti-

convulsant drug petencies were evaluated at the two time
points, which appeared from our biochemical studies to represent the peak and trough of CNS biogenic amine levelso
2.

Pharmacological Studies and Drug Protocol
a.

Acute Toxicity of Convulsant Drugs

The acute toxicity of convulsant drugs in mice was
determined at six hour intervals for a period of 24 hours.
The animals were conditioned to a normal light cycle three
to four weeks prior to this study.

Two to three groups of

9 animals each were injected I.P. with different doses of

the test drug.

After injection, the mice were placed in

individual cages to avoid interaction with each other.

The

drugs used are potent central stimulants, and the movement
t

or touch of one animal could trigger a seizure in an adjacent

~nimal

if aggregate housing was used.

The toxic

effects upon the animals were evaluated over a six hour
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period, and the number of denths in that time interval was
recorded.
Allylglycine (Sigma Chemical Co., St. Louis, Mo.)
was dissolved in 0.9% saline prior to use.

The concen-

tration was adjusted to allow the injection of 0.1 ml. per
10 grams of animal weight.

Strychnine sulfate (Merck,

Rahway, N.J.) was prepared in a concentrated stock solution, so that it could be diluted 1:100 prior to use.

It

was administered_py means of a 1.0 ml. tuberculin syringe
in volumes of 0.01 ml. per gram of animal weight.

The

stock solutions were refrigerated when not in use.
The LD50 doses of these drugs were calculated as
described in the statistics section (vide infra).
b.

Protective Doses of the Anti-convulsant Drugs
The PD50 (median protective dose) against MES of

each of the following drugs was determined during anticipated peaks and troughs of biogenic amine levels:

di-

phenylhydantoin (Parke, Davis & Co., Detroit, Mich.),
phenobarbital sodium (Merck, Rahway, N.J.), meprobamate
(Wyeth Laboratories, Philadelphia, Pa.), acetazolamide
(Lederle Laboratories, Pearl River, N.Y.), and amino(

oxyacetic acid hemihydrochloride (Aldrich Chemical Co.,
Milwaukee, Wisc.).

Phenobarbital sodium and amino-

oxyacetic acid (AOAA) were administered in 0.9% saline
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solution.

Diphenylhydantoin,

acetnzol~mide,

and mepro-

bamate were dispersed in a 5% acacia suspension.

When

necessary, the pH of solutions was adjusted to a range of
7.0-8.0 as determined with narrow range Hydrion test paper.
Drug concentrations were adjusted so that 0.1 ml. of fluid
would be injected for each 10 grams (mouse) or 100 grams
(rat) of animal body weight.
Groups of 9 mice or 7 rats each were injected I.P.
with a series Of J>redetermined doses of the test drug,
such that the low dose would produce protection below, and
the high dose above, the anticipated PD50 value.

In ad-

dition, a group of ten saline control mice, a group of ten
acacia-treated control mice, or 7 saline-treated rats were
tested with MES at the chosen time intervals.

These mice

were specially selected for a uniform body weight of 34 gm.
Rats weighed in the range of 275-290 gm.
saline or

gum

The volume of

acacia administered was similar to that of

the drug-treated animals.

One hour after drug or control

-

media, the animals were subjected to MES stimulation (vide
supra).

The timing of the seizure components of the con-

trols was recorded as well as the timing of those seizure
phases which occurred in drug-treated animals.
PD50's were calculated for the various drugs as described in Chapter III E.
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c.

Neurological Evo.luations of Motor and
Reflex Activity of Rodents

Following injection of the anti-convulsant agents,
animals were evaluated as follous:

1) observed activity -

a visual observation of the a.nimal's alertness, interaction
with his environment, and a comparison to control animals
with regard to frequency of movement; 2) balance - a test
of the animal's ability to balance on the edge of a cage
for at least five seconds (normal animals can perform this
task readily);

•

3)

reflex activity - an evaluation of the

animal's capability to return his hindlimb to a surface
following its withdrawal from that surface (replacement
is rapidly performed by a neurologically sound animal, but
not by a neurologically deficient one).
The summary of these evaluations is described in
the results section.
E.
1.

Statistical Analysis of !!!&

~

Calculation .Q! Standard Deviation, Standard Error of

lli

~' ~ ~ Values

The calculation of standard deviation (S), standard
error (Sy), and arithmetic mean (Y) were all performed on
(

an SCM Cogito 1016 PR computer programmed with a Iota 1
tape input accessory.

The formulae used for calculation

of these values are described below.
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Arithmetic mean

2

variance (S ) =

=

sum of the indol/c~:--.dcnt values = ~Y..
t'henumbei;:.~o~i-c:.~ tries
n
tthere n - 1 degrees of freedom
and y = each entry

&(y-Y)2

n - 1

=~

standard deviation (S)

standard error of the mean
2.

=~

Calculation of !
The t test for non-paired data ·m::i.s used to evaluate

the level of significance of compared samples.
was entered into the

SCM

computer and a programmed formula

was used to calculate t.

The formula is represented below.
y2

Y1
t

n1S1

2

+

n~s 2

n1 + n 2 - 2
).

Calculation of PD50

The data

~

2

( !1

+

~2)

LD50

The statistical analysis of these parameters and
their respective calculations were performed according to
the method of Litchfield and Wilcoxon (1949).

The method

is as follows:
1) an odd number of animals is always used to insure

that the 50% value tcan be interpolated from the data.

2) the number of animals protected, or the number of

deaths, at each dose level is converted to a percentage of the total amount of animals used at that
dose. This is then converted to a probit value. A
probit value of 5.000 represents tho median lethal
dose.

II""'
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3) x1

= high dose (mg. /Kg.);

4) Y1
Y2

= mortality rate, or protsction rate from x 1
=mortality rate, or protection rate from Y2

v

1 - y 2 (Probit)
x 1 - x 2 (log)

5)

The slope, b, =

6)

Standard Deviation (S) = 1 /b

7) Log dose=

x1

= low dose (mg. /Kg.)

A2

Y

( Jn/2 ) where n = the
total number of animals
per dose.

+ (5.000 - Y1 )

•

b

8)

The anti-log of the log dose is equal to the LD50 or
the PD50 in mg./Kg.
A specific example of this procedure (Friedman, 1966) is
shown below:
~

mg. LKg.

Los Dose

Mortalit.l

X1.

- 100

2.00000

y1

X2

75

1.87506

y2

y1 - y2

=

= 7/9
= 2/9

Percent

Probit

77.8

5.765

22.2

4.235

5.765 - 4.235

b =

= 12.1456
X1 - X2
2.00000 - 1.87506
S = 1/b (Jn/2) = 1/12.2456 (/9/2) = 1/25.9774 = 0.03849
Log dose =

x1

1

+ 5.000 - Y1/b = 2.00000 + 5.000 - ~:~~~
= 2.00000 - 0.06247 = 1.9375j

Antilog of 1.93753 = 86.60
1.93975) + 0.03849(= 1.97602
1.939753 - 0.0)849 = 1.89904
The antilog of 1.97602 = 90.63
The antilog of 1.89904 = 79.26
Difference
= 15.37
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15.37/2 = 7.685, or a st~nd:::.rd deviation of 7.685 mg./Kg.

Therefore, the LD50 = 86.60

±

7.685 mg./Kg.

The same method is also uced fo::- the calculation of the

PD50 of the anti-epileptic drugs used.

4.

Analysis .Q! Variance
This test of significance was also used.

ology and data are noted in Appendix C.

The method-

•

CHAPTER IV
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1.

Rectal Temperature
The rectal temperature of si::::ty rats monitored every

three hours for a twenty-four hour period is indicated in
Figure 9.

Average temperature of these nocturnally-active

animals ranges from 37.95 ± 0.35° Co in the dark phase to
37.25

±

0.25°

c.

during the light phase.

The peak tempera-

ture of 38.3 ± 0.3 is noted at 2400 hours and a trough tempera ture of 37. 1 ±• 0. 3 at 0900 hours.
characteristic pattern of this

The curve shows the

par~moter

with a sharp in-

crease in temperature following awakening.

This increase

is maintained throughout most of the dark phase, and the
temperature decreases sharply as the light phase approaches.
Points recorded on the curve at the following times
were found to be significantly different (P <0.001) from
each other when compared by the Student t-test:

0300 hours

vs. all points; 0600 hours vs. both 0900 hours and 1200
hours; 0900 hours as compared with all points other than
1200 hours; 1200 hours vs. 2100 hours; 2400 hours as compared with all other points.

The peak value is statisti-

cally significant with regard to all other values; and the
t

trough is statistically significant with regard to all points
on the curve except that at 1200 hours.

Comparisons of all

temperature values recorded in the light phase with all those
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Figure 9.
rat s.

The c ircad i an pattern for rectal t emperature in

Each cl ear cir cle indicat es the average t emperature

of a group of sixty r ats .

The ordinate repre sents rectal

temperature in d egr ee s

The bl a c

dicat es d arkness.

C~

bar on the a bsc i ssa in-

Standard d evi ations are i nd icat ed by the
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of the dark phase also are Gt:'.tiEtico.lly sisnificanto
2.

Motor Activity
The motor activity curves for both "normal" and "re-

verse" cycled mice are indicated in Figure 10.

The activ-

ity is expressed as a percent of the twenty-four hour average because of the variability of the rate of motor activity in the individual. animals.

This procedure for ex-

pressing data allows one to compare the activity of each

• others whose rate of activity might
animal with that of
differ markedly.
Motor activity rises sharply following the onset of
the dark phase.

Both mice and rats are considered to be

::.i.octurnal animals, and this curve is characteristic for
;,hese species.

~igu.re

10 cleai"ly shows that reversal of the

light program reverses the motor activity rhythm.
Peak motor activity on the normal cycle occurs at
2400 hours (266%), and trough activity at 1800 hours (23%).
The 2400 hour value is significantly greater (P <0.001)
than all other curve values.

Peak motor activity on the

reverse cycle also occurs during the dark phase at 1200
hours (226%) while a trough occurs at 2400 hours (41%).
t

This peak value is also significantly greater (P < 0.001)
-;;han

all other values of the curve.

11)
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2400
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R
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Figure 10.

The motor activity of mice on "normal" and "re-

vers e " cycl es .

The ord i nate indic ate s the p ercent of av-

erage 24 hour activity.

The

black~

dicat es the period of darkn ess .
f or both "normal " (N) and

11

on the ab sc i ssa in-

Time in hours is i nd ic at ed

r ev ers e" (R) cycles.

The open

circl es represent N animals, and t he fill ed circles the R
ani mals.

The vertical brackets deno te the standard d eviation

( n = 6 animals per point ) ; the standar d d eviati on of the
2400 N and 1200 R points are 266 ± 57 and 226 ± 46 r espectively.

11 4

Inhibi to:r~
1.

Trs:~,eri tters

Dopamine

The dopamine (DM) levels of the corpus striatum of
"normal" cycle rats are indicated in Figure 11.

Levels

_ rise during the dark phase to a peak at U300 hours.

There-

after, they decrease steadily as the light phase approaches
and finally trough at 1500 hours.
range from 3.46

l

The DJvI concentrations

0.08 micrograms/gram of uet tissue weight

(WTW) to 6.82 + 0.24 mcg./gm. WTW.

The peak value is sig-

nificantly different (P<0.05) from both the 1500 hour
point and the 1800 hour point.

The trough is also signif-

icantly different from the 0300 and 0600 hour values
(P<0.05).
The study depicted by Figure 11 was one performed in
December, 1968, and the DM levels (assayed by the Sourkes
and Murphey technique) were found to be much lower than
those of a subsequent "reverse" cycle study (for discussion,
see section C-1 of this chapter).

DM levels were deter-

mined again in "normal" cycle animals in June, 1970.

This

study (Figure 12) includes measurement of DM levels in the
upper and lower brainstem as well as in the corpus striatum
(assayed by the Ansell and Beeson procedure).
DM levels in the corpus striatum peaked during the
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The circadian pa tt ern for dopamine l evel s in the

corpus striatum of the rat (D ecember )o
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Figure 12.

Dopami ne levels in the rat corpus striatum (CS),

upper brainstem (US), and lower brainstem (LS) in a 24hour period (June).

The ordinate represents the l evel of

DM in mcg. / gm. WTW .

Time is represent ed on the abscissa.
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dark phase as in the previous study; however, this study
was conducted with four sample period:::/24 hours instead of
8/24 hours as in the former study.

The peak DM levels ::ere

obtained at 0600 hours, and the trough value at 1800 hours.
DM levels of the corpus striatum ranged from 4.81
mcg./gm. WTW (1800 hours) to
hours).

7~99

± 0.71

± 0.87 mcg./gm.. WTW (0600

The peak value was significantly greater (P <0.01)

than both DM values of the light phase.
The DM lev.is of the un1Jer b'.':'.'ninstem also peak during the dark phase at 0600 hours, and the trough value, as
in the case of the corpus striatum, '\·ras noted at 1800 hours.
The DM levels varied from 0.46 ± 0.16 mcg./gm. WTW (1800
hours) to 1.2j ± 0.41 mcg./gm. WTW (0600 hours).

The peak

value was found to differ significantly (P < 0.05) from both
values obtained during the light phase.

In the lower brain-

stem, DM concentrations were found to have a similar pattern to those of the corpus striatum and the upper brainstem; however, the trough levels occurred at 1200 hours.
The 1200 hour value was significantly lower (P<0.05) than
both values obtained during the dark phase.
tissue ranged from 0.25

Levels in this

± 0.11 mcg./gm. WTW (1200 hours) to

0.54 ± 0.23 mcg./ gm. WTW (0600 hours).
2.

NorepineRhrine
The levels of NE obtained during a 24-hour period,

1'18

are indicated in Figure 13.

J:TE

ancl Dl!f levels 1:1ere sampled

in the same tissues in order that -"1:;he levels of these two
amines could be compared.
NE levels in the corpus striatum were maximal during
the dark phase with a peak at 0600 hours.

A significant

difference (P <0.01) was obtained w·hon the peak value was
compared with values obtained for either of the points occurring during the light phase.

The level of NE at 2400

hours (0.24 .± 0.01.: mcg./gm. WT 1:l) was significantly higher
(P <0.01) ·when compared with the levels of samples obtained

for either point during the light phase.

The levels ranged

from o.06 ± 0.02 mcg./gm. (1800 hours) to 0.24 ± 0.07
mcg./gm. WTW (0600 hours).
The pattern of NE levels of the upper brainstem was
similar to that of the corpus striatum.

Maximal levels

were noted at 0600 hours with a trough at 1200 hours.

Each

point of the dark phase was greater and significantly different (P<0.01) from each point of the light phase.
Levels varied from a trough value of 0.95
WTW (1200 hours) to a peak value of 1.85

± 0.24 mcg./gm.
± 0.34 mcg./gm.

WTW (0600 hours).
NE concentrations( in the lower brainstem exhibited
a unimodal pattern; however, in this case, the peak levels
were noted at 2400 hours and a statistically significant
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Figure 13.

Norepinephrine l ev els in the rat corpus striatum

( CS ) , upper brainst em ( US) , and 101·1 er brains tem (LS ) in a

24-hour period.
mcg ./gm. WT\\.

The ordinate indicates the level of NE in
Time is not ed on the abs cissa .

The bl a ck

t

~

on the abscis s a indicates t he d ark phase of the phot o-

period.

The v ertic al brae et§ indicate the standard de-

viation of the r espective l evels (n = 6 animals per point ).
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( P <0.01) trough uas obtained at 1200 hours.

The cone en-

trations varied from a trough value of 0.64 ± 0.03 mcg./gm.
WTW (1200 hours) to a peak value o:f 0.88 ± 0.12 -ccf!,./C':Il•
WTW (2400 hours).
It is apparent in the tissues examined that DM and
NE level patterns are similar.
).

Serotonin
The circadian patterns for 5-HT levels in the corpus

•
striatum, upper brai.:.lstem,
and lo;,·1cr brainstem are depicted in Figure 14.

5-HT levels of the corpus striatum fol-

low a pattern inverse to those of the catecholamines.
pattern is marked by a trough in the dark phase:

This

both

points of this phase are significantly different (P<0.05)
from the peak value.

5-HT levels in the corpus

str:_a.-~t."'..fil

ranged from 0.46 + 0.15 mcg./gm. WTW (2400 hours) to Oo94

± 0.30 mcg./gm. WTW (1800 hours).
A similar pattern for 5-HT levels was noted in the
upper brainstem. ·Levels varied in a circadian fashion with
a peak value at 1800 hours and a trough value at 0600 hours.
Values obtained for both points of the dark phase were significantly different (P<0.05) from the peak value.

Levels

ranged from o.65 + 0.16 mcg./gm. WTW (0600·hours) to 0.93

± 0.14 mcg./gm.

WTW ( 1800

hours).

The pattern of 5-HT levels in the lower bra.instem
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Fi gure 14 .

Serot onin l evels in the ra t c orpus striatum

( CS ) , upp er brainstem (US ) , and lower brai nstem (LS ) over
a

~ 4 -ho ur

peri od .

Th e ordinate i ndi cates t he t i ssue l evel

of 5-HT in mcg ./gm . WTW. ( Time i s noted on t he abscissa .
The black bar on the abscissa indic ates the dark phase of
the photoperiod .

The vertic

ind ic ate the s t an-

dard d viat ion ( n = 6 animals per point )e
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differs markedly from those described above for this amine.
A un.j_c:10dal rhythm was obtained with a peak at 0600 hours
and a trough value at 1200 hours.

The

p·::iak value was sig-

nificantly different (P<0.05) fro:'l either of the points in
the light phase.

The concentrations varied from 0.81 ±

0.26 mcg./gm. WTW (1200 hours) to 1.25

±

0.26 mcg./gm. WTW

(0600 hours).

4.

(~)

4-aminobutyric Acid
The GABA

in the cortex and cerebellum are

pa~terns

indicated in Figure 15.

The cortical rhythm peaks during

the dark phase at 0600 hours and troughs in the light phase
at 1200 hours.

The significant difference between these

two points is only borderline (P<0.10).

The study repre-

sented in Figure 15 was performed in June, 1970.

A sim-

ilar pattern was obtained in a study performed in March,
1969 (cf. Appendix A).

However, the levels were propor-

tionately lower (perhaps because GABA levels exhibit
seasonal alteration).

Cortical GABA levels varied from a

trough value of 2.68 ± 0.33 mct-1./gm. WTW ( 1200 hours) to
a peak of :;.15 ± 0.45 mcM./gm. WTW (0600 hours).
The GABA levels of the cerebellum also exhibit a
t

unimodal pattern with a peak in the dark phase at 0600
hours.

The difference between peak and trough values is

significantly different (P < u.01).

Levels varied from a
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Figure 15 .

GABA levels in the rat cort ex (CTX) and cerebel-

lwn (CBLM ) over a 24-hour period.

The ordinate r epresents

the tissue level of GABA in mcM. / gm. WTW .
sented on the abscissa .

Time is repre-

The black area on the abscissa in~

dic a~e s

~ i

the dark uh .s e of the photoperiod.

Vertical brack-

dicate the sta ndard deviation (n = 6 animals per

point).
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trough of 1.80 + 0.38 mcM./gm. \'JT:·; ( 1200 hours) to a peak
value of 2.76

±

0.53 mcM./gm. UT\'! (0600 hours).

GABA patterns in the corpora quadrigcmina and in the
thalamus-hypothalamus are displayed in Figure 16.

GABA

levels of the corpora quadrieemina exhibit a circadian pattern with a peak during the dark phase.

Levels rise gradu-

ally, peaking late in the dark phase at 0600 hours; and
they decrease to a trough value at 1500 hours.

The peak

value is significantly different (P < 0.01) from all other
values except the 0900 hour point.

The trough value was

significantly di,fferent (P <0.01) for all points except the

1800 hour value.

Levels ranged from a trough of 4.28 ±

0.51 mcM./gm. WTW (1500 hours) to a peak of 6.66 ± 0.45
mcM./gm. WTW (0600 hours).
GABA levels of the thalamus-hypothalamus exhibited
a multi-modal rhythm with a definite increase in concentrations during the dark phase.

The saw-tooth pattern of

this rhythm is distinctive, and a statistically significant
difference (P<0.05) exists between either the 2400 hour
point or the 0600 hour point and the 0300 hour point.

The

0600 hour point is significantly different (P<0.05) from
all oth£:r points except the 2400 hour value.

Levels ranged

from a trough value of 3.82 ± 0.61 mcM./gm. WTW (2100
hours) to a peak value of 5.48 ± 0.29 mcM./gm. WTW (0600
hours).
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GABA l evels in the r at corpora quadrig emina

(CQ) and the thal amus-hyp othal amus ( TH-HT ) express d as a
function of time.

The or i a , and the a scissa are similar

to tho se of the previous figure.
dicate the standard deviation (n
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Glycine
The glycine patterns in the rat hindbrain are indicated in Figure 17.

In the pons, the glycine levels rise

to a peak late in the derk phase, then decrease to a trough
in the early light phase.

The peak value is significantly

different (P < 0.001) from both of the values obtained in
the light phase.

It is also significantly different

(P < 0.01) from the other point measured in the dark phase.
The levels ranged from a trough value of 2.04 ± 0.37 mcM./

•

gm. WTW (1200 hours) to a peak of 3.56

±

0.23 mcM./gm. WTW

(0600 hours).

Glycine levels, of the medulla do not fluctuate as
markedly as those of the pons.

Levels of this region do

not exhibit any significant diffeTence when various time
points are compared.

The levels ranged from 2.91

mcriJ:./gm. WTW (1200 hours) to 3.45

±

±

0.56

0.28 mcM./gm. WTW

( 1800 hours) •
Glycine level patterns in the spinal cord regions
are depicted in Figure 18.

The patterns of the cervical

and lumbar enlargements are similar to each other, but
markedly different from the pattern observed in the thoracic cord.

The thoracictcord pattern resembles that seen

in the pons, with a sharp peak at 0600 hours followed by a
rapid fall in levels to a trough at 1200 hours.

The peak
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Glycin ~

l evels i n the r a t pons and medulla

( MED ) expressed as a function of t i me .

The ordina t e de-

picts the tissue l evels of glycine in mcM. / gm . WTW.
is noted on the abscissa .
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Tim e
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Glycine l evels in the r at cervi c al cord (CV),
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and trough values in the thoracic cord are significantly
different (P < 0.001) from each other.

Glycine levels

re.::1ged from 1 • 77 .:!: 0. 21 mcH. /gm. UTW ( 1 200 hours) to 3. /:.4

± 0.23 mcM./gm. WTW (0600 hours).
Glycine levels in the cervical enlargement exhibit
a circadian pattern with a peak at the end of the dark
phase.

The peak is significantly different (P < 0. 01 ) from

the trough value.

However, levels between the points at

0600, 1800, and 2400 hours are not significantly different •

•

Concentrations ranged from 2.96
hours) to 3.61

±

±

0.23 mcM./gm. WTW (1200

0.30 mcM./gm. WTW (0600 hours).

The glycine pattern in the lumbar cord is similar
to that of the cervical cord, except that the peak value
occurs at 2400 hours.

The peak is not significantly dif-

ferent from the level obtained at 0600 hours.

However, it

is significantly different (P < 0.01) from the trough value.
The levels ranged from 2.96

±

0.50 mcM./gm. WTW (1800

hours) to 4.00 ± 0.30 mcM./gm. WTW (2400 hours).
The cumulative glycine levels in either the dark or
light phase for the tissues above are indicated in Table 1.
The medullary glycine levels during light and dark phases
are for all practical

pu~poses

equivalent.

Although gly-

cine levels in both cervical and thoracic cord are higher
in the dark phase than those of the light phase, these
levels are not significantly different from one another.
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LIGHT

DARK

PHASE

PHASE

2. 36

PONS

± 0.47 ·)(-

3.03 ± o.67
3.26 ± 0.69

± o. 38

CERVICAL CORD

3.23 ± 0.55n.s.

3.57

THORACIC CORD

t'.32 ± 0.68n.s.

2.78 ± 0.81

LUMBAR CORD

3.12

± 0.64 **

3. 94 ± 0.10

Table 1.

Cumulative glycine levels in the rat pons, med-

ulla, cervical cord, thoracic, and lumbar cord in mcM./gm.
WTW ("normal"· cycle).

Each phase consists of 12 hours.

Levels are expressed in micromoles/gram

± standard devi-

ation (n = 12 animals per entry).

*
**

p <0.05

between light and dark phases

<0.01

between light and dark phases

p

n.s. Difference between light and dark phases,. not statis~

tically significant.
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Significant differences beti·ICon dc.rk and light phase levels
of glycine were obtained in the pons (P

lumbar cord (P < 0.01).

< 0.05) and the

Table 1 denotes the rostro-caudal

gradient differences in glycine concontration described
by Aprison and co-workers (1968; 1969b).

The levels of

glycine are generally higher in the medulla than in the
'

pons, and levels in the thoracic cord are markedly lower
than those of the cervical or lumbar enlargements •
C.

•

Effects .Q.f Photouoriod Reversal .Q!1

~

·Levels of Putative Transmitters
1.

Dopamine
DM levels of the rat corpus striatum of animals on

a "reverse" cycle display a circadian periodicity (Figure

19). Levels rose

th~oughout

the dark phase to a peak at

1800 hours and a trough at 0300 hours.

The peak is sig-

nificantly different (P < 0.001) from the trough value.
Levels of DM ranged from 6.79

±

1.34 mcg./gm. WTW (0300

hours) to 11.12 ± 0.47 mcg./gm. WTW (1800 hours) and were
considerably higher than those of the normal cycle.

A

significant difference (P < 0.001) was obtained between comparable levels of the two cycles.

Since the "normal"

cycle study was performed in mid-summer, the possibility
of a seasonal rhythm must be considered in accounting for
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this difference in levels.
In an attempt to exclude the seasonal factor, the
study was repeated and Dr.I levels

"t-lOre

determined

:::;j_r.1ul-

taneously in animals on tho "normal" and "reverse" cycles
(this combined study was performed in June, 1970, cf.,
Figures 12 and 20).

The study was extended to include DM

levels of the upper and lower brainstem as well as those of
the corpus striatum.
The Dr.I

of the corpus striatum describe a

lev~s

unimodal circadian pattern with a peak at 1200 hours in the
dark phase.

This point is significantly different (P < 0.001)

from either point obtained in the light phase.
ranged from 5.59

± 0.55

± 0.55 mcg./gm. WTW

The levels

mcg./gm. WTW (0600 hours) to 8.74

(1200 hours).

This rhythm appeared to

be exogenous since it was reversed by photoperiod inversion.
The DM rhythms in both areas of the brainstem were
distinctly different from that of the corpus striatum.
Brainstem levels decreased during the dark phase of the
photoperiod; these rhythms, apparently are endogenous, as
the patterns were not reversed by photoperiod inversion.
These rhythms are similar to those of Figure 12 when compared on the basis of

ti~e

and not on the basis of photo-

period interval.
In the case of the upper brainstem, the trough is
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Figure 20.
pe

DM l evel s in the rat corpus striatum (CS ) , up-

brainstem (US ), and lower brainstem (LS) expressed as

a func t ion of time ( °'rever se" cycl e ) .

The ordin te r epre-

sents t he t i ssue level of dopamine in mcg . / gm. WT'f.
i s no ted on the abscissa .

The b ack

~

on the ab s ciss a

i ndicat es the dark pha se of the photoperiod .
brae ets indicate the standard deviat ion ( n
point) .

Time

The v ertical

=6

animals per

r
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significantly different (P<0.01) =ron either point obtained in the light ph2.se.
sten ranged from 0.42
0.93

±

D:-1 levols of th;:; upper brain-

0 .. 08 ccg./c;:u.o \'!TU ( 1200 hours) ·:;o

± 0.23 mcg./gm. WTW

(0600 hou:cs).

The trough in DM concentrations of the lower brainstem is highly significant statistically (P < 0.001), when
compared with the points obtained during the light phase.
DM levels in this region ranged from 0.42

± o.os mcg./gm.

UT';! ( 1200 hours) ~o 0.82

±

In summary, DM levels

the corpus striatum apparently are

exogenousl~

o~

0.10 mcg .. /gm. WTW ( 0600 hours).

controlled since they follow alterations in

photoperiod, while those of the upper and lower brainstem
apparently are endogenousli controlled, since they resist
a change due to reversal of photoperiod.
The cumulative levels of DM during the respective
phases of both

11

normal 11 .and "reverse" cycles are indicated
I

in Table 2.

In the corpus striatum (column 1), the DM

levels are elevated significantly (P <. 0 .05) in the dark
phase of the "reverse" cycle over those of the dark phase
of the "normal" cycle.

In a similar comparison of the

light phase levels significance was ·not proven (P< 0.10).
As can be seen in Table 2, levels in the dark phase of
either cycle are significantly different when compared with
those of the light phase.
A con?arison of DM levels of the upper brainstem

CYCT,E

--~~,-

PHASE

IiS

5.27 ± 0.88

0.52 ± 0.17

DARK

7.19 ± 1. 35

0.93 ± 0.45

LIGHT

5.90 ± 0.65

0.84 + 0.21

LIGHT

*"':<-*

NORMAL

REVERSE

DARK

Table 2.

!I§.

Q§.

***

• ± 1.01
8.56

0.27 ± 0.13

*

***

0.55 ± 0.23
0.82 ± 0.08

*·lHE·

0.47 ± 0.14

***

0.43 ± 0.09

Cumulative dopamine levels in corpus striatum

(CS), upper brainstem (US), and lower brainstem (LS).

Levels are expressed in micrograms/gram ± standard deviation, (n = 12 an;i_mals per point).

*

One asterisk indicates a P-valuo of less than 5%.

***

Three asterisks indicate a P-value of less than 0.1%.
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(column 2) in the light and dark phases of either "normal"
or "reverse" cycles indicates that they are significantly
different from each other.

The failure of this rhythm to

exhibit reversal is detected by the higher levels found in
the ligh,t phase of the "rcverscn cycle.
relative. to clock

~

In other words,

levels arc not significantly changed.

Comparison of the total levels of DM in the upper brainstem
of animals on the "normal" cycle versus those on the "reverse 11 cycle indioe.tes that they are not significantly different.
Comparison of DM levels of light versus dark phase
of either cycle in the lower brainstem indicates a highly
significant difference (Table 2).

However, in this case,

DM levels are also significantly higher when the same
phases of the "reverse" cycle are compared with those of the
"normal" cycle.
In summary, after photopcriod reversal increased
levels of DM are found in the corpus striatum and lower
brainstem, but not in the upper brainstem.
2.

Norepinephrine
NE patterns obtained in the various brain areas

studied for animals on a "reverse" cycle are depicted in
Figure 21.

Peak and trough NE levels of the corpus stria-

tum are not significantly different from each other
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Figure 21 .

NE l evels in the r a t corpus striatum (CS ) ,

upper brains tem (US ) , and lower brainst em (LS ) expr essed
as a funct ion of the tie of day ( r c re r se cycl e ) .
o dinat e r epresents NE cont ent, mc 0 0/ gm o i• TW.
p

ases are as in pr eviou s fi gures .

dic ate the standar

d evia tion (

The

Time and
in-

= 6 ani mal s p er point ) .
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(P < 0.10).

Levels ranged fron Oo08 ± 0.03 mcg./gm. WT\·[

(0600 hours) to 0.15

± 0.08 mc:s,./{!,rD.. WTH (1200 hours).

Although only borderline significance was attained, the NE
levels of this area exhibit a pattern similar to that of
DM on the "reverse" cycle.
The NE patterns in the upper and lower brainstem
are in sharp contrast to those obtained in the corpus stria tum.
phase.

NE levels of both brainstem areas trough in the dark

• brainstem, the minimal point is
In the upper

sig~

nif-_cantly different (P <0.05) from those of the light
phase.

Levels of NE in this area ranged from 1.31 ±

0.14 mcg./gm. WTW (1800 hours) to 1.80

± 0.19 mcg./gm. WTW

(0600 hours).
NE levels of the lower brainstem exhibit a significant (P <0.01) trough during the dark phase.
ranged from 0.54

NE levels

± 0.24 mcg./gm. WTW (1200 hours) to

0.17 mcg./gm. WTW(2400 hours).

1.15

±

These brainstem rhythms

appear to be unaffected by inversion of the photoperiod and
appear to be free-running, or endogenous rhythms.
Cumulative NE levels in these tissues are presented
in Table 3.

The light/dark phase comparisons of both cycles

in all areas studied are significantly different except for
2.evels in the corpus striatum on the "reverse" cycle.

NE

levels in the corpus striatUr:J. during the dark phase of the

140

CYCLE

NORMAL

us

cs

PHASE
LIGHT

0.07 ± 0.03

DARK

0.24 ± 0.07

***

1.05 + 0.22
"K**
1.74 ± 0.27

I&
0.71 ± 0.10
0.83 ± 0.11

*

•
LIGHT
REVERSE
DARK

Table 3.

0.08 ± 0.06
1.70 ± 0.25
n.s.
***
0.13 ± 0.07
1.35 ± 0.24

1.04 ± 0.17

***

0.71 ± 0.24

Cumulative NE levels in rat corpus striatum (CS),

upper brainstem (US), and lower brainstem (LS).
phase consists of 12 hours.

Each

Levels are expressed in

micrograms/gram± standard deviation (n = 12 animals per
entry).

*
One asterisk indicates a P-value of less than 5%.
*** Three asterisks indicate a P-value of less than 0.1%.,,.
n.s. Non-significant

diff~rence
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5-HT levels in the rat corpus striatum (CS),

upp er brainstem (US), and 10 1er brainst em (LS) expressed
as a function of time of day ( reve·.. s e cycle).
represents 5-HT content in mcg./gm. WTW .
are as in previous figures.
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(1200 hours) to a peak value of 0.86 ± 0.17 mcg./gm.
h.)U:.'.'S).

(060(

These two values are significantly different at
significance level.
5-HT levels in the upper brainstem also exhibit a

unimodal circadian pattern uith a trough in the dark phase.
Both values of the dark phase are significantly different
(P <0.05) from the peak value.

Levels ranged from 0.62

0,07 mcg./gm. WTW (1200 hours) to 0.82

(2400 hours).

±

± 0.07 mcg./gm. WTW

•

5-HT levels in the lower brainstem do not vary significantly over 24 hours.

Photoperiod reversal apparently

counteracts the rhythm obtained on the "normal" cycle.
levels in this area ranged from 1.04 ± 0.35 mcg./gm.

The
WTW

(1200 hours) to 1.41 ± 0.31 mcg./gm. WTW (2400 hours).
Cumulative 5-HT levels are compared in Table

t;"

Statistically significant dark/light differences were found
for all comparisons of 5-!IT on the "normal" cycle, but only
for the upper brainstem on the "reverse" cycle.

Levels of

5-HT are generally higher in the light phase except in the
lower brainstem on the "normal" cycle.

When similar phases

of different cycles are compared, the only significant dif(

ference (P<0.01) found occurs in a comparison of the levels
of the "normal" light phase to those of the "reverse" dark
phase in the lower brainstem.

Reversal of the illumination

r
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CYCLE

Q§.

LIGHT

•0.81 ±

0.29

DARK

0.49

0.15

LIGHT

0.76

NORMAL

REVERSE

DARK

Table 4.

us

PHASE

±

0.85

I&

± 0.16

*** 0.67
±

0.13

0.84

*

± 0.24 0.80 ± 0.09
n.s.
***
o.67 ± 0.11
0.60 ± 0.28

1.10

±
±

0.21
0.29

*

± 0.28
n.s.
1 .18 ± o. 31
1.28

Cumulative serotonin levels in corpus striatum

(CS), upper brainstem (US), and lower brainstem (LS).
els are expressed in micrograms/gram

±

Lev-

standard deviation.

Each phase consists of 12 hours light or 12 hours dark.

*
***

Three asterisks indicate a P-value of less than 0.1%

n.s.

Non-significant difference

One asterisk indicates a P-value of less than 5%
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schedule apparently affects 5-HT levels in a different manner than it does catecholamine levels.
4.

4-amino bu tyri.2 11£.!£. ( G.~::BA)
The effects of photoperiod inversion on GABA levels

are shown in Figure 23 and 24.
The GABA rhythm of the frontal cortex (Figure 23)
shows a trough in the light phase with a gradual rise to a
peak late in the dark phase.

In contrast to the rhythm of

• on the "normal" cycle, the reversed
cortical GABA levels
rhythm is highly significant (P<0.01) when peak and
values are compared.
value of 2.24

troug~

The levels ranged from a trough

± 0.35 mcM./gm. WTW (0600 hours) to a peak

value of 3.00 ± 0.23 mcM./gm. WTW ( 1800 hours).
GABA levels of the cerebellum in animals on the reverse cycle exhibit a rhythm similar to that of cortical
GABA i.e., a unimodal pattern with a peak late in the dark
phase.

A significant difference (P <0.05) between the peak

and trough values was obtained.
trations varied from 1.90
to a peak of 2.35

The range of GABA concen-

± 0.24 mcM./gm. WTW (2400 hours)

± 0.34 mcM./gm. WTW (1800 hours).

On the reversed cycle, GABA levels of the corpora
~

quadrigemina (Figure 24) exhibit an unusual circadian pattern.
>~:.ase.

Both the peak and trough occurred during the dark
It suggests the possibility that the rhythm of the
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The level s of GABA in the front al cortex (CTX)

and cereb ellum (CBLM ) express ed as a funct ion of the time
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(C Q) and the thalamus- hypothal amus ( TH-HT ) expressed as a
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co::po:::a quadrigemina resists rcve:.nsal, and that if th0
period of adaptation were increased, a more defined
sal rhythm would be obtained.

rc~ar-

GABA levels throughout

light phase seem remarkably stable.

-~lie

They fall at the onset

of the dark phase, and rise sharply to a peak at 1500 hours.
The trough value at 0900 hours is significantly different
(P <0.05) from all other points in the dark phase.

Levels

-.

varied from 3.77 + 0.33 mcM./gm. WTW (0900 hours) to 5.66

± 0.62 mcM./gm. WTW (1500 hours).
The GABA pattern for the thalamus-hypothalamus is
also different from previous rhythms shown in Figure 24.
As on the "normal" cycle, the levels fluctuate in a sawtooth fashion (Figure 25).

This rhythm possibly is an

endogenous six hour ultradian rhythm superimposed on an
exogenous circadian pattern.
ference (P
case.

<0.01)

There is significant dif-

between peak and trough values in this

The levels ranged from 3.30

±

0.27 mcM./gm. WTW

(0900 hours) to 4.11 ± 0.67 mcM./gm. WTW (2400 hours).
Cumulative GABA levels are compared in Table 5.

The

light/dark phase comparisons for each tissue region are
presented.

The only region exhibiting a significant, read-

ily reversible rhythm, was the cerebellum.

Comparison of

"normal" and "reverse" cycle levels in the cerebellum indicates no significant differences.

Levels of cortical
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Figure 25.

The levels of GABA i n the tha lamus- hypothala-

mus on both the "normal" (I) and

11

reverse" (II) cycles

wh ich are i nd icated on the abscissa.

The orclin_ate and

<'

vertical brackets are as in the previous figure.
circles and solid lines r epresent t h e normal

Clos ed

c y cle rhythm,

and open circles and dotted lines t he reverse c ycle rhythm .
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NOlli·lAL CYCLE

DARK

LIGHT

PHASE

PHASE

CQ

5.24 ± 0.49

TH-HT

4.45 ± 0.34

CTX

2.78 ± 0.29

CBLM

2.00 ± 0.44

*-K*

**
2.94 ± 0.42

n.s.

2.47 ± 0.51

*
REVERSE CYCLE
DARK

•LIGHT

PHASE

4.79 ± 0.21

CQ

PHASE

4.64 ± 0.41

n.s.

3.70 ± 0.32

TH-HT

n.s.

2.38 ± 0.34

CTX

2.71 ± 0.42

*
CBLM
Table 5.

1.91 +

-

o.~6

2.21 ± o.,o

*

Cumulative 4-aminobutyric acid levels in the

corpora quadrigemina (CQ), thalamus-hypothalamus (TH-HT),
frontal cortex (CTX), and cerebellum (CBLM).
expressed in micromoles/gram
animals per entry).
or 12 hours dark.

standard deviation (n = 12

Each phase consists of 12 hours light
Significance
is indicated by asterisks
t

as in previous tables.
difference.

±

Levels are

"n.s." indicates non-significant

1 51

GABA on the normal cycle arc significG.ntly higher ( P < 0 01)
6

than those of the "reverse" cycle.

Comparisons of levGls

of similar phases of different cycles in the
riscmina and

thal~mus-hypothalamus

~orpora ~uad-

indicate that the nor-

mal cycle levels are significantly higher (P <0.001) than
those of the "reverse" cycle.
D.

Resuonse to MES as a Function of Time:

Vehicle Controls

•• of various components of MES seizures
The duration
during a normal cycle in control animals are presented in
Table 6.

Both saline and the suspending agent, 5% acacia,

were evaluated in order to determine effects of the
vehicles.

All mice used in these groups had been careful-

ly selected for a single body weight ( 34 grams) to facilitate the detection of small changes in the time course of
the seizure pattern.
Each animal exhibited a full tonic-clonic type
seizure.

Two deaths o.ccurred in every group of ten, except

the 0600 hour acacia group, in which one death occurred.
Animals whi9h died during the seizure were excluded from
these statistics.

All animals exhibited post-ictal de-

pression and short-term refractoriness (30-45 seconds) to
subsequent shock.

The onset time of tonic extension

(extensor latency) in the saline-injected group was
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EXTENSOR
LATENCY,
.SECONDS

SECOl:TDS

1.86 ± 0.28

13.74

TIME

TREATMENT

0600

0.9% Saline

1800

0.9% Saline 0 2.17 ± 0.32

TONIC
EX':L·Di'TSION,

± 1.52

13.29 ± 0.86

CLONUS,
SECOlU)S

6.10

± 1.44

7 .69 ± 2.83

0600

5% Acacia

2.17 ± 0.36

15.77

± 1.13

6.79

± 2.59

1800

5% Acacia

2.12

± 0.31

14.88

± 1.41

6.58

±

Table 6.

2.06

Time, in seconds, for seizure components of

normal sal.iil;-e and. 5% acacia-treated control mice at 0600
and 1800 hours.
(n

=8

Values are expressed ± standard deviation

for all groups except the 0600 hou:r acacia group,

in which n

= 9).
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decroased (P < 0.05) at 0600 hours uhcn compared with the
group at 1800 hours.
dif~c~ance

between

However, there i:rn.s .no significD.i'l.t
groups in the duration of tonic

th~ae

e::-::;c::;.sion or of clonus.

Seizure component times of the

acecia-treated groups were not significantly different in
a

si~ilar

comparison.

An evaluation of seizure component times of salinetreated animals versus those of acacia-treated animals at
similar times revelled significant differences (P <0.05)
in the duration of tonic
and the duration of

cxten~

at 0600 and 1800 hours,

~~ ~ncy

at 0600 hours.

The minimal electroshock threshold (Swinyard, et al.,
1952) was determined at 0600 and 1800 hours.

The minimal

seizure pattern is generally of the alternating limb-clonic
tyye, although some mice will exhibit a tonic-clonic pattern

at these low currents.

The minimal threshold current was

9.67 ± 1.10 ma. at 1800 hours (n = 9), and 10.29
at 0600 hours (n

= 9);

± 0.98 ma.

however, those values did not differ

significantly from each other.

The percent of mice dying

at 10 ma. of current was higher at 0600 hours (33%), than
e~J.;

1800 hours ( 11%), .but this difference was also not sta.

~

tistically significant when tested by the Chi-square method.
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E.
1.

Circadian Variations

:i.n

1h£ lifli.£.acy of Drugs

Convulsa.nt Drugs
a.

Allylglycinc

The circadian toxicity (LD50) of two potent central
stimulants is graphed in Figure 26.

The lethality of allyl-

glycine was significantly higher (P <0.05) in the light
(especially at 1800 hours) than in the dark phase.

Animals

receiving allylglycine exhibited signs of increased motor

•

activity and hyperexcitability that led to convulsive episodes in a majority of them.

Animals which convulsed ex-

hibited a typical seizure pattern of clonic movements of
the limbs followed by flexion and extension (and sometimes
a short clonus).

When death occurred, it generally follow-

ed repetitive convulsions of the clonic-tonic type, with
the animals dying in extension.

All deaths occurred within

ninety minutes after injection of the compound.
b.

Strychnine Sulfate

The pattern for strychnine sulfate toxicity was
similar to that of allylglycine.

A significant difference

(P<0.05) occurred between the LD50's at 0600 and 1800

hours.

The toxicity of this compound is maximal during the

light phase, and minimal in the dark phase of the illumination cycle.

After receiving the drug, all animals exhibited
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tcr:.ic extension terminating in death.

All deaths occurred

within ninety minutes after injection of the drug.
2.

Anti-convulsant DruP.s
a.

Acetazola~ide

The PD50's with respect to MES for acetazolamide in
bo-!:h

•

light and dark phases are indicated in Tables 7 (mice)

and 8 (rats).

Animals receiving this drug could not be

differentiated from control animals \·Ji th regard to motor
function.
dent.

No changes in neurological functions were evi-

The PD50 of the drug did not vary significantly be-

tween the test times.

Table 9 (mice) and Table 10 (rats)

indicate the seizure component times in those drug-treated
animals that exhibited seizures at the low dosage level.
After acetazolamide, the extensor latency time was significantly elevated (P < 0.001) from that of control animals of

.

'both species in both phases.

In mice, tho duration of

clonus was significantly increased (P< 0.05) from values
in the light phase (1800thours).

Other times of rodent

seizure components were not significantly different from
control.
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TIME

0600 (dark)

DRUG
Ac etazol amide

84.45 ± 15.35
9.79 ±

1800
l"lo G •

(light)

91.00 ± 40.43

2 .18 n.s.

9.26 ±

1.48

± 8.30 *•ri- .. ..
Phenobarbital Sodium 2:;.68 ± 4.40 n. s.

152.90 ±

9.70

23.04 ±

1 • 01

Diyhenylhydantoin •
Meprobamate

Ta:::;::._.:; 7.

187.40

~

The PD50 of anti-convulsant drugs in mice during

light or dark phase of the illumination cycle.

Values are

expressed in mg./Kg., I.P., ±standard deviation (n = 18
mice per determination).

***

= p <0.001

n.s. = non significant difference
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Tnrn
0300 (dark)

DRUG

Acetazolamide

•

Diphenylhydantoin
Meprobamate
Phenobarbital Sodium

Table 8.

9.80 ±

6.30 n.s.

1500 (light)
i

0.88 ±

3.22

8.47 ± 4.39 n.s.

8.47 ± 4.39

± 26.50 x
5.85 ± 2.86 n.s.

76.98 ± 10.12

90.82

5.85

± 2.86

The PD50 of anti-convulsant drugs in rats during

the dark or light phase of the illumination cycle.

Values

are expressed in mg./Kg., I.P., ±the standard deviation
(n = ·14 rats per determination).

x

= p<o.10

n.s. = non-significant difference

Table 9.

Time, in seconds, for seizure components of normal saline control

and drug-treated mice ·which still showed convulsions.

Values are expressed

± standard deviation.
TIME

DRUG TREATHENT

n

EXTENSOR LATENCY

TONIC EXTENSION

CLO NUS

0600

Saline, 0.9%

10

1.86 .:!: 0.28

1800

Saline,

o. 91~

10

2.17 ± 0.32

0600

Acetazolamide,
80 mg./Kg •

5

3.86 .:!: 0.61

13.06 ± 3.54

10.70 + 4.}0

1800

Acetazolamide,
80 mg./Kg.

5

3.64 ± 0.49

11.72 ± 3.30

11.94 + 3.78

0600

Diphenylhydantoin,
8 mg./Kg.

6

4.00

± 0.55

6.85 ± 2.73

27.87 ±13.03

1800

Diphenylhydantoin 1
8 mg./Kg.

6

3.95 ± o.67

10. 9 5 -:- 4. 13

16. 1 6 -,· 5 . 58

0600

Neprobamate,
180 mg./Kg.

6

4. 57 -:- 0. 50

1800

M:eprobamate,
150 mg./Kg.

5

3.92

0601)

Phenobarbital Sodium,
20 mg./Kg.

6

3.87 i 0.54

Phenobarbital Sodium,
20 mg./Kg.

8

4.58

.

1800

± 1.36

± 1.55

13.74

•

.± 1.52

13.29 + 0.86

7.92

±

1.16

9.14 ± 3.S5

6. 10 + 1 • 44
7.69

-r

12.82 i

2.83

5.15

10.72 ± 2.33

.± 2.38

14.38

.± 3.52

7.63 ± 4.07

18.85

± 4.43

7.08

lllll!ll•··•;;;w*""''"''"
Table 10.
and

MotG•-wc::swJW.MQUi$WIAUL$1£1Jt.Z4WSJI~
saline-~ coll"L~l'o1

Time, in seconds, for seizure components of normal

those drug-treated rats which still showed convulsions.

Values arc exp:r:es-

sed + standard deviation.
THIE

DRUG TREATMENT

n

EXTENSOR LATENCY

TONIC EXTENSION

10.72 + 1.62

0300

Saline, 0.9%

7

1. 98 + o. 10

1500

Saline, 0.9%

7

1.95 ....
+ 0.10

0300

Acetazolamide,
.. 8 mg, /Kg.

4

3.87

1500

Acetazolamide,
8 mg./Kg.

5

3.12 + 0.24

9.72 -:- 2.21

0300

Diphenylhydantoin,
5 mg./Kg.

5

2.82

.± o.63

10.52 + 1.59

1500

Diphenylhydantoin,
5 mg./Kg.

5

3.28 + 0.44

O:JOO

Meprobamate,
67 mg./Kg.

5

3.70

1500

Meprobamate,
67 mg./Kg.

0300

Phenobarbital Sodium,
5 mg./Kg.

1500

Phenobarbital Sodium, 4
5 mg./Kg.

-

.± 0.90

•

11. 42 + 1.03
8.85

-i-

a.so

CLONUS

16. 11 +
-

17.48 +

22.47

-1-

7.30
5.51
11. 13

-

20.44 + 10.58
25.36

-

-~

10.31

-

7.08

2.31

28.36 -:-

q

.± 0.55

8.40 + 1. 53

-

21.74 +

-

5.97

5

3.24 .± 0.37

8. 4-6 + 2.76

26.04 -:-

4.23

f;

3.90 -:.. o.67

-

7.95 + 2.05

24.10

5.76

.± 0.38

7.15 + 2.23

29.37 + 8.44
-

3.77

-'-

'

-

-

-

-f-

.,,.r

_:, • .) 0
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. There was no significa.n.t di:Z:fc::... ·.:::1cc: in seizure component times between

acetazo12~oidc-t1".::c.:~cd

rodents in light

or dark phases.
b.

Diphenylhydantoin

Rodents receiving

diphenylhyd~ntoin

exhibited normal

motor activity and no apparent neurological deficits.

The

PD50 of 1iphenylhydantoin in the dark phase did not differ
significantly from that of the light phase in either species
(Table 7 and 8).

•

Seizure component times of convulsed animals, are
indicated in Tables 9 and 10.

Exten~ l~tencI

and duration

of clonus times in both phases were significantly increased
(P <0.001) above those found in the control mice, while
the duration of tonic extension was decreased significantly
(P<0.05).

In rats, extensor latenc;y: time was increased

significantly (P ( 0.001) from that of control, but the
time of clonus was significantly increased (P < 0.05) only
during the light phase.
A comparison of seizure component times in the diphenylhydantoin-trea ted rats of different phases indicated
that the extension phase was significantly decreased
~

(P<0.01) in the light phase.

A similar comparison in mice

indicated only borderline significance ( P < 0 .10) in the
following parameters:

increased duration of tonic
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EXTENSOR
DOSE

17. 3G

20

2.2G

15.18

30

2.44 ± i.23*

15.40

50

2.46 ± 0.86

21.15

'"<
;

~-

second.s

± 0.66
1.68 ± 0.13*

5

100

Table 11.

2.,0

2.53

± 0.15

± 0.58*

CLOllUS
seconds

E!'"''i']N$~!_071

seconds

mg. /Kg.

~L,

TONIC

_!:}\.TEW CY

13. 30

24.03

±
±
±
±
±
±

1.45

19.48

± 18.19

3.30*

5.66 ±

1.98

8.48

0.97*

7.40 ±

2.40***
6.39***

10.55

4.17

± 2.74
1.80

± 2 .. 90*

8.47 ±

1.42

The effects of I.P. doses of AOAA on various com-

ponent times of MES seizures in mice.
tered at 1200-1400 hours.

Drugs were adminis-

Testing was begun at 1400 hours,

and concluded at 1600 hours.

Values are shown in seconds

±their respective standard deviation (n = 5).

Signifi-

cance against pooled saline controls from 0600 and 1800
hours is indicated by:

*
p <0.05
*** P<0.001
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Tr,-.-TTf"J

El:TE:,TSOR

LATENCY
seconds

post drug, m:in.

CONTROL

\,.,....;.., .LV

~~~£l-Te}_QN

seconds

13. 57 ±

CI, ONUS

seconds

1 • 19

6.90 ± 2.10

17.90 ± 4.40

30

2.02 ± 0.27
1.97 ± 0.10

60

2.10

± 0.75

·15. 90 ± 1.65*

6.15 ± 0.85
e.·10 ± .•• 90

90

2.1~

± 0.)5

16.2~

8.10

120
AOAA average
(n = 12)

Table 12.

±

~.00*

± 1.55

2.43 ± 0.(:!5

19.GJ ± 1.65*** 6.44 ± 1.55

2. 31 ± 0.36

17. 31 + 2.42*** 7 .19

± 1.46

The effects of AOAA, 50 mg./Kg., I.P., on MES

seizure component times at various times after administration in mice.

Values are expressed in seconds ± stan-

dard deviation (n = 3).

Averaged saline controls are in-

cluded for comparative purposes.

*
***

= p <0.05
= P<0.001

Table 13.

Seizure component times, in mice, during both lic;ht (1800 hours) and

dark

hours) phases of the illumination cycle follovrints

(0600

chloride administration, 50 or 70 mg./Kg.

AOAA

hemi-hydro-

Values are expressed in seconds

.±

standard deviation.
-::- = p

0.05

.

.,~ ~,{-

= p

0.01

-lHH~

DRUG

TREATll'iENT

n

0. 001

= p

EXTENSOR
LATENCY
-seconds

•

TONIC
EXTENSION
seconds

seconds

.± 1.88

8.66 + 0.91

0600

"0.9% Saline, I.P.

7

2.24 .± 0.44

13.94

1800

0.9% Saline, I.P.

6

2.53 .± 0.73

11.80 :!: 2.52

0600

AOAA, 50 mg./Kg.,
I.P.

6

3.37

±

0.82 7~

14.37

1800

J.i.01\.i\ 9

50 mg. /Kg.,

5

3.32

.:!:

0.91

12.38 + 3.33

AOJ.'1-A, 70 mg. /Kg.,

7

3 • 69 .±; 0, 41 ·::--:H:·

AOAJ\, 70 mg. /Kg.,

7

3. 56

I.P.

0600

I.P.

1800

I.P.

.±

0, 74-x·

.± 4.57

CL01ms

9.17

1.00

11.68 + 2.73

8.45
10,02

1 6 • 4 6 .:!: 2.• 2 2-::--::-

.:!:

-r-

3.26

T

1,48

10.72..:. 2.66

r
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CHAPTER FIVE
GENERAL DISCUSSION
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A.

Possible Relationshins of Circadian Rhythms in
Levels of Putative

Inhibitor~

Transmitters

lli

12

Physiological Parameters
Several types of 24-hour patterns in the concentrations of the putative CNS neurotransmitter substances
studied can be described.
circadian pattern

~

These include: 1) Type I:

!: maximum .!!!

~ ~

-a

phase as seen

with the 1 evel s of. DM and NE in the CS , US , and LS , of
5-HT in the lower brainstem, of GABA in the cerebral cortex, cerebellum, and corpora quadrigemina, and of giycine
in the pons an,d spinal cord regions examined.
tern was also obtained with
activity, . 2)

in 1h!

Type' II:

r~ctal

This pat-

temperature, and motor

!: circadian pattern with!: maximum
.

.

light phase as noted in the case of the 5-HT levels

of the corpus striatum and upper brainstem, 3)
!: "sawtooth" fluctuation apparently

Type III:

~uperimposed

.Q!! !:

circadian pattern as noted in the case of the GABA levels
of the thalamus-hypothalamus, 4)

Type IV:

!: relatively

stable pattern noted in glycine levels of the medulla.
1.

Dopamine
The DM content of all examined tissues exhibited a

Type I circadian pattern {Figures 11 and 12).

This pattern

differed from that described by Scheving and co-workers
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(1968a), who found that DM content of the
varied in an ultradian fashion.

whole~

brain

It is apparent from this

difference that DM rhythms noted in the specific brain
areas studied are not typical of all brain regions.·
The brain regions used for this study of circadian
DM content were selected because they represent a probable
site of adrenergic pathways.

The corpus striatum, which

plays an important role as a "relay center" in the extrapyramidal motor sy~tem (Crosby ~ .!.!·, 1962), was shown to
contain extremely high concentrations of DM (Carlsson,
1959).

Subsequent studies demonstrated the presence of a

nigro-neostriatal pathway, which influences DM levels of the
corpus striatum (Anden

~

.!.!•' 1964). A transmitter role

for DM in this region has been proposed because DM fulfills
the presence of degradative

certain necessary criteria:
enzymes (Bogdanski
::

~ ~·,

t

957; Axelrod

·n .!.!•,

1959), the

presence and accumulation of DM in the varicosi ties of fine
neurons (Fuxe

~

!!J.,., 1964), an inhibitory action of DM on

spontaneous firing induced by DL-homocysteic acid (Bloom
and Salmoiraghi,

19~5;

York, 1967),

~vitro

DM release

from DM-storing vesicles isolated from porcine caudate and
lentiform nuclei (Philippu and Heyd, 1970) and.!!! .Y.!.Y.Q DM
release from the cat caudate nucleus (Riddell and Szerb,
1971).

In light of the circadian changes in DM content in
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this region, it is tempting to consider that these circadian fluctuations are occurring concomitantly with changes
in the overall level of inhibition originating in this
area.

This supposition becomes more plausible when' one con-

siders that trough levels of DM are noted during the sleeping phase of this nocturnal species, a time when motor ac-

--

tivity is at a nadir (Scheving et al., 1968a).
The adrenergic pathways that have been mapped in the

•
upper and lower brainstem
appear to be noradrenergic rather
than dopaminergic

(~infra).

The role of DM in these

tissues is probably that of a precursor rather than a transmitter, and its fluctuation reflects circadian fluctuations

t·

in enzyme activity (Figure 13).

The tyrosine hydroxylase

~~

step of catecholamine biosynthesis has been shown to be the
rate-limiting step

(Spector,!!!~.,

1965).

McGeer and

McGeer (1966) demonstrated that the activity of this enzyme
is maximal in the rodent pineal during the dark phase.
Thus, regardless of DM'S role in neurotransmission, its
levels could be increased by augmented nocturnal tyrosine
. hydroxylase activity.

However, it is also possible that

increased DM content noted
~

d~ring

the dark phase reflects

an increased content of DM precursors.

In this regard,

Wurtman and co-workers (1968) have noted a circadian rhythm
in the levels of phenylalanine and tyrosine in blood.

In
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actuality, both factors mentioned could be coupled to set
the pattern in DM content.
An additional controlling factor in the regulation
of DM levels could be attributed to the activity of the degradative enzymes of catecholamine biosynthesis.·

Piepho

and Friedman (1968) demonstrated an inverse relationship
between the striatal levels of DM and its primary metabolite, HVA (cf. Appendix B).

The aforementioned study sug-

gests that fluctuations occur in the activity of either
MAO, COMT, or both.
The pharmacological implications of this rhythm in
DM content are of considerable interest.

Oxotremorine, a

parkinsonomimetic agent that alters striatal DM content
(Friedman and Anton, 1967), exhibits peak toxicity at noon
in animals on a similar 12:12 light/dark regimen (Walker,
1969).

The peak toxicity of this substance occurs at a

time when the striatal DM content is minimal, thus reemphasizing the role of DM in the parkinsonomimetic action
of oxotremorine.

More recently, Speciale and Friedman

(1971) noted a circadian pattern in the sleeping time following a 350 mg./Kg. dose of the hypnotic agent, gammabutyrolactone (GBL).

~

Increased levels of CNS DM have been

noted following treatment with this agent (Roth and Suhr,
1970; Aghajanian and Roth, 1970).

However, the maximum
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sleeping time noted with GBL occurred at 1800 hours, a
time when the DM content of the brainstem and corpus striatum is minimal.

It appears that if the action of GBL is

directly related to DM content, this action is exerted in
a brain region other than those studied.

However, ·GBL

also effects carbohydrate metabolism (Leonard and Watkinson,
1971), and this effect may be involved in the mechanism of
its hypnotic action (cf. Discussion, V-A-4) •

•
2.

Norepinephrine
The NE content of brain regions studied varied on

a Type I circadian basis (Figure 13).

Friedman and co-

workers (1968) demonstrated a similar pattern in the rat
caudate nucleus and midbrain; .this rhythm has recently
been confirmed in the hypothalamus and caudate nucleµs
(Walker _2!

&·, 1971). The latter workez:s also noted a

correlative circadian pattern in the number of granular
catecholamine-storing vesicles in the pre-synaptic nerve
terminals of these areas.
The pattern of striatal NE content has a time course
similar to that of DM in this tissue.
of NE in this area

~as

A functional role

been questioned because of the rel-

atively small amount of NE found here {Bertler and Rosengren, 1959); however, NE may have a definite role in this
region and may be synthesized as required (Phillis, 1970).
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Regardless of its actual role, it is apparent that this NE
rhythm follows that of DM.

The conversion of DM to NE

proceeds readily in the striatum due to high dopamine-betaoxidase ac ti vi ty there (Kaufman and Friedman, 1965) '•

The

striatal NE rhythm might be attributed to the interference
of high DM concentrations in the fluorimetric assay of NE·
However, using the Ansell and Beeson technique, comparable
levels of a DM standard- solution caused no increase in
fluorimetric readfngs.over that of a reagent blank when
treated and quantified in the NE procedure.

Thus, the

rhythm is not an artifact of the analytical method.
The twenty-four.hour patterns of brainstem NE content also represent Type I patterns.

The upper brainstem

rhythm 'is more marked than that of the lower brainstem.
This relationship is similar to that noted for DM in these
regions.

The hypothalamus contains the highest NE levels

of the CNS (Glowinski and Iversen, i 966).

1.B vivo release

of NE has recently been demonstrated. in the cat hypothalamus (Philippu

~al.,

1970).

This area has been implicated

in the control of body temperature by the work of Feldberg
and his co-workers (1964), who found that application of
~

NE close to the cat hypothalamus decreases body temperature.
The present study in rats indicates that peak NE levels are
found at a time when body temperature is also maximal,
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which would seem at odds with Feldberg's finding.

However,

the measurement of total tissue levels of NE does not rule
out the possibility of a highly localized adrenergic con~~

t&··

trol of temperature, which could not be detected by· the
quantitative methods used in the current study.

Further-

more, localized applications of neurotransmitter substances produce sudden changes in concentration in the face
of endogenous transmitter currents, and the time course of
these effects is d'istinct from those observed in circadian
studies.
Noradrenergic mechanisms have also been implicated
in the central regulation of food intake in the hypothalamus (Grossman, 1962; Booth, 1968).

The NE rhythm found.is

in keeping with the postulated role of this area in satiety.
Hillarp and co-investigators (1966) demonstrated
several noradrenergic pathways in the upper brainstem area.
Ascending neurons of group A1 extend rostrally in the reticular formation to the median forebrain bundle, hypothalamus, and parts of the limbic system.

These pathways

appear to be important in the function of the waking animal,
and higher NE concentration would be necessary in these
~

areas during the waking hours to maintain the alert state.
The NE rhythm of the lower brainstem (pons-medulla)
also peaks during the phase of maximal motor activity.
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Fluorescence microscopic techniques have also been used to
f,

map noradrenergic systems of the lower brainstem.

~

and co-workers (1966) found that the majority of NE-con-

~-

Hillarp

taining nerve cell bodies are found in the pons and' medulla.
Descending neurons of group A2 extend caudally from the ventrolateral reticular formation via the anterior and lateral
funiculi.

These fibers give rise to NE-containing nerve

terminals in the spinal cord (Dahlstrom and Fuxe, 1964) •

•

Some possible roles of NE in motor function have been described (a review of these spinal cord actions of NE is
available, cf. Phillis, 1970).

The increased NE content of

the pons-medulla during the dark phase is concurrent With
the peak of locomotor activity in these nocturnal animals.
This result is not unexpected when one considers the
physiological implications of the research of the Swedish

.

'

workers regarding these descending pathways.
Control of these NE rhythms might be attributed to
biochemical mechanisms similar to those described for DM
(cf. Discussion, V-A-1).

The time course of the NE rhythms

in this study is similar to that of rat pineal gland NE
(Wurtman .,!!! !!!.•• 1967).

(

The latter rhythm is thought to

be controlled by light impulses impingfng upon the retina,
and it is abolished by blinding.

The actual biochemical

control of the rhythm in the current study oould be similar
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to the mechanism controlling the pineal rhythm, viz., alterations in tyrosine hydroxylase activity.
sible mechanism of control for the

Another pos-

fluctua~ions

o.f Nli: might

lie in altered activities of the degradative enzymes, MAO
and COMT.
The pharmacological significance of the NE rhythm is
demonstrated by studies such as that of Black and co-work•
ers (1969).

They found that the depletion of NE in the rat

brain by reserpine•

va~ies.in

a circadian fashion, with a

greater NE depletion occurring during the dark phase.

This

is plausible if one. considers that depletion of NE by reserpine occurs via a decreased granular binding capacity.
Since more NE is available in the dark phase, a larger
amount will be unbound by reserpine leading to a greater
percentage of depletion.

Studies of this type aid in clar-

ifying one source of biological variation, so that measures
can be taken in future scientific protocol to limit variability of this nature.
}.

Serotonin
The patterns of 5-HT content in the corpus striatum

and upper brainstem

exh~bited

an inverse relationship to

those noted for the catecholamines, viz., a Type II circadian pattern as seen in most 5-HT studies in rodents

179
(cf.

II-B-6).

In contrast, the 5-HT content of the lower

brainstem exhibited a Type I circadian pattern similar to
that obtained with the catecholamines (Figure 14) •
. The striatal 5-HT rhythm is similar in time course
to that previously described in this laboratory (Friedman
and Walker, 1968).

The corpus striatum has the highest

activity of trypto;phan-5-hydroxylase

(Peters~~.,

1968),

the rate-limiting enzymatic step in 5-HT biosynthesis
(Garattini and· Val•zelli, 1965).

However, recent reviews

of CNS neurotransmitter activities fail to mention any action of 5-HT on the neurons of this region (Curtis, 1969;
Phillis, 1970).

Dah1strom (1969) has described an ascend-

ing pathway from the pons-medulla that terminates in the
striatal region, but the function of this pathway is not
specified.

It is plausible that this latter pathway could

be a part of the

trophotroph~c

system, in which 5-HT is the

postual ted transmitter (Brodie and Reid, 1968).

This system,

when activated, leads to increased parasympathetic output,
drowsiness, sleep, and decreased motor activity;·all of
these parameters are maximal during the sleeping phase in
mammals.

The present study demonstrates that these func(

tions attributed to the trophotrophic system do occur when
5-HT levels are maximal in the

cs.

The 5-HT rhythm of the US is quite similar to that
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of the CS.

The peak in 5-HT levels occurs at a time when

body temperature and motor activity are minimal.

The pos-

sible roles of 5-HT in the various stages of sleep have
been described by

s~veral

1966; Koella, 1968;

authorities (Koella and Czicman,

Pujol~.!!.!,.,

1971).

Koella (1968)

postulated that 5-HT receptor sites are present in the
vicinity of the area postrema; once stimulated, ascending
hypnogenic pathways, presumed to be serotonergic, are activated.

An ascent.ing serotonergic pathway has been demon-

strated histochemically; it ascends from the rostral raphe
nuclei to the diencephalon and telencephalon (Fuxe !1 !Y:_.,
1968).

The diurnal increase in 5-HT levels of this area

coincides with the sleeping phase of rats.
In addition to the aforementioned functional role of
5-HT in the US, Scapagnini and co-investigators (1971) postulated that serotonergic· pathways in the limbic regions
play a role in the regulation of pituitary-adrenal function.
A parallelism has been described in the rhythms of 5-HT
content and plasma corticosterone in the cat.

It is also

interesting to note that US 5-HT levels peak when body
temperature is minimal (cf. Figures 9 and 14).

This seems

to be in contrast to the relationship suggested by Feldberg and Myers (1964) which propose a direct relationship
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between 5-HT levels and body temperature.

However, Bruin-

vels (1970) has demonstrated that intra-cisternal injection of 5-HT produces a dose-dependent hypothermia.

This

latter study is in better agreement with the 5-HT data of
the current study than is. the data of Feldberg and Myers
(1964).
The 5-HT rhythms of the LS exhibit a Type I pattern
similar to that of the catecholamines of this area,

• 14).
(Figures 12, 13, and

This 5-HT rhythm is in marked

contrast to those obtained more rostrally in the CNS (Quay,
1968; Friedman and Walker, 1968).

.

Dahlstrom and Fuxe (1964)

demonstrated the presence of 5-HT terminals in the motor
nuclei of cranial nerves V and X, and in the nucleus of
the tractus solitarius; they also describe a descending
system between the caudal raphe nuclei and the lumbosacral
areas of the spinal cord.

In view of the probable role of

such a system in motor function, a pattern of maximal levels
during the period of greatest motor activity is not surprising (Figure 10).

The depressant actions of 5-HT on

dorsal root potentials, spinal cord reflexes, and interneuronal pathways have been recently reviewed (Phillis,
f

1970).
Control of the 5-HT rhythms could involve one or
more of the following mechanisms.

It could occur via the
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pineal gland, which exhibits a rhythm in 5-HT content similar to that noted in the CS and US (Quay, l963a).

This

pineal rhythm appears to be regulated via alterations in
the level of 5-HTP decarboxylase, the activity of which
varies according to the amount of light in the environment
(Snyder ,tl &·, 1965a&b).

'The 5-HT rhythm of the LS could

be regulated by the pineal rhythm of melatonin, which has
a similar time course.

This latter rhythm appears to be

controlled by alt:rations in the activity of HIOMT, which
~

is inhibited by light (Axelrod!.! !!1•, 1965).

One can

postulate that the 5-HT rhythm of the LS might also be
controlled by a fluctuation of MAO activity (vide supra),
or by an alteration in the dietary intake of tryptophan,
as increased plasma tryptophan has been shown to increase
brain tryptophan concentrations, which in turn leads to increased brain 5-HT levels (Fernstrom and 'Wurtman, 1971).

4.

4-aminobutyric

!£!!!

The only biorhythm that has been described so far
for GABA levels was demonstrated in 1969 (Piepho and
Friedman, 1969).

This previous report described circadian

and ultradian patterns in the CQ and TH-HT respectively
(~infra).

GABA levels of the frontal cerebral lobe exhibit a
circadian pattern in which the difference between peak and
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trough was of borderline statistical significance (cf.
Figure 15,Appendix A).

The rhythm however, is reproducible

and was demonstrated in two different seasons.

The noc-

turnal maximum of this.rhythm coincides with the peak of
motor activity in the rat (Scheving

~

!!:.!.•• 1968).

The

inhibitory actions of GABA on cortical neurons have been
amply demonstrated (Krnjevic and Schwartz, 1967; cf. Bradley,
1969); increased levels of this inhibitory substance in this
area could be ant11lipated with increased motor function,
since motor pathways are associated with the frontal cortex
(Crosby.!! !:J:.., 1962).

On the other hand, one might ask

"why GABA content is not elevated during sleep".

Jasper

and co-workers (1965) demonstrated a positive relationship
between GABA levels in the pia-arachnoid space and the
sleeping state.

Since the brain

prepa~ation

used in this

study involved a saline rinse prior to dissection, some of
·this "released" or unbound GABA, present during the sleeping state, would have been rinsed from the tissue surface.
This procedure might have distorted the true nature of
the tissue rhythm, and a more accurate picture would probably be obtained if tissue levels and ventricular fluid
(

content were both measured.
GABA levels of the CBLM exhibit a more definitive
rhythm than those of the cortex, but have a similar time

-~
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course (Figure 15).

The function of the cerebellum in

motor coordination has been well established, and the biosynthesis of GABA has been confirmed in this structure
Levels of GABA are quite high in the· axons
of cells with proposed inhibitory function, viz. Purkinje,
(vide infra).

basket, stellate, and Golgi II cells.

The content of GAD,

the immediate synthetic enzyme of GABA synthesis, is also
higher in the Purkinje cell layer (Roberts and Kuriyama,

1968).

The catab~ic enzyme of this pathway, GABA-T, also

exhibits highest activity in the neuronal areas receiving
inhibitory synapses, viz. Purkinje, and Golgi cells, and
fiber terminals (Roberts and Kuriyama, 1968).

The inhib-

itory actions of GABA in this region have recently been
reviewed (Phillis, 1970); and its release has also been
documented following stimulation of afferent tracts (Obata
and Takeda, 1969).

In view of the inhibitory role of GABA

in this motor center, a rise in levels, concomitantly with
augmented inhibition associated with motor activity in the
waking phase, is not unexpected.
The GABA rhythm of the corpora quadrigemina (Figure

16) is similar to that of the cerebrum and cerebellum, ie.
a Type I pattern.

Relatively high GABA levels have been

reported in this structure (Fahn and Cote, 1968), suggesting a possible inhibitor7 function of GABA associated with

r
r'
i

"
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this region.

The functions of the superior and inferior

colliculi involve, respectively, the integration of visual
and auditory impulses.

Alteration in the level of inhibi-

tion in these structures might be anticipated due to the
need for discrimination of pertinent stimuli during the
waking phase.

The GABA levels of the TH-HT exhibited a

unique rhythm (Type III) that appeared as a "sawtooth"
fluctuation superimposed on a circadian pattern (Figure 16).
This type of fluc11uation might seem plausible in light of
the multiple functions of this area (Harris, 1966).

These

include regulation of body temperature, responsiveness to
painful stimuli, maintainence of alert behavior, modulation
of the pituitary axis, control of the drive for food and
water, partial input into the physical expressions of emotion, and autonomic regulation.

Although a circadian pat-

tern might occur in some of the aforementioned functions,
the homeostatic nature of others might require patterns
with shorter periods and increased frequencies.

An addi-

tional consideration concerns the possible role of GABA
in modulation of monoamine activity, since the monoamines
NE and 5-HT are found in high concentrations in this area
(Glowinski and Iversen, 1966; Bogdnaski et al., 1957).
t

.

--

-

Yessaian and collaborators (1969) demonstrated in vitro
that GABA releases NE from hypothalamic slices and inhibits

e
~·
k'.

~'-·
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5-HT release.
The central mechanisms of GABA rhythm control could

~
~

"

1

:·~..
:7,

be concerned with several parameters.

Dietary intake of

either glucose or pyridoxine (vitamin B6 ) could affect
GABA biosynthesis, as GABA is the product of an oxidative
pathway with an anabolic B6-catalyzed enzyme, GAD (Roberts,
1960). Tower (1960) demonstrated that virtually all of
the energy metabolism of the CNS depends on the oxidation

•
of glucose, the levels
of which vary on a circadian

pattern~

(Bahorsky and Bernardis, 1967). ·The latter investigators
noted in the rat that the plasma glucose levels are highest during the dark phase,

~resumably

due to increased

feeding; levels of GABA are also maximal during this phase.
Since vitamin B6 is intimately involved in the GABA shunt
(Roberts.!!!!:!.•• 1964), the possibility of a feeding
rhythm could also be implicated as a controlling factor.
This supposition becomes more plausible in light of recent
information that mouse brain GAD activity is higher in the
dark phase than in the light (Roberts, personal communication).

The coincident variation of a coenzyme could be

involved in this difference in enzyme activity.
There has been some discussion in the literature concerning the mechanism of action of gammabutyrolactone, a
sedative agent.

Aghajanian and Roth (1970) have proposed
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that dopaminergic pathways are responsible for the pharmacological effects of GBL, but that a time lag appears between maximal effect on DM content and the sedative reMore recently, Leonard and Watkinson ( 1971) have

sponse.

reported that gammahydroxybutrate, the active metabolite
of GBL, caused an increase in brain glucose levels by any
or all of the following factors:

increased glucose syn-

thesis, decreased glycolysis, or decreased amino

•
thesis from g1ucose.

~

syn-

The circadian pattern of GBL sleeping

time (Speciale and Friedman, 1971) would indicate that altered carbohydrate metabolism is more important than DM in
GBL's action, since the DM rhythm was 180° out of phase
~:

f.

with that of GBL sleeping times.

In other words, DM levels

are lowest when GBL sleeping time is longest.

However, the

GABA content is also lowest at maximal GBL sleeping time;
thus, it appears that when synthesis of this amino acid is
minimal, sleeping time is extended.
The rhythm in GABA levels also seems to affect the
convulsant actions of allylglycine (cf. discussion, section
V-D-1a).

5.

Glycine
Glycine content exhib.i ted different patterns in the

t
I.

F
I

l

individual brain regions examined (Figures 17 & 18).

Type
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I patterns were noted in the pons (Figure 17) and thoracic
cord (Figure 18); the glycine content of these areas varied
in a circadian fashion with a sharp peak late in the dark
phase.

The latter pattern has also been demonstrated for

blood glucose levels in the rat (Friedman and Walker, 1969},
with the peaks of both rhythms occurring coincidentally.
Geiger (1958) found that brain glucose levels are proportional to those of the blood, and that the brain levels of

• in turn, proportional to brain glucose.
free amino acids are,
Shank and Aprison (1970} reported that glycine synthesis
in the CNS occurs predominently via serine conversion catalyzed by serine hydroxymethyl transferase {EC 2.1.2.1).
Furthermore, they demonstrated that glucose is the principle
source of the carbon units of serine in the rat CNS.

Thus,

it is likely that the glycine patterns noted in the pons
and TC reflect the pattern described

~y

olood glucose

~evels,

a pattern defined initially by glucose intake in the feeding cycle of the rat.
The glycine content of the medulla was relatively
stable, exhibiting a Type IV pattern, in contrast to glycine
patterns found in other CNS tissues examined.

It is pos-

sible that regulation of a steady state level of glycine
in this tissue occurs via interconversion to serine, the
common storage form of glycine (Blakley, 1954; Kawasaki
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et al., 1966). This stability of medullary glycine levels
-might be indicative of its association with a non-fluctuating medullary function.

Indeed, glycine has been shown to

:.

exert a potent inhibitory influence on neurons of the cun-

1

eate nucleus

(Galindo~,!!.,

1967), which with their pro-

jection systems, function in the transmission of proprioceptive and tactile impulses.

It is quite possible

that these systems are maintained during both sleeping and
waking phases witn• a fairly constant level of inhibition.
Fluctuations of glycine content of the cervical and
lumbar spinal enlargements described a Type I circadian
pattern (Figure 18).

The pattern in these areas was not

as sharp as that defined by the pons and TC, but the range
in levels was still significant.

The proposed role of

glycine as a spinal inhibitory transmitter has been reviewed (Aprison and Werman, 1968; Werman'and Aprison, 1968).
These investigators
the spinal cord

hav~

described higher glycine levels in

enlarg~ments

relative to the mass of mus•

culature supplied by these regions (Aprison ,.!! ,!l., 1969b).
Glycine has also been show to possess an equilibrium po..

tential similar to that of the physiol:ogical interneuronal
inhibitory transmitter indicating that they are probably
the same (Curtis et Jll., 1968a).

~

~

in glycine

co~tent

The circadian changes

parallel those of .motor activity as
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might be anticipated due to the greater need for regulatory
modulation during movement.

This regulation would require

some specialized control mechanisms to prevent extreme
fluctuation as noted in the pone and TC.

Some of the mech-

anisms controlling glycine content in these areas include
interconversion to

serine(~

glycine into protein
1966; Aprison

!! !!!,.,

from the CSF (Apri\on

(Mase~

supra), incorporation of

ai., 1962; Sky-peck ,!U .!!l.••

1969a), active uptake of g1ycine

!!

.!!_., 1~69a), and active transport

of glycine from CSF into blood (Murray and Cutler, 1970).
Any or all of the aforementioned controlling mechanisms
might aid in maintaining the constancy of glycine levels
during motor activity, but it is not now possible to assign the degree of contribution of each factor.

Thus, al-

though large fluctuations in glycine content occur in the
pons and TC where glycine probably

funct~ons

only in inter-

mediary metabolism, less marked variations are noted in the
cervical and lumbar enlargements, where it appears to play
a role in motor inhibition.
The pharmacological implications of these rhythms
can be appreciated when one examines the data on the cir(

cadian toxicity of strychnine, a glycine antagonist- (cf.
discussion section V-D-1b).
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B.

Effects .Q!.

Photope~iod

Reversal .Q.U 1ill! Levels of

Putative Qli§. Neurotransmitters
The technique of photoperiod reversal was utilized
in this study to evaluate both the endogenous or exogenous
character of the

r~ythm

and the effect of reversal as a

stress on cumulative amine levels.

Exogenous, or extrinsi-

cally regulated rhythms were noted in the striatal DM, NE,
and 5-HT content,

~pper

brainstem 5-HT content, and cerebral

and cerebellar GABA content.

Endogenous, or intrinsically

controlled rhythms were demonstrated in catecholamine content of both brainstem regions.

In other rhythms inves-

tigated (5-HT of the lower brainstem,collicular GABA, and
GABA of the TH-HT), reversal appeared to cause a flattening
of the pattern seen on a normal cycle.
1.

Dopamine
The pattern of DM levels in the corpus striatum ap-

peared to be exogenous as it was readily reversed by photoperiod reversal (Figures 19 & 20).

The exogenous nature of

this rhythm was not surprising in light of the relationship
of DM to the extrapyramidal motor system (cf. discussion,
~

section V-A-1).

Thus, atriatal. DM levels apparently peak

during the phase of maximal motor activity regardless ot
the light/dark cycle used.

On the other hand, the rhythms
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in DM content of both brainstem areas were found to be
endogenous (Figure 20).

It is difficult to ascribe a

function to these latter pattern• because of the limited
number of studies dealing with the effect of photoperiod
reversal on physiological functions.

However, it should

be noted that brainstem NE, which is derived from DM, is
also endogenously regulated.
A comparison of the striatal DM content in the comparative phases o~the two experimental cycles reveals that
photoperiod reversal leads to increased basal DM content
(Table 2).

In the pilot study on DM content (Figures 11 &

19), an increased basal level of DM was noted under reversal conditions.

Since the possibility of seasonal varia-

tion existed in this initial study, a second study was performed with rats conditioned on both cycles simultaneously
(Figures 12 & 20).

Striatal DM levels were once again high-

er on the reverse cycle, suggesting the possibility of a
stress-induced increase.

Although DM levels are stable

under some types of stress, viz. foot-shock stress (Bliss
~

.!J:,., 1968), oscillatory stress {Smookler and Buckley,

1969), and aggregation {Bliss and Ailion, 1969), other
~

forms produce increased DM levels.

Welch and Welch {1969)

noted increased DM levels due to a chronic fighting stress.
Furthermore, NE turnover has been found to increase in a

193

variety of stress situations (cf. discussion, section

v-B-2), suggesting that an increased level of DM would be
needed to augment NE bioeynthesis.
A comparison of brainstem DM content during the aotivi ty or sleep phases reveals an interesting difference in
the effect of photoperiod reversal on this tissue.

The DM

. content of the lower brainstem is increased during inversion, but that of the upper brainstem is not.
of photoperiod

re~rsal

The action

on lower brainstem DM might produce

a stress similar to that described for the

cs.

The lack of

any apparent effect on the US suggests that this brainstem
area responds differently to "inversion stress", but the
reasons for this localized specificity in response are unclear.

It is unfortunate that many studies dealing with

stress involve catecholamine levels of the whole brain, or
brainstem _!!! !Q!g_, rather than individuaJ! regions of the
brain.

Localized responses of the type demonstrated in

this study might occur, but are obscured by homogenization
of the whole brain.
2.

Norepinephrine
Photoperiod reverqal has similar effects on the NE

patterns as on those of DM

(Figu~e

21).

The reversal of

the striatal pattern of ME is not surprising, as NE levels
of this tissue

~robably

follow those of DM (ct. discussion,
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section V-A-2); thus,the reversal of the DM

-

rhythms(~

supra)is of prime importance in the NE rhythm.
The NE rhythms of the brainstem were unchanged by

photoperiod reversal indicating an endogenous character.
These endogenous rhythms might play a role in some nonreversibl e endocrine or autonomic function, since the noradrenergic pathways of the brainstem extend rostrally to
the level of the diencephalon (Hillarp !,! _!!., 1966).

The

question of defini!l.g a non-reversible parameter is a difficult one since most studies indicate reversibility of hypothalamically-controlled functions, viz. body temperature
(Figure 9), locomotor activity (Figure 10), and ACTH re•
lease (Krieger, 1970).

It is also interesting that one of

the previously postulated control mechanisms, pineal influence, would not appear to control this rhythm, as the
NE rhythm of the pineal gland is affected by photoperiod
alterations {Wurtman

.!! .!J:.., 1967).

Both the control mech-

anisms of, and the parameters affected by this rhythm offer
fertile areas of future stu4y.
Cumulative striatal NE levels are significantly
higher during the phase of activity of the reverse cycle
than during this phase of the normal cycle.

This could

indicate a stress factor associated with photoperiod reversal, as has been previously described for DM content
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(vide supra).

Changes in NE turnover have been associated

-

with several stressful situations, viz. intense muscular
exercise (Gordon§.! .!!l•• 1966), immobilization (Corrodi

--

et al., 1968a; Welch and Welch, 1968), changes in environ-

mental temperature (Corrodi ,!.!

.!!••

1968b; Simmonds and

Iversen, 1969), chronic electroshock (Kety ,!! !J:.., 1967),
and foot-shock treatments (Thierry et.!!•• 1968; Bliss
et al.,
--

1968).

.

•
Two alterations
in cumulative NE levels were pro-

duced by photoperiod reversal:

increased minimal NE levels

in the US, and increased maximal NE content in the LS.

The

reason for these localized increases in NE content on the
reverse cycle remains obscure, but some stress factor in
local brainstem pathways could explain these alterations.
It is quite possible, if these rhythms are assumed to be
'

due to increased enzyme activity, that the increased NE

;-.

levels during the phase of maximal NE content in the LS
merely reflect the higher DM levels of this tissue during
reversal.

3.

Serotonin
The effects of phdtoperiod reversal on 5-HT content

involve reversal of the 5-HT rhythms of the CS and US, and
a flattening of the pattern in the LS (Figure 22).
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striatal 5-HT levels are reversed so that their maximum
still coincides with the troughs of motor activity, or the
sleeping phase of this nocturnal species.

Although the

role of 5-HT in this area is unclear, it is evident that
levels follow the pattern of those in the upper brainetem,
which appear to be involved in sleep mechanisms (cf. discussion, section

V-A-~).

A similar reversal occurs in the pattern of 5-HT
content in the US.• This reversal strengthens those
theories that relate 5-HT content to sleep, as reversal of
the sleep/wakefulness cycle also occurs.

Thus, maximal

5-HT content is still noted during the sleeping phase.
The control of these rhythms of the CS and US could be
seated in the pineal gland, which exhibits a similar rhythm
determined by fluctuations in the activity of 5-HTP decarboxylase (Snyder.!!

!J.., 1965a).

The 5-HT pattern of the LS, which was 1ao 0 out of
phase with the other 5-HT rhythms on the normal cycle,
seemed to disappear when subjected to reversal.

The aboli-

tion of the rhythm offers an intriguing possibility, that
coinciding exogenous and endogenous patterns are present.
These patterns might be in phase on the normal cycle, but
out of phase on the reverse cycle.

This possibility gains

credence when one considers that Quay (1968) haa reported
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differential 5-HT rhythms in the brainstem, an exogenous
one in the lateral brainstem and the absence of any 5-HT
rhythm in the medial brainstem.

An additional considera-

tion involves the different pathways described by Dahlstrom
and Fuxe (1964).

They demonstrated serotonergic pathways

from the vasopressor region of the rat medulla to the sympathetic lateral column of the spinal cord, and an ascending

pathw~y

to the median forebrain bundle.

Differential

pathways of this t'Ype could possess differential rhythms
depending on their function; thus, it is possible that the
apparent loss of this rhythm actually represents the effect
of a reversed photoperiod on an exogenous rhythm, and its
lack of effect on an endogenous one.
A

c~mparison

of the cumulative 5-HT levels of com-

parable phases indicates only one significant difference
(Table 4) - an increased 5-HT trough level in the.LS on the
reverse cycle.

This increase further emphasizes the pos-

sibility of an endogenous 5-HT rhythm in .1!!!.!! tissue, which
resists reversal and overrides the effects of photoperiod
inversion.

The lack of any other alteration in 5-HT con-

tent is not surprising since other studies of stress have
indicated that 5-HT l'eveis are essentially unchanged (Bliss

.!! !!·• 1968; Bliss and Ailion, 1969; Welch and Welch, 1969).
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4.

~-aminobutyric

Acid

The effects of photoperiod reversal on central GABA
levels involved some differential inversion patterns dependent on the tissue under study.

The inversion of the

pattern in GABA content was marked in the frontal cerebral
lobe and cerebellum (Figure 2}).

This reversal parallels

that of motor activity, and such a response might be expected in view of the potential roles of GABA previously
described (cf. dis~ussion, section V-A-4).

The reversed

rhythm also coincides with the feeding rhythm, so that the
:;.

dietary intake of glucose and pyridoxine might also be involved in regulation of this reversed pattern.

It is also

possible to speculate that some of the enzymes involved in
oxidative metabolism in these areas might express photodependent changes in activity.
A "pure" circadian rhythm could not be demonstrated
in the CQ following photoperiod reversal, although a pattern with marked peak and trough was noted (Figure 24).
The peak and trough, however, both occurred in the dark
phase, possibly indicating a greater resistance to the
effects of reversal in this tissue.

The reason for the

~

increased resistance can only be speculated upon, but it
might be related to the high concentration of GABA in this
tissue (Fahn and Cote, 1968), and the degree to which the
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enzymatic activity adapts to the new photoperiod.

It may

be that adaptation of a sufficient percentage of the total
enzyme content necessary for a clear demonstration of in~
version does not occur in the limited three week period of
adaptation commonly used.

The possibility of differing ad-

aptation periods for specific rhythms, depending on the
tissue level of transmitter and the controlling factors
involved, must be considered in studies of this type •

• fluctuation of TH-HT GABA content preThe "sawtooth"
viously described resists photoperiod reversal, although
the circadian component of this rhythm appears to be reversed (Figures 24 & 25).

This apparently is an example

of an extreme fluctuation occurring in the presence of
an exogenous circadian pattern.

It is quite possible that

more than one type of,rhythmic pattern in the levels of
this putative inhibitor could occur in a.multi-functional
area as the hypothalamus (Harris, 1966).

It appears as

.though patterns of different periods may be synchronized
on the normal cycle, but become desynchronized on the reverse cycle as the ancillary fluctuations are less clearly
defined following inversion (Figure 25) ·•
~

When the cumulative GABA levels of various phases
are. compared (Table 5), significant increases in GABA content of the normal cycle.are noted' in the CQ and the TH-Hf.

r
'·
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However, the significance of this finding is suspect, since
the studies on these two areas were conducted during different seasons.

Seasonal fluctuations in GABA levels have

been reported (Roberts, personal communication) due to
·

seasonal differences in the pyrido:xine content of various
rat food formulae.

~.

These diets are made from grain sources

which have different vitamin content depending on environmental factors, eg. length of growing season, time of harvest, etc.

A simi-iar comparison of GABA levels of the fron-

tal cerebrum and OBLM revealed only one significant difference - cortical GABA levels of the normal light phase
are higher than those of the reverse light phase (Table 5).
The range of values of cortical GABA levels was greater on
the reverse cycle due to the fact that levels of the light
phase had decreased leading to a significant difference be-

..

r

tween peak and trough not seen in the normal cycle.

This

definition of the reverse cycle GABA rhythm is puzzling.
It is possible that GABA plays some hitherto unsuspected
role in stress-related situations, but no studies of the
effects of stress on central GABA levels have been found
in the literature.

Moreover, GABA levels are apparently
~

affected only in the cortex {of those areas examined in the
current study).

A correlative study of catecholamine and

amino acid levels of the cerebrum during stress might aid
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in evaluating this regional difference.

c.

Evaluation .2!, Electroshock Convulsive
Mechanisms During Different Phases

The effects of maximal electroshock seizure induction (MES) were evaluated in Ha/ICR mice in light and dark
periods of the normal. cycle.

Since 0.9% saline solution

and 5% gum acacia suspension were to be used as vehicles
for the test

drug~

it was important to determine whether

they affect control mice in the same way (Table 6).

The

evaluation involved a measurement of the timing of the
seizure components:
and clonic phase.

extensor latency, tonic extension,
These phases were used by Tedeschi and

co-investigators (1956) in their evaluation of the effects
of current intensity on the timing of seizure components.
At the 50 ma. level utilized in these studies, the seizure
times were consistent with those of the former study.
The mechanisms underlying generalized tonic/clonic
seizure patterns appear to be located in the spinal cord
Esplin and Freston (1960) demonstrated tonic/clonic patterns following synchronous stimulation of the cervical
spinal cord.

~

They proposed that the motor expression of

the seizure involved the "sterotyped response of spinal reflex systems to generalized stimulation of 'the cerebroepinal tracts".

The initial response to a massive stimulus
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;;

is one of nexion because the flexor muscles are under a
lower degree of inhibition than are the extensors.

t).

i
.

.

Tonic

flexion leads to a lessening of inhibition on the more
powerful extensors, thus allowing this dominant muscle
group to contract resulting in tonic extension.

The ter-

minal clonic movements appear to depend on "interactions
between the antagonistic

mo~oneuron

pools through inverse

myotactic reflexes, as well as upon the nature of the
cerebral seizure lischarges which play upon the moto1

neurons".

Gastaut and Fischer-Williams (1959) demon-

strated that the caudal reticular formation is the critical brainstem area for transmission of seizure· impulse
traffic from brain to spinal cord.

The mode of activation

of the caudal reticular formation might involve either hypersynchronous activity or a release from higher central
,

inhibitory mechanisms.
Circadian changes in certain types of seizure phenomena have been reported in various species of nocturnal
rodents. 'The susceptibility to Indoklon-induced seizures
has been shown to be greater in the: dark phase in both
mice and rats (Davis and Webb, 1963; Webb and Russell,
~

1966).

Schrieber and Schlesinger (1971) noted a circadian

pattern with peak susceptibility in the nocturnal. phase
to both sound-induced and electrically-induced seizures
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in DBA/2J and F1 hybrid mice.

A similar rhythm of

margin~

significance (P<0.1) was described in C57BL/6J mice.
Wada and Askura (1970) have also described maximal susceptibility to audiogenic seizures in the Wistar albino
rat during the nocturnal phase.

Thus, peak susceptibility

to these seizure induction procedures occurs during the
dark phase in these nocturnal rodents.
The only diurnal/nocturnal difference that was noted
in the current stu~y utilizing control Ha/ICR !!!..£.!! involved
a shortening of the extensor latency
(Table 6).

~

in the dark phase

A decreased latency time might be expected dur-

ing the nocturnal phase, owing to the increased seizure
susceptibility found in this

phase(~

supra).

Extensor

latency time is essentially equal to the time of the tonic
flexion phase.

Since the levels of most excitatory and

inhibitory putative transmitter substances are maximal at
night, impulse traffic might be transferred more readily
in this situation in which the animal is normally involved
in motor function.
Some differences in seizure component times were
also noted in comparisons of saline-treated versus acacia~

treated control animals (Table 6).

Extensor latency time

in saline-treated animals was significantly shorter at
0600 hours, and the time of tonic extension was shorter in
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saline-treated animals at both time points.

Acacia was

utilized in this study because of its previous use in evaluation of the anti-convulsant activity of meprobamate
(Berger, 1954).

The compound is commonly used for the

suspension of insoluble substances in water; it is considered ideal because it exerts a similar osmotic pressure
to that of serum protein

(Martin.!!~.,

1961).

Gum

arabic (acacia) consists mostly of arabin, the calcium
~

of arabic

aci~;

upon hydrolysis, it yields arabinose,

galactose, and arabinosic acid (Martin!!!!•• 1961).

It

appears that the components of this suspending agent, or
perhaps the.possible alteration of calcium levels, or
some ionic binding properties of the gum might have an
action on the timing of the tonic extension phase.
The lack of a:Lteration in both seizure component
times and minimal electroshock threshold•suggest the possibility of a "homeostatic equilibrium" in the excitability
of the CNS.

As noted in the current study, levels of

putative "threshold-elevating" substances (DM, NE, GABA,
c;

glycine)- are maximal during the dark phase.

Thus, it

'

might be assumed that the threshold would also be higher

' be remembered that CNS excitain this phase, but it must
bility is based on the relative levels of both excitatory
and inhibitory influences.· The level of acetylcholine in

r
.
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the rat brain is also maximal in the dark phase (Walker,
1969), and ACh has "threshold-lowering" actions (cf. Maynert, 1969).

The increased ACh level might offset the

increased levels of inhibitory substances leading to a
stability in seizure susceptibility.
that the

level~

It is also possible

of another potential excitatory substance,

glutamate, are elevated during the dark phase as the levels
of glucose are maximal during this phase (cf. discussion,
section V-A-5).

Tie CNS levels of this amino acid trans-

mitter suspect should be proportional to the level of free
glucose.

In conclusion, the constancy of most seizure

component times as well as of minimal electroshock seizure
threshold might be due to a balance between the excitatory
and inhibitory neurochemical influences on the CNS.

These

substances appear to fluctuat.e in similar circadian patterns; thus, it appears

t~at

the measurement of any in-

dividual neurochemical component cannot serve as an index
for the Qomplex mechanisms involved in MES seizure production.
D.

!!!!

Evaluation~

Drug Efficacy !!! Respon,!!

12 Lj,ght £!: Darkness
Convulsant Compounds
a. Allylglyoine
The peak toxicity of allylgl.yoine was found to occur
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at 1800 hours, late in the light phase (Figure 26).

This

peak coincides with minimal levels of GABA in the whole
rat brain (calculated from the previously noted individua1
data), or minimal activity of GAD in the mouse brain
(Roberts, persona1 comm:u.nication).

Allylglycine was shown

to have convuleant properties by Schneider and co-investigators (1960).

Alberici and collaborators (1969) demon-

strated that the drug definitely inhibited GAD with no aiteration in the ac\ivity of GABA-T (this action leads to a
;,

decreased level of GABA in the rat CNS).

Allylglycine was

'>
"

found to have no effect on the metabolism of pyridoxine,
aspartate, glutamate, glycine, glutamine, or a1anine in the
CNS.

Administration of

t~is

convulsant agent fµrther led·

to a marked structural alteration in the nerve endings of
the cerebellar Purkinje cell layer.
The peak toxicity of allylglycine·also occurs coincidentally with minimal glycine content in the lumbar
spinal cord.

Recent evidence presented by Roper (1970) has

indicated a similar membrane receptor site for both glycine
and allylglycine in the Mauthner cells of the goldfish.
Thus, it is possible that a competition of a similar nature
~

could occur in the mammalian

sp~nal

cord.

The minimal toxicity of allylglycine was noted during the dark phase, when levels of .l!.2!b GABA and glycine

r
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are maximar.

From these results, it is impossible to

assess the relative importance of either transmitter suspect in-the action of allylglycine; however, both compounds
might be involved (vide supra).

In contrast to electro-

shock, a circadian pattern was obtained with this convulsant agent.
;

Thie response is probably seen because, unlike

electroshock, allylglycine affects one, or possibly two,
inhibitory systems.

•

Thus, it is capable of upsetting the

balance of excitatory and inhibitory CNS factors, resulting in a differential pattern of toxic actions.
b.

Strychnine Sulfate

The circadian toxicity curve of strychnine sulfate
is similar to that of allylglycine (Figure 26).

Peak tox-

icity of strychnine was also noted at 1800 hours, when
glycine levels of the lumbar spinal cord are minimal.

The

role of glycine as an inhibitory transmitter in this latter
region has been extensively investigated (cf. Aprison and
,,

Warman, 1968).

Strychnine has been shown to supress re-

versibly both post-synaptic inhibition in the spinal cord
and the hyperpolarization of spinal neurons due to the
iontophoretic application of glycine (cf.

"

Curtis~

1969).

Thus, it appears that the glycine levels of the spinal
cord influence the toxicity of strychnine, a supposition
borne out by a comparison of their respective circadian

r
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patterns. ...I.n contrast to the actions of allylglycine,
strychnine has been shown to have no actions on the effects
elicited by iontophoretically-applied GABA (cf. Curtis,

l

1969), so the effects noted here can be more directly related to glycine content.
In contrast to the rhythm noted in this study, Tsai
and co-workers (1970) reported a circadian toxicity curve
for strychnine in which maximal toxicity occurred during
the dark phase in -rats on a programmed L/D cycle.

It

should be emphasized that these investigators did not

~so-

late the .strychnine-treated rodents, so that. greater interaction would be expected during the dark phase. This enhanced interaction of animals housed together would lead
to increased seizure

su~ceptibil.ity.

The mice in the cur-

rent study were isolated following strychnine injection
(cf. Methods section, II-D-2-a), therby preventing the
aggregation effect and allowing a truer appraisal of the
pharmacological actions of the drug.
2.

Anti-convul.sant Compounds
a.

Acetazolamide.

The anti-convulsant action of acetazolamide did not
vary appreciably when tested during different phases of
the illumination cycle in either the mouse (Table 7) or

i

the rat (Table 8)-.

The anti•oonVUleant action ot
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acetazolamide has been postulated to occur via various
mechanisms (cf. Millichap, 1965, 1969).

The most inves-

tigated of these mechanisms involves the inhibition of
brain carbonic anhydrase by acetazolamide which leads to
increased

co 2

levels in the CNS, a decreased blood pH, and

a decreased seizure susceptibility (Millichap, 1969).
increased brain

co 2

This

level is accompanied by an increased

CNS ratio of extracellular/intracellular sodium ions,

• neuronal membranes and limits aberrant
which stabilizes the
discharges.

Additional studies have demonstrated that

acetazolamide decreases the uptake of radioactive sodium
by brain cells (Millichap, 1965).

It is difficult to eval-

uate the role of light programming on this mechanism, since
the possibility of rhythms in brain carbonic anhydrase activity has not been investigated.

However, the stability

.

of dosage demonstrated would indicate that either carbonic
anhydrase activity is relatively unvarying, or that
acetazolamide is detoxified at a rate that varies in opposition to carbonic anhydrase activity.

Acetazolamide

is rapidly absorbed, well distributed and excreted mainly
in an unchanged form in the urine (cf. Millichap, 1965).
~

Thus, a circadian pattern in urinary excretion, which is
greater in the dark phase in nocturnal species (Zsoter and
Sebok, 1955; ct.

Mills, 1966), might be expected to
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increase acetazolamide clearance duriµg this phase.
..

Two ancillary mechanisms for the action of acetazol-

.~"

~··

amide involve putative CNS neurotransmitters.

Woodbury

and Esplin (1959) demonstrated that acetazolamide administration results in increased levels of glutamic acid,
glutamine, and GABA.

Thus, if the action of aoetazolamide

depends on GABA, a maximal response might be expected during the dark phase (when CNS levels of GABA are maximal) •

• rememQered that excretion of acetazolaHowever, it most oe
mide might be maximal in the dark phase (.!19:.! supra), and
would thereby "neutralize" the rhythmic fluctuations in
i'

response.

Gray and Rauh ( 1971) indicated an involvement

of the monoamines NE and 5-HT in the anti-convulsant action
of carbonic anhydrase inhibitors.

These researchers claim

that a reduction of anti-convulsant potency accompanies depletion of the monoamines by synthesis inhibitors.
.~

However,

more recently, Koslow and Roth ( 1971) have shown that monoamines are probably not involved in this action because the
anti-oonvulsant action of acetazolamide was similar in reserpinized and control animals.

The fact that NE and 5-HT

rhythms are 180° out of phase with each other complicates
~

any assessment of the role of monoamines in the anti-convu.lsant action of acetazolamide.

Acetazolamide increased the extensor latenc7 time
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over that of control animals in both phases of the illumination cycle (Table 9 & 10).

This result was not surpris-

ing since similar changes are commonly noted in the labor-

atory evaluation of anti-convulsant agents (cf. Millichap,
1965).

Acetazolamide also increased the time of clonus in

mice during the light phase (when compared to control).
'•

This phenomenon is seen with other anti-convulsants, eg.

..

'

diphenylhydantoin, and is said'to be related to the ability
of a compound to p'°event the spread of seizure impulses
(cf. Millichap, 1965 and Woodbury, 1969).

The factors be-

hind this increased clonic time in the mouse during the
light phase remain unclear. ·
;

.

b.

Diphenylhydantoin

As in the case of acetazolamide, there was no difference in the PD50 dose of diphenylhydantoin between
phases in either species studied (Tables'7 & 8).

~

Diphenyl-

hydantoin is well absorbed, and is distributed readily to
most tissues.
20-~5%

Due to extensive protein binding, only

of the drug exists in the free form in plasma.

A

large percentage of the total dose (95%) is metabolized
in the liver, with the major metabolite being the phydroxyphenyl derivative.'

The anti-MES activity of di-

;_·

phenylhydantoin is due to its ability to prevent the
spread of the seizure by blocking post-tetanic potentiation
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(PTP).

The blockade occurs by stimulating "sodium pump"

activity (Woodbury and Kemp, 1971).

The lack of any cir-

cadian response is unexpected in view of the work of
Radzialowski and Bousquet (1968), who noted that hepatic
drug-metabolizing enzymes in the rat exhibit maximal activity during the dark phase.

..Thus, with an enhanced drug

,'

metabolism and an increased urine flow to remove the met-

4

abolized drug in the dark phase, a decreased potency could

J·

be anticipated.

H'bwever, the higher levels of GABA in the
I

CNS during the dark phase would tend to enhance the action
of diphenylhydantoin.

The drug has been shown to decrease

the concentration of brain' glutamic acid while increasing
that of GABA (Vernadakis and Woodbury, 1960).

More

recently, Woodbury and Kemp ( 1971) postulated that the "hyperpolarization of nerve endings of inhibitory neurons by
DPH could also increase release of inhibitory neurotransmitters".

The increased nocturnal GABA content could lead

.

to a greater inhibitory action and compensate for the en-

'
·.•

.

!\··

.'

!!,''

hanced

degrad~tion

of the drug in this phase, dampening

any circadian fluctuation.
When: the seizure component times of diphenylhydantoin
(

were compared with control, the following differences were
noted:

1) increased extensor latency time in both species

and during both phases, 2) increased clonic time during

the light phase in the rat, 3) decreased tonic extension
time during both phases in the mouse and during the light
phase in the rat (Tables 9 & 10).

The increased extensor

latency time and decreased tonic extension time would be
',

anticipated in the case of diphenylhydantoin as these
changes are noted with most anti-convulsants (cf.
chap, 1965).

Milli-

The lack of a decreased tonic extension time

in the rat during the dark phase suggests a decreased effectiveness of dilhenylhydantoin, although the fluctuation
of this component is not reflected in the PD50 comparisons.
This supposition is r,einforced by the decreased period of
clonus seen in the rat during the dark phase.

An increased

period of clonus is characteristic of the hydantoins (cf.
Woodbury and Kemp, 1971).

This exacerbation of clonus

has been attributed to a hydantoin-induced decrease in the
·,..
<'i

level of pre-synaptic inhibition in various tracts involved
with the production of clonic movements (Woodbury, 1969).
These fine changes in component timing might indicate a greater rhythmic fluctuation in the metabolism of
diphenylhydantoin in the rat.

This possibility is further

emphasized by the significant decrease 'in tonic extension
in the light phase as compared to that of the dark phase in
diphenylhydantoin-treated rats.

Thus, the comparatively

prolonged tonic extension during the dark phase could be
indicative of a lower efficacy at that time, although this
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change is subliminal when only the PD50 is considered.

A

study of the circadian pattern in diphenylhydantoin metabolism and turnover could prove to be valuable in considering these aforementioned fine changes.

c.

Meprobamate

In contrast to the two drugs previously discussed,
the PD50 of meprobamate was significantly higher in the nocturnal phase in the mouse, and a similar difference of bor-

•

derline significance was obtained in the rat (Tables 7 & 8).
Meprobamate's anti-convulsant actions were first described
~

by Berger (1954), although the drug is more commonly used

.:'.

as a sedative anti-anxiety agent (Domino, 1971).
is readily absorbed and uniformly distributed;

The drug

88-9~

of

the total dose is metabolized to either the hydroxy deriva·'

:···

tive

(6~)

or the glucuronide metabolites (30%).

These met-

abolic ch~nges occur in the liver, and their products are
excreted in the urine (cf. Domino, 1971).

The mechanisms

of meprobamate action probably lie in its depressant actions on several CNS areas, viz. the

thal~us,

limbic

system, reticular formation, hypothalamus, and spinal cord
(cf. Smith, 1965).
dark phase

~ight

The higher PD50 values obtained in the
~

be due to the

alt~red

motor activity of

Increased motor activity during this stage
in the circadian cycle could

have antagonistic effects

on
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the general depressant action of meprobamate.

One addi-

tional factor involved in the nocturnal elevation of the
PD50 would be an increased hepatic metabolism of the drug
during this phase.

Radzialowski and Bousquet (1968) demon-

strated that the hepatic drug metabolizing enzymes have
maximal activity in the. dark phase in rodents.

These com-

bined factors probably lead to the altered efficacy of the
drug seen in the dark phase.
Meprobamate•increased extensor latency time and decreased tonic extension time in both species and all phases,
;,

when compared with controls (Tables 9

&

10).

As dis-;.

cussed previously (cf. discussion, section V-D-2-a and
V-D-2-b) these changes were anticipated, and confirm the

r

:(

anti-convulsw;a.t efficacy of this agent.

The duration of

the clonic phase was also increased during both phases in
the mouse and during the light phase in the rat.

This

increased clonus with diphenylhydantoin and acetazolamide
has been previously discussed (cf. discussion, section
V-D~2-b);

however, an action of the type noted for di-

phenylhydantoin has not been demonstrated for meprobamate.
The enhanced clonue noted during the light phase in the
~

rat might be indicative.of the increased potency of·mepro·

bamate during this phase of diminished activity.
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d.

Phenobarbital Sodium

Phenobarbital in rodent species during both phases
gave identical changes as those noted with diphenylhydan:.c

toin, viz. an unaltered PD50 value (Tables 7

&

8), with

finer differences in the duration of rat seizure components
(Tables 9 & 10).

Phenobarbital is 77-89% metabolized in

the liver via para hydroxylation of the phenyl ring.

This

inactive metabolite is excreted in the urine (Woodbury and
Kemp, 1971).

In ae.dition, roughly one third of an ad-

ministered dose of phenobarbital is bound to plasma protein
(cf. Millichap, 1965).

The anticonvulsant actions of phen-

obarbi t'al are "multiple and rather nonselective as compared
with the rather pure effects possessed by DPH" (Woodbury,
1969).

Some of these effects include inhibition of oxi-

dative metabolism, altered transport of sugars, uncoupling
of oxidative phosphorylation (cf. Woodbury, 1969) and a
decrease in the production of free acetylcholine (McLennan and Elliot, 1951).

In consideration of phenobarbital's

metabolism and mechanisms of action, a maximal effect
might be expected to occur during the light phase of the
cycle due to decreased hepatic metabolism (Radzialowski
and Bousquet, 1968) and decreased urinary flow (Zsoter and
'"

Sebok, 1955).

In addition AOh levels are lower at this

time (Friedman and Walker, 1969b; Massarelli

.!!

~·•

1970)

217

and oxidative metabolism appears to be minimal as reflected
·y.·

"

by the decreased GABA levels of this phase.

The stability

of the PD50 and phenobarbital's reeemblence to diphenylhydantoin under similar conditions suggests that these
aforementioned mechanisms are less important for phenobarbital's anti-convulsant action than the common action
that it shares vith diphenylhydantoin - an inhibition of
post-tetanic potentiation (cf. Woodbury, 1969).
When

seizu~

component times are considered, pheno-

barbital administration led to an increased extensor
latency time in both species during both phases, and a decreased tonic extension and.an increased clonic time during
both phases in the mouse, and during the light phase in
the rat (Tables 9 & 10).

Once again, these alterations

were similar to those of diphenylhydantoin, and might be
due to similar mechanisms.

The reason for the fine dif-

ferences in the seizure component times of the rat during
different phases is unclear, but might lie either in some
difference in the metabolic pattern or in the degree of
subliminal depression in these two species.
e.

Amino-oxyacetic Acid

' . (AOAA) has been reported to
Amino-oxyacetic acid
.
.
be an effective ant1-oonvuJ.eant oapable of abolishing the
tonic extensor phase ot electroshock seizures (Kuriyama
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--

et al., 1966).

i-,·.

Attempts to duplicate this action in the

present study were unsuccesefu1, even though the trial

doses ranged between the

ED1

and LD40.

There were only two

apparent differences between the two studies:

1) the

seizure induction method, 2) the type of light source used.
Kuriyama and co-workers ( 1·966) used sku11 electrodes,
whereas corneal electrodes were used in the present study.
·

i.

These two methods of seizure induction are apparently different in their ac4tion, as the minimal electroshock threshold is 61 ma. in

~ne

(sku11 electrodes) and 10 ma.' in the

other (corneal electrodes).

A plausible explanation of

this difference might lie in the pathways involved in
seizure induction. ·A shock administered via sku11 electrodes might initiate seizure by either direct stimulation
of surface tissue layers or by a direct spread of the current across the sku11 or meningial linings to the spinal
cord.

Administrati.on of shock via corneal electrodes

probably initiates a seizure via supra maximal stimulation
of afferent tracts; the seizure occurs due to transmission
of this stimu1us through the brain pathways to the spinal
, cord.
~

It is also possible that the difference in the
quality of light source used could contribute to the dif•
ferences noted in the data between the two laboratories.
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Fluorescent lighting was used as a light

~ource

in the in-

itial study (Roberts, personal communication), while full
spectrum. daylight (Vitalite) was used in the current study
(cf. Figure 1).

Although this difference might seem unim-

portant, the effects of altered spectrum. of light can be
marked in certain biological systems (cf. section II-A-2).
Two consistent findings were noted with higher
doses (50-70 mg./Kg.) of AOAA: an increase in extensor
latency and tonic•extension times (Table 13).

The in-

'

creased extensor latency time is not surprising in light
of the action of AOAA in increasing GABA content of the
CNS (Kuriyama

.ll .!J:..,

1966).

The role of increased content

of this putative inhibitory substance in seizure mechanisms has already been described (cf. section II-D-5).
However, the increased duration of tonic extension is quite
interesting as many drugs that prolong extensor latency
time cause a decreased tonic extension time (.!!!!!supra).
However, both tonic phases (flexion and extension) of MES
seizure are enhanced by the drug.
tonic phase seems to be quite an

This prolongation of the
ano~alous

response in

light of GABA's inhibitory actions, and a study of the
~

actual role of GABA in the timing of seizure components
would prove to be a most informative and valuable study.
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E.

A Critique .2! the

~

.Qf Twenty-four

1!Q!!!: Rhythms ..!!! Research
Studies of the 24-hour fluctuations in the content
of biochemically important substances are necessary for a
true assessment of the dynamic relationships involved in
homeostasis.

Studies of this type allow the investigator

to observe a dynamic rather than the static picture usually
observed in studies done at a single timepoint.

•

All too

often, investigators observe static phenomena at a specified timepoint and fail to denote the time of their observation in their reports.

Misleading estimates of par-

ameters result when one attempts to evaluate data obtained
by different research groups at undefined times.

In con-

trast to the incomplete information gleaned from a single
timepoint study, the knowledge of circadian patterns allows
the investigator to establish dynamic interrelationships in
biochemical and/or physiological systems, and permits him
to select an optimal time for the study of a given system.
A certain amount of caution must be exercised in
the interpretation of 24-hour fluctuations in biochemical
levels since the contenttof the substance is not the only
critical factor.
:~

receptor l•Tel

The actual mechanisms occurring at the

t~r

these aubatancee are also quite impor-

tant, and measurement of the total content of a eubetanoe
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yields little information concerning the intrinsic activity
at a given time.

Furthermore, the presence of simultan-

eous rhythms of different biochemical substances in mutually \antagonistic or ·synergistic systems can obscure the
specificity of a related physiological rhythm.
studies in chronotherapeutics are just beginning to
elicit useful information concerning diurnal and nocturnal
drug dosage schedules.

The relative importance of an ap-

preciation of circ\.dian rhythms in drug metabolism becomes apparent in the latter sections of the discussion
(~supra).

Monitoring of the rhythms in drug responses

allows for some speculation concerning the drug's relationship to biochemical parameters, and studies of this type
might eventually aid in clarifying the actual mechanism of
action of certain drugs.

It is apparent from this study

that drugs, which affect a specific neurochemical system,
are more likely to follow the circadian fluctuations of
that system than drugs, which' have non-specific actions.
This latter group appears to affect multiple neurochemical
systems and their rhythms, if present at all, are more difficult to define due to .the possibility· of actions on many
(

systems that might have differential patterns with differing
maxima and periods.
.::.

In conclusion, the current atudy in-

dicates the need for further research in the area o.f chronopharmacology

a~d

chronotherapeutics.

•
CJIAPTER SIX
SUMMARY

.. ·
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1.

The study involved an initial adaptation of adult rats

and mice to controlled laboratory conditions for three
weeks prior to analyses of regional brain content of transmitter suspects or to evaluation of convulsant and anticonvulsant activity.

Full spectrum lighting was used.

Two lighting cycles that were 1800 out of phase with each
other were used to determine the endogenous or exogenous
character of some of the measured parameters.
cycle lasted from

~800-2000

The normal

hours, and the reverse cycle

from 2000-0800 hours.
2.

The.catecholamine (either DM.or NE) content of various

areas of the rat brain was found to vary in a circadian
fashion.

The

lev~ls

of these amines in the corpus stria-

tum varied in an exogenous circadian pattern, while that of
the _upper brainstem (US) and lower
an endogenous circadian one.

brain~tem

(LS) exhibited

The peak of the striatal

rhythm was noted during the nocturnal phase, while that of
the brainstem rhythm occurred at 2400 or 0600 hours, regardless of the lighting cycle used.

3.

Serotonin levels of rat brain exhibited differential

'
circadian patterns depending
upon the region examined.
Striatal and upper brainstem 5-HT content varied in an exogenous circadian pattern with a diurnal peak.

The rhythm
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of 5-HT levels of the LS exhibited a circadian pattern with
a nocturnal peak on the normal light cycle.

Reversal of

the light cycle appeared to cause a flattening of the
rhythm, possibly because of the presence in this ti'saue of
concomitant endogenous and exogenous rhythms.
4.

The GABA levels of the rat frontal cerebral lobe,

cerebellum, and corpora quadrigemina fluctuated in an exogenous circadian pattern with a nocturnal maxima.

The

GABA rhythm of the TH-HT appeared to represent the interaction of two or more patterns, since an exogenous circadian
pattern !!!h marked fluctuation was noted in this area.
5.

Circadian patterns were found in glycine levels in most

regions of the CNS examined.

Patterns with sharp nocturnal

peaks were noted in the pons and thoracic cord, while
rhythms with sustained maximal levels throughout the dark
phase were found in the cervical and lumbar enlargements.
No definitive pattern was noted in the medulla.

The

rhythms of the spinal cord enlargements were thought to
be related to the inhibitory functions of glycine in interneuronal inhibition.
6.

Photoperiod reversal appeared to cause some alterations

in catecholamine metabolism, while it had little effect
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on the levels of 5-HT or GABA.

Dopamine content of the

CS and LS is significantly elevated by the reversed light
cycle.

Norepinephrine levels of ' the CS and LS also ex-

hibited a significantly increased peak level over that seen
on the normal cycle, while the basal level of NE in the US
was elevated by photoperiod reversal.

These effects on

regional catecholamine content are indicative of the adaptation stress due to photoperiod reversal.
7.

An examination of the susceptibility of vehicle-

treated mice to MES seizure in different phases of the
programmed lighting schedule revealed only one significant
alteration in seizure component timing.

The extensor lat-

ency time was shorter in duration during the dark phase.
No change was noted in the minimal electroshock seizure
threshold.

A comparison of the two control groups, saline-

treated versus acacia-treated, revealed a significantly
increased tonic extension time in the acacia-treated group.
8.

Peak toxicity of the convulsant compounds allylglycine

and strychnine in mice occurred during the light phase.
This peak toxicity corresponded with the phase in which
t

minimal GABA and glycine level,s occur in rodent species.
The data suggest that information regarding the action of
such agents on biochemical systems can be obtained in
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studies of 24-hour fluctuation in drug effect.

9.

The anti-convulsant action of acetazolamide, diphenyl-

hydantoin, and phenobarbital in the rat or mouse was unchanged when evaluated in light and dark phases.

Diphenyl-

hydantoin and phenobarbital gave similar changes in seizure
component times in both rodent species:

increased ex-

tensor latency during both phases in both species, and increased duration of clonus with decreased tonic extension
time in both phases in the mouse and during the light
phase in the rat.

These phase differences in the rat ·sug-

gest some finer differences in the metabolism or responsiveness between the two species.
10.

The PD50 of meprobamate was significantly elevated

during the dark phase in the mouse.

A similar elevation of

borderline significance occurred in the rat.

This fluc-

tuation of the PD50 appeared to be due to an alteration of
the animal's responsiveness to the general depressant actions of meprobamate.
11.

Amino-oxyacetic acid pretreatment .in mice prolonged

the tonic extension
greater than 50

phas~,

mg~/Kg.

when administered in doses of

No discernible circadian differ-

ences were noted in thie response.

Although potent anti-

convulsant actions have been attributed to this agent when

r

;
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seizure is induced

~ia

skull electrodes, these effects are

apparently lacking when MES is administered via corneal
electrodes.

CHAPTER SEVEN

APPENDIX
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Appendix !
Cortical GABA levels of rate on a "normal" illumination
cycle.*

Table 14.

GABA levels are expressed in micromoles/gram

WTW plus or minus their respective standard deviation
(n

= 6).
TIME

GABA, mcM./gm. WTW

0600

2.68 ± 0.26

1200

2. 33

± 0.43

1800

2.38

± 0.45

2400

2.47 ± 0.32

[)

*This study was conducted in the month of March, 1970.

~
I

[;.

r
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Appendix

~

A comparison of the circadian fluctuations of dopamine and homovanillic acid levels in rat CS revealed an
inverse relationship (Figure 27 & 28).
;

HVA levels were determined by the method of Juorio
and co-workers (1966).

The method involved the separation

of HVA from an acetic acid brain extract on a Dowex 1X2
column (0.4 x 2.0-2.5 cm.).

The column was washed with

distilled water, and HVA was eluted with 0.1N HCl.

A

portion of the acid eluate was developed for fluorimetric
quantification by addition of 5N NH40H containing FeCl3,
20 mcg./ml.

The reaction was stopped after four minutes

by addition of 0.1% cysteine hydrochloride, and fluorescense was read at }20 mm. (excitation) and

4~5

sche~e

2).

sion) on an Aminco-Bowman SPF (slit

mm. (emis-

The biphasic rhythm was probably produced by the
housing of these animals in our general research laboratory.

Thus, a peak occurred at the mid-dark phase, with

a supplemental peak occurring in the midafternoon, when
environmental stimuli and feeding led to arousal in these
normally quiescent animals.

These circumstances caused

an increase.in motor activit7 during the afternoon.

i

l
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Figure 27.

.

The concentration of DM and HVA in the rat cor-

pus etriatum ae a function of time.

DM content ie expres-

sed in mcg./gm. WTW on the 1eft ordinate.

The concentra-

tion of HVA in mcg./gm. WTW is expressed on the right ordinate.

~

The black

~

is expressed on the abscissa in hours CST.
indicates the dark phase of the illumination
~

cycle.

yertical brackets are used to indicate the stan-

dard error of the mean (n = 6).
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Figure 28.

18

9

The concentration of DM and HVA in rat corpus

striatum as a function of time.

The levels of DM and HVA

from the previous figure are expressed 'as a percentage of
<

the minimal, or trough, value.
cated on the ordinate.
vious figure.

The percentage is indi-

The abscissa is as for the pre-
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Q

The analysis of variance (ANOV) was also performed
on the pooled

~

to investigate the significance of the

differences noted between tissues, phases, and cy.cles.
Interactions between tissues and phases, tissues and cycles,
phases and cycles, and.tissues and phases and cycles were
also examined by this method.
The 3-way ANOV determination was performed at the
University of Illinois College of Pharmacy, using a standardized program on.the Wang 700-A computer (a description
of this technique can be found in "Biostatics in Pharmacological Testing" by
~l

c.w.

Dunnett in Selected Pharmacolott-

Testing Methods, Volume 3, Marcel Dekker, Inc.:

New

York, 1968).
The P-values are summarized in Table 15.
dent from this table that

s~atistically

It is evi-

significant dif-·

ferences were noted only between pooled levels of DM and of
glycine.

Significant differences between the normal and

reverse cycles were noted in the case of DM and GABA levels
of the CTX and CBLM indicating the possibility of a lunar
or annual influence in these rhythms,
t

A tissue-phase interaction was noted in the case of
D~

content.

Thie is not surprising as other statistical
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5-HT

GABA

(CQ/

COMPARISONS

~

TH-HT)

(CTX/
CBLM)

-GLY

Tissuetissue

( 0.01

<0.01

<0.01

<0.01

<0.01

0.05

~!~~tph~::e-

<0.01

>0.05

>0.05

0.05

>0.05

0.05

0.05

>0.05

)0.05

)0.05

(0.01

Tissuephase

(0.01

>0.05

>0.05

>0.05

>0.05 >0.05

Tissuecycle

>0.05

>0.05

>0.05

)0.05 >0.05

Phasecycle

>0.05

<0.01

>0.05

>0.05

)0.05

Tissuephas ecycle

>0.05

0.01

>0.05

)0.05

>0.05

Normal cycleReverse cycle
INTERACTIONS

Table 15.

Summary of probability values determined by

analysis of variance.

Compounds are. indicated horizontal(

ly and the various items compared are described in the
vertical column at the left.
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procedures had indicated a reversal in only one of the
rhythms tested.

When tissue-cycle interactions were tested,

no significant differences were found.

NE levels exhibited

significant differences when tested for both phase-cycle
and tissue-phase-cycle interactions.
From this finding it is apparent that reversal in the
amine rhythm was not complete for the period of the reversed
illumination cycle used.

This fact was evident and noted

earlier when it was shown that reversal of the brainstem
NE did not occur.
This analysis differs from that utilized in the thesis
in that only pooled data was considered.
ever, are in
Section.

g~neral

The findings, how-

agreement with those of the Results

Some of the significant differences obtained be-

tween peak and trough values by techniques normally used in
chronobiology are lost when data is thusly pooled •
•
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